References

Abbotts, A. P., and N. D. Stow. 1995. The origin-binding domain of the herpes simplex virus type 1 UL9 protein is not required for DNA helicase activity. J Gen Virol. 76(Pt 12):3125-30.
Abe, T., K. Tsuchida, and M. Tamai. 1996. A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis. Graefes Arch Clin Exp Ophthalmol. 234(7):419-24.
Aboody-Guterman, K. S., P. A. Pechan, N. G. Rainov, M. Sena-Esteves, A. Jacobs, E. Y. Snyder, P. Wild, E. Schraner, K. Tobler, X. O. Breakefield, and C. Fraefel. 1997. Green fluorescent protein as a reporter for retrovirus and helper virus- free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. Neuroreport. 8(17):3801-8.
Aboudy, Y., E. Mendelson, I. Shalit, R. Bessalle, and M. Fridkin. 1994. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int J Pept Protein Res. 43(6):573-82.
Abrahams, P. J., A. Houweling, D. M. Cornelissen-Steijger, F. Arwert, F. H. Menko, H. M. Pinedo, C. Terleth, and A. J. van der Eb. 1996. Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromes. Cancer Res. 56(11):2621-5.
Abrahams, P. J., A. Houweling, P. D. Cornelissen-Steijger, N. G. Jaspers, F. Darroudi, C. M. Meijers, L. H. Mullenders, R. Filon, F. Arwert, H. M. Pinedo, A. P. Natarajan, C. Terleth, A. A. Van Zeeland, and A. J. van der Eb. 1998. Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes. Mutat Res. 407(2):189-201.
Ackermann, M., D. K. Braun, L. Pereira, and B. Roizman. 1984. Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol. 52(1):108-18.
Ackermann, M., R. Longnecker, B. Roizman, and L. Pereira. 1986. Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology. 150(1):207-20.
Ackland-Berglund, C. E., D. J. Davido, and D. A. Leib. 1995. The roles of the cAMP-response element and TATA box in expression of the herpes simplex virus type 1 latency-associated transcripts. Virology. 210(1):141-51.
Adams, R., C. Cunningham, M. D. Davison, C. A. MacLean, and A. J. Davison. 1998. Characterization of the protein encoded by gene UL49A of herpes simplex virus type 1. J Gen Virol. 79(Pt 4):813-23.
Addison, C., F. J. Rixon, J. W. Palfreyman, M. O'Hara, and V. G. Preston. 1984. Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids. Virology. 138(2):246-59.
Advani, S. J., R. Brandimarti, R. R. Weichselbaum, and B. Roizman. 2000. The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1- infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J Virol. 74(1):8-15.
Aguilar, J. S., M. Rice, and E. K. Wagner. 1999. The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells. Virology. 258(1):141-51.
Ahn, B. M., H. U. Chung, S. Y. Kim, W. S. Shin, B. S. Lee, K. W. Chung, J. H. Kang, and H. W. Hwang. 1994. Acute herpetic esophagitis--a case report. Korean J Intern Med. 9(2):120-4.
Akanitapichat, P., C. T. Lowden, and K. F. Bastow. 2000. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication. Antiviral Res. 45(2):123-34.
Akkaraju, G. R., J. Huard, E. P. Hoffman, W. F. Goins, R. Pruchnic, S. C. Watkins, J. B. Cohen, and J. C. Glorioso. 1999. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. J Gene Med. 1(4):280-9.
al-Shawi, R., J. Burke, H. Wallace, C. Jones, S. Harrison, D. Buxton, S. Maley, A. Chandley, and J. O. Bishop. 1991. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter. Mol Cell Biol. 11(8):4207-16.
Albrecht, M. A., N. A. DeLuca, R. A. Byrn, P. A. Schaffer, and S. M. Hammer. 1989. The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol. 63(5):1861-8.
Albright, A. G., and F. J. Jenkins. 1993. The herpes simplex virus UL37 protein is phosphorylated in infected cells. J Virol. 67(8):4842-7.
Aleshkov, S. B., M. B. Ustab, and A. A. Baev. 1991. [Recombinant murine cell lines transformed by various vectors based on bovine papillomavirus type 1 and expressing human tissue plasminogen activator]. Mol Biol (Mosk). 25(5):1239-47.
Ali, M. A., B. Forghani, and E. M. Cantin. 1996. Characterization of an essential HSV-1 protein encoded by the UL25 gene reported to be involved in virus penetration and capsid assembly. Virology. 216(1):278-83.
Allen, R. G., C. Carey, J. D. Parker, M. T. Mortrud, S. H. Mellon, and M. J. Low. 1995. Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrinol. 9(8):1005-16.
Allen, K. E., and R. D. Everett. 1997. Mutations which alter the DNA binding properties of the herpes simplex virus type 1 transactivating protein Vmw175 also affect its ability to support virus replication. J Gen Virol. 78(Pt 11):2913-22.
Alvira, M. R., W. F. Goins, J. B. Cohen, and J. C. Glorioso. 1999. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. J Virol. 73(5):3866-76.
Amoros, M., E. Lurton, J. Boustie, L. Girre, F. Sauvager, and M. Cormier. 1994. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J Nat Prod. 57(5):644-7.
Amundsen, S. K., and D. S. Parris. 1984. Detection of herpes simplex virus intertypic recombinant genomes in infected cell DNA. J Virol Methods. 8(1-2):19-25.
Anders, D. G., and W. Gibson. 1988. Location, transcript analysis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similarities to ICP8 of herpes simplex virus type 1. J Virol. 62(4):1364-72.
Andoh, T., K. Shiraki, M. Kurokawa, and Y. Kuraishi. 1995. Paresthesia induced by cutaneous infection with herpes simplex virus in rats. Neurosci Lett. 190(2):101-4.
Andreansky, S., L. Soroceanu, E. R. Flotte, J. Chou, J. M. Markert, G. Y. Gillespie, B. Roizman, and R. J. Whitley. 1997. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 57(8):1502-9.
Andrei, G., R. Snoeck, E. De Clercq, R. Esnouf, P. Fiten, and G. Opdenakker. 2000. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J Gen Virol. 81 Pt 3:639-48.
Ankel, H., D. F. Westra, S. Welling-Wester, and P. Lebon. 1998. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology. 251(2):317-26.
Annunziato, P., O. Lungu, A. Gershon, D. N. Silvers, P. LaRussa, and S. J. Silverstein. 1996. In situ hybridization detection of varicella zoster virus in paraffin- embedded skin biopsy samples. Clin Diagn Virol. 7(2):69-76.
Anthony, D. D., W. B. Wentz, J. W. Reagan, and A. D. Heggie. 1989. Induction of cervical neoplasia in the mouse by herpes simplex virus type 2 DNA. Proc Natl Acad Sci U S A. 86(12):4520-4.
Antunes Bras, J. M., A. L. Epstein, S. Bourgoin, M. Hamon, F. Cesselin, and M. Pohl. 1998. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem. 70(3):1299-303.
Aono, T., S. Murakami, N. Yanagihara, and K. Yamanishi. 1994. Detection of human alpha-herpesvirus DNA using consensus primers and specific probes. Acta Otolaryngol Suppl. 514:132-4.
Apeler, H., U. Gottschalk, D. Guntermann, J. Hansen, J. Massen, E. Schmidt, K. H. Schneider, M. Schneidereit, and H. Rubsamen-Waigmann. 1997. Expression of natural and synthetic genes encoding herpes simplex virus 1 protease in Escherichia coli and purification of the protein. Eur J Biochem. 247(3):890-5.
Aranda-Anzaldo, A., and M. A. Dent. 1997. Loss of DNA loop supercoiling and organization in cells infected by herpes simplex virus type 1. Res Virol. 148(6):397-408.
Aranda-Anzaldo, A. 1998. The normal association between newly replicated DNA and the nuclear matrix is abolished in cells infected by herpes simplex virus type 1. Res Virol. 149(4):195-208.
Argnani, R., F. Focher, S. Zucchini, A. Verri, G. E. Wright, S. Spadari, and R. Manservigi. 1995. Herpes simplex virus type 1 (HSV-1) uracil-DNA glycosylase: functional expression in Escherichia coli, biochemical characterization, and selective inhibition by 6-(p-n-octylanilino)uracil. Virology. 211(1):307-11.
Armaka, M., E. Papanikolaou, A. Sivropoulou, and M. Arsenakis. 1999. Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1. Antiviral Res. 43(2):79-92.
Arnosti, D. N., C. M. Preston, M. Hagmann, W. Schaffner, R. G. Hope, G. Laughlan, and B. F. Luisi. 1993. Specific transcriptional activation in vitro by the herpes simplex virus protein VP16. Nucleic Acids Res. 21(24):5570-6.
Arrunategui-Correa, V., J. Dutt, and C. S. Foster. 1994. The role of B lymphocytes in experimental herpes simplex viral retinitis. Scand J Immunol. 40(3):299-307.
Arrunategui-Correa, V., J. E. Dutt, and C. S. Foster. 1997. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis. Acta Virol. 41(3):145-52.
Arrunategui-Correa, V., S. Baltatzis, and C. S. Foster. 1999. The role of cytokines in experimental herpes simplex keratitis. Acta Virol. 43(5):325-9.
Arsenakis, M., J. Hubenthal-Voss, G. Campadelli-Fiume, L. Pereira, and B. Roizman. 1986. Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol. 60(2):674-82.
Arsenakis, M., G. Campadelli-Fiume, and B. Roizman. 1988. Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively? J Virol. 62(1):148-58.
Arthur, J. L., R. Everett, I. Brierley, and S. Efstathiou. 1998. Disruption of the 5' and 3' splice sites flanking the major latency- associated transcripts of herpes simplex virus type 1: evidence for alternate splicing in lytic and latent infections. J Gen Virol. 79(Pt 1):107-16.
Ashida, N., S. Sakata, and H. Machida. 1997. Metabolic fate of [3H]1-beta-D-arabinofuranosyl-5-[(E)-2- bromovinyl]uracil in herpes simplex virus type 1-infected cells. Microbiol Immunol. 41(12):957-64.
Aubert, M., J. O'Toole, and J. A. Blaho. 1999. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol. 73(12):10359-70.
Aubert, M., and J. A. Blaho. 1999. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol. 73(4):2803-13.
Audonnet, J. C., J. Winslow, G. Allen, and E. Paoletti. 1990. Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. J Gen Virol. 71(Pt 12):2969-78.
Avitabile, E., P. L. Ward, C. Di Lazzaro, M. R. Torrisi, B. Roizman, and G. Campadelli-Fiume. 1994. The herpes simplex virus UL20 protein compensates for the differential disruption of exocytosis of virions and viral membrane glycoproteins associated with fragmentation of the Golgi apparatus. J Virol. 68(11):7397-405.
Azumi, A., and S. S. Atherton. 1994. Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: requirement for either CD4+ or CD8+ T cells. Invest Ophthalmol Vis Sci. 35(8):3251-9.
Babu, J. S., J. Thomas, S. Kanangat, L. A. Morrison, D. M. Knipe, and B. T. Rouse. 1996. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol. 70(1):101-7.
Bachmann, M., H. Deister, A. Pautz, J. Laubinger, M. Schmitz, D. Falke, J. Podlech, and D. Grolz. 1998. The human autoantigen La/SS-B accelerates herpes simplex virus type 1 replication in transfected mouse 3T3 cells. Clin Exp Immunol. 112(3):482-9.
Baghian, A., J. Jaynes, F. Enright, and K. G. Kousoulas. 1997. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread. Peptides. 18(2):177-83.
Bahr, B. A., R. L. Neve, J. Sharp, A. I. Geller, and G. Lynch. 1994. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Brain Res Mol Brain Res. 26(1-2):277-85.
Bailey, A. C., and R. Thompson. 1992. A sequence-specific DNA-binding protein recognising a GA-rich element cooperates with Oct-1 at the herpes simplex virus type 1 IE3 promoter. Intervirology. 34(2):74-85.
Baines, J. D., and B. Roizman. 1992. The cDNA of UL15, a highly conserved herpes simplex virus 1 gene, effectively replaces the two exons of the wild-type virus. J Virol. 66(9):5621-6.
Baines, J. D., A. P. Poon, J. Rovnak, and B. Roizman. 1994. The herpes simplex virus 1 UL15 gene encodes two proteins and is required for cleavage of genomic viral DNA. J Virol. 68(12):8118-24.
Baines, J. D., A. H. Koyama, T. Huang, and B. Roizman. 1994. The UL21 gene products of herpes simplex virus 1 are dispensable for growth in cultured cells. J Virol. 68(5):2929-36.
Baines, J. D., C. Cunningham, D. Nalwanga, and A. Davison. 1997. The U(L)15 gene of herpes simplex virus type 1 contains within its second exon a novel open reading frame that is translated in frame with the U(L)15 gene product. J Virol. 71(4):2666-73.
Baker, R. O., and J. D. Hall. 1998. Impaired mismatch extension by a herpes simplex DNA polymerase mutant with an editing nuclease defect. J Biol Chem. 273(37):24075-82.
Balan, P., N. Davis-Poynter, S. Bell, H. Atkinson, H. Browne, and T. Minson. 1994. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol. 75(Pt 6):1245-58.
Balzarini, J., E. de Clercq, D. Ayusawa, and T. Seno. 1985. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth- inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. FEBS Lett. 185(1):95-100.
Balzarini, J., E. De Clercq, A. Verbruggen, D. Ayusawa, K. Shimizu, and T. Seno. 1987. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Mol Pharmacol. 32(3):410-6.
Baradaran, K., C. E. Dabrowski, and P. A. Schaffer. 1994. Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPC. J Virol. 68(7):4251-61.
Barequet, I. S., Q. Li, Y. Wang, T. P. O'Brien, J. J. Hooks, and W. J. Stark. 2000. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 129(5):672-3.
Baringer, J. R. 1996. Herpes simplex virus and Bell palsy [editorial; comment]. Ann Intern Med. 124(1 Pt 1):63-5.
Barinskii, I. F., V. V. Bakaev, T. A. Posevaia, S. A. Klincheva, N. P. Nikolaeva, V. V. Dlinn, and N. V. Shebalina. 1994. [Selection of primers and their use in the polymerase chain reaction for diagnosing infections caused by herpes simplex virus and cytomegalovirus]. Vopr Virusol. 39(6):245-7.
Barnard, E. C., G. Brown, and N. D. Stow. 1997. Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins. Virology. 237(1):97-106.
Barnett, B. C., A. Dolan, E. A. Telford, A. J. Davison, and D. J. McGeoch. 1992. A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses. J Gen Virol. 73(Pt 8):2167-71.
Baron, J. M., A. Rubben, and E. I. Grussendorf-Conen. 1996. Evaluation of a new general primer pair for rapid detection and differentiation of HSV-1, HSV-2, and VZV by polymerase chain reaction [published erratum appears in J Med Virol 1997 Feb;51(2):137]. J Med Virol. 49(4):279-82.
Bartoletti, A. M., M. Tognon, R. Manservigi, and A. Mannini-Palenzona. 1985. Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV- 1(MP)]. Virology. 141(2):306-10.
Bastide, L., P. E. Boehmer, G. Villani, and B. Lebleu. 1999. Inhibition of a DNA-helicase by peptide nucleic acids. Nucleic Acids Res. 27(2):551-4.
Bataille, D., and A. Epstein. 1994. Herpes simplex virus replicative concatemers contain L components in inverted orientation. Virology. 203(2):384-8.
Bataille, D., and A. L. Epstein. 1995. Herpes simplex virus type 1 replication and recombination. Biochimie. 77(10):787-95.
Batchelor, A. H., K. W. Wilcox, and P. O'Hare. 1994. Binding and repression of the latency-associated promoter of herpes simplex virus by the immediate early 175K protein. J Gen Virol. 75(Pt 4):753-67.
Bates, P. A., and N. A. DeLuca. 1998. The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia. J Virol. 72(9):7115-24.
Batterson, W., and B. Roizman. 1983. Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes. J Virol. 46(2):371-7.
Baxi, M. K., S. Efstathiou, G. Lawrence, J. M. Whalley, J. D. Slater, and H. J. Field. 1995. The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J Gen Virol. 76(Pt 12):3113-8.
Beaudet-Miller, M., R. Zhang, J. Durkin, W. Gibson, A. D. Kwong, and Z. Hong. 1996. Virus-specific interaction between the human cytomegalovirus major capsid protein and the C terminus of the assembly protein precursor. J Virol. 70(11):8081-8.
Beck, T. W., and R. L. Millette. 1982. Regulation of herpes simplex virus gene transcription in vitro. J Cell Biochem. 19(4):333-47.
Becker, Y., Y. Shtram, A. Honigman, A. Laban, and A. Cohen. 1983. Herpes simplex virus type 1 thymidine kinase gene expression in Escherichia coli. Gene. 21(1-2):51-8.
Becker, Y., J. Hadar, E. Tabor, T. Ben-Hur, I. Raibstein, A. Rosen, and G. Darai. 1986. A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice. Virology. 149(2):255-9.
Becker, Y., E. Tavor, Y. Asher, C. Berkowitz, and M. Moyal. 1993. Effect of herpes simplex virus type-1 UL41 gene on the stability of mRNA from the cellular genes: beta-actin, fibronectin, glucose transporter-1, and docking protein, and on virus intraperitoneal pathogenicity to newborn mice. Virus Genes. 7(2):133-43.
Becker, Y., Y. Asher, S. Bujanover, and G. Darai. 1999. The dynamic herpesvirus DNA genome: the case of MDV-1 and HSV-1. Acta Virol. 43(2-3):81-9.
Belec, L., J. Authier, M. C. Eliezer-Vanerot, C. Piedouillet, A. S. Mohamed, and R. K. Gherardi. 1998. Myoglobin as a polymerase chain reaction (PCR) inhibitor: a limitation for PCR from skeletal muscle tissue avoided by the use of Thermus thermophilus polymerase. Muscle Nerve. 21(8):1064-7.
Ben Hur, T., J. Rosenthal, A. Itzik, and J. Weidenfeld. 1996. Adrenocortical activation by herpes virus: involvement of IL-1 beta and central noradrenergic system. Neuroreport. 7(4):927-31.
Ben-Hur, T., Y. Asher, E. Tabor, G. Darai, and Y. Becker. 1987. HSV-1 virulence for mice by the intracerebral route is encoded by the BamHI-L DNA fragment containing the cell fusion gene. Arch Virol. 96(1-2):117-22.
Ben-Hur, T., A. Rosen-Wolff, W. Lamade, G. Darai, and Y. Becker. 1988. HSV-1 DNA sequence determining intraperitoneal pathogenicity in mice is required for transcription of viral immediate-early genes in macrophages. Virology. 163(2):397-404.
Ben-Porat, T., R. A. Veach, and S. Ihara. 1983. Localization of the regions of homology between the genomes of herpes simplex virus, type 1, and pseudorabies virus. Virology. 127(1):194-204.
Bennett, A. M., L. Harrington, and D. C. Kelly. 1992. Nucleotide sequence analysis of genes encoding glycoproteins D and J in simian herpes B virus. J Gen Virol. 73(Pt 11):2963-7.
Berkowitz, C., M. Moyal, A. Rosen-Wolff, G. Darai, and Y. Becker. 1994. Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice. Arch Virol. 134(1-2):73-83.
Berkowitz-Balshayi, C., A. Rosen-Wolff, G. Darai, and Y. Becker. 1995. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs. In Vivo. 9(2):155-62.
Berman, P. W., D. Dowbenko, L. A. Lasky, and C. C. Simonsen. 1983. Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D. Science. 222(4623):524-7.
Berra, A., J. E. Dutt, and C. S. Foster. 1996. Detection of herpes simplex virus type 1 by an in situ polymerase chain reaction technique. Cornea. 15(1):55-61.
Berthomme, H., B. Jacquemont, and A. Epstein. 1993. The pseudorabies virus host-shutoff homolog gene: nucleotide sequence and comparison with alphaherpesvirus protein counterparts. Virology. 193(2):1028-32.
Berthomme, H., S. J. Monahan, D. S. Parris, B. Jacquemont, and A. L. Epstein. 1995. Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction. J Virol. 69(5):2811-8.
Berthomme, H., S. Fournel, and A. L. Epstein. 1996. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Virology. 216(2):437-43.
Berthomme, H., J. Lokensgard, L. Yang, T. Margolis, and L. T. Feldman. 2000. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency. J Virol. 74(8):3613-22.
Besse, S., M. Vigneron, E. Pichard, and F. Puvion-Dutilleul. 1995. Synthesis and maturation of viral transcripts in herpes simplex virus type 1 infected HeLa cells: the role of interchromatin granules. Gene Expr. 4(3):143-61.
Besse, S., J. J. Diaz, E. Pichard, K. Kindbeiter, J. J. Madjar, and F. Puvion-Dutilleul. 1996. In situ hybridization and immuno-electron microscope analyses of the Us11 gene of herpes simplex virus type 1 during transient expression. Chromosoma. 104(6):434-44.
Bevilacqua, F., N. Davis-Poynter, J. Worrallo, D. Gower, P. Collins, and G. Darby. 1995. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV. J Gen Virol. 76(Pt 8):1927-35.
Bhattacharya, B. K., J. O. Ojwang, R. F. Rando, J. H. Huffman, and G. R. Revankar. 1995. Synthesis and anti-DNA viral activities in vitro of certain 2,4- disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides. J Med Chem. 38(20):3957-66.
Bhella, D., F. J. Rixon, and D. J. Dargan. 2000. Cryomicroscopy of human cytomegalovirus virions reveals more densely packed genomic DNA than in herpes simplex virus type 1. J Mol Biol. 295(2):155-61.
Biesiadecka, A., and B. Litwinska. 1997. Application of polymerase chain reaction for the detection of herpes simplex virus DNA. Acta Microbiol Pol. 46(4):405-8.
Bjornberg, O., A. C. Bergman, A. M. Rosengren, R. Persson, I. R. Lehman, and P. O. Nyman. 1993. dUTPase from herpes simplex virus type 1; purification from infected green monkey kidney (Vero) cells and from an overproducing Escherichia coli strain. Protein Expr Purif. 4(2):149-59.
Black, M. E., and L. A. Loeb. 1993. Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro. Biochemistry. 32(43):11618-26.
Black, M. E., T. M. Rechtin, and R. R. Drake. 1996. Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase. J Gen Virol. 77(Pt 7):1521-7.
Black, M. E., T. G. Newcomb, H. M. Wilson, and L. A. Loeb. 1996. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A. 93(8):3525-9.
Black, D. H., and R. Eberle. 1997. Detection and differentiation of primate alpha-herpesviruses by PCR. J Vet Diagn Invest. 9(3):225-31.
Blackburn, R. V., S. S. Galoforo, P. M. Corry, and Y. J. Lee. 1998. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res. 58(7):1358-62.
Blaho, J. A., C. Mitchell, and B. Roizman. 1994. An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products. J Biol Chem. 269(26):17401-10.
Blaho, J. A., C. S. Zong, and K. A. Mortimer. 1997. Tyrosine phosphorylation of the herpes simplex virus type 1 regulatory protein ICP22 and a cellular protein which shares antigenic determinants with ICP22. J Virol. 71(12):9828-32.
Block, T., J. Brzykcy, N. Hastie, and R. G. Hughes, Jr. 1985. Genetic linkage but independent expression of functional HSV-1 tk and mammalian aprt genes after cotransfer to L cells. Can J Microbiol. 31(4):311-6.
Block, T., and R. Jordan. 1988. Herpes simplex virus type 1 alpha gene containing plasmids can inhibit expression regulated from an alpha promoter in CV-1 but not HeLa cells. Virus Res. 11(4):269-79.
Block, T., R. Jordan, D. H. Farkas, and R. G. Hughes, Jr. 1991. Inhibition of transient gene expression with plasmids encoding herpes simplex virus type 1 UL55 and alpha genes. J Gen Virol. 72(Pt 1):131-41.
Block, T., S. Barney, J. Masonis, J. Maggioncalda, T. Valyi-Nagy, and N. W. Fraser. 1994. Long term herpes simplex virus type 1 infection of nerve growth factor- treated PC12 cells. J Gen Virol. 75(Pt 9):2481-7.
Bloom, D. C., and J. G. Stevens. 1994. Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol. 68(6):3761-72.
Bloom, D. C., G. B. Devi-Rao, J. M. Hill, J. G. Stevens, and E. K. Wagner. 1994. Molecular analysis of herpes simplex virus type 1 during epinephrine- induced reactivation of latently infected rabbits in vivo. J Virol. 68(3):1283-92.
Bloom, D. C., J. M. Hill, G. Devi-Rao, E. K. Wagner, L. T. Feldman, and J. G. Stevens. 1996. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol. 70(4):2449-59.
Bloom, D. C., and R. G. Jarman. 1998. Generation and use of recombinant reporter viruses for study of herpes simplex virus infections in vivo. Methods. 16(1):117-25.
Bludau, H., and U. K. Freese. 1991. Analysis of the HSV-1 strain 17 DNA polymerase gene reveals the expression of four different classes of pol transcripts. Virology. 183(2):505-18.
Blumel, J., and B. Matz. 1995. Thermosensitive UL9 gene function is required for early stages of herpes simplex virus type 1 DNA synthesis. J Gen Virol. 76(Pt 12):3119-24.
Blumel, J., and B. Matz. 1996. Study on simian virus 40 DNA synthesis in herpes simplex virus-infected cells. Virology. 217(1):407-12.
Boehmer, P. E., M. S. Dodson, and I. R. Lehman. 1993. The herpes simplex virus type-1 origin binding protein. DNA helicase activity. J Biol Chem. 268(2):1220-5.
Boehmer, P. E., M. C. Craigie, N. D. Stow, and I. R. Lehman. 1994. Association of origin binding protein and single strand DNA-binding protein, ICP8, during herpes simplex virus type 1 DNA replication in vivo. J Biol Chem. 269(46):29329-34.
Boehmer, P. E. 1996. Expression, purification, and characterization of the herpes simplex virus type-1 DNA polymerase. Methods Enzymol. 275:16-35.
Boehmer, P. E., and I. R. Lehman. 1997. Herpes simplex virus DNA replication. Annu Rev Biochem. 66:347-84.
Boehmer, P. E. 1998. The herpes simplex virus type-1 single-strand DNA-binding protein, ICP8, increases the processivity of the UL9 protein DNA helicase. J Biol Chem. 273(5):2676-83.
Bogner, E., M. Reschke, B. Reis, T. Mockenhaupt, and K. Radsak. 1993. Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology. 196(1):290-3.
Bohenzky, R. A., M. Lagunoff, B. Roizman, E. K. Wagner, and S. Silverstein. 1995. Two overlapping transcription units which extend across the L-S junction of herpes simplex virus type 1. J Virol. 69(5):2889-97.
Bohn, M. C., Q. Lin, and H. J. Federoff. 1994. Stimulation of neurite growth rat adrenal chromaffin cells infected with a defective herpes simplex virus carrying an NGF minigene. Gene Ther. 1(Suppl 1):S70.
Bolovan, C. A., N. M. Sawtell, and R. L. Thompson. 1994. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol. 68(1):48-55.
Bond, V. C., S. Person, and S. C. Warner. 1982. The isolation and characterization of mutants of herpes simplex virus type 1 that induce cell fusion. J Gen Virol. 61(Pt 2):245-54.
Bonneau, R. H., T. M. Fu, and S. S. Tevethia. 1993. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope. Virology. 197(2):782-7.
Bonneau, A. M., P. Kibler, P. White, C. Bousquet, N. Dansereau, and M. G. Cordingley. 1996. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates. J Virol. 70(2):787-93.
Booy, F. P., B. L. Trus, A. J. Davison, and A. C. Steven. 1996. The capsid architecture of channel catfish virus, an evolutionarily distant herpesvirus, is largely conserved in the absence of discernible sequence homology with herpes simplex virus. Virology. 215(2):134-41.
Bordonaro, M., and J. L. Nordstrom. 1994. Different mechanisms are responsible for the low accumulation of transcripts from intronless and 3' splice site deleted genes. Biochem Biophys Res Commun. 203(1):128-32.
Botma, H. J., H. Dekker, P. van Amstel, I. Cairo, and F. M. van den Berg. 1995. Differential in situ hybridization for herpes simplex virus typing in routine skin biopsies. J Virol Methods. 53(1):37-45.
Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol. 155(8):3964-71.
Bower, J. R., H. Mao, C. Durishin, E. Rozenbom, M. Detwiler, D. Rempinski, T. L. Karban, and K. S. Rosenthal. 1999. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J Virol. 73(5):3843-53.
Brady, H. J., C. G. Miles, D. J. Pennington, and E. A. Dzierzak. 1994. Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci U S A. 91(1):365-9.
Brandimarti, R., T. Huang, B. Roizman, and G. Campadelli-Fiume. 1994. Mapping of herpes simplex virus 1 genes with mutations which overcome host restrictions to infection. Proc Natl Acad Sci U S A. 91(12):5406-10.
Brandimarti, R., and B. Roizman. 1997. Us9, a stable lysine-less herpes simplex virus 1 protein, is ubiquitinated before packaging into virions and associates with proteasomes. Proc Natl Acad Sci U S A. 94(25):13973-8.
Bratanich, A. C., N. D. Hanson, and C. J. Jones. 1992. The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1. Virology. 191(2):988-91.
Braun, K. M., J. L. Degen, and E. P. Sandgren. 2000. Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med. 6(3):320-6.
Brehm, M., L. A. Samaniego, R. H. Bonneau, N. A. DeLuca, and S. S. Tevethia. 1999. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0. Virology. 256(2):258-69.
Brewis, N., A. Phelan, J. Webb, J. Drew, G. Elliott, and P. O'Hare. 2000. Evaluation of VP22 spread in tissue culture. J Virol. 74(2):1051-6.
Brice, S. L., J. D. Jester, M. Friednash, L. E. Golitz, M. A. Leahy, S. S. Stockert, and W. L. Weston. 1993. Examination of cutaneous T-cell lymphoma for human herpesviruses by using the polymerase chain reaction. J Cutan Pathol. 20(4):304-7.
Bridges, K. G., Q. Hua, M. R. Brigham-Burke, J. D. Martin, P. Hensley, C. E. Dahl, P. Digard, M. A. Weiss, and D. M. Coen. 2000. Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase. J Biol Chem. 275(1):472-8.
Broker, M., K. J. Abel, R. Kohler, J. Hilfenhaus, and E. Amann. 1990. Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2. Med Microbiol Immunol. 179(3):145-59.
Bronstein, J. C., and P. C. Weber. 1996. Purification and characterization of herpes simplex virus type 1 alkaline exonuclease expressed in Escherichia coli. J Virol. 70(3):2008-13.
Bronstein, J. C., S. K. Weller, and P. C. Weber. 1997. The product of the UL12.5 gene of herpes simplex virus type 1 is a capsid-associated nuclease. J Virol. 71(4):3039-47.
Brown, S. M., J. Harland, and J. H. Subak-Sharpe. 1984. Isolation of restriction endonuclease site deletion mutants of herpes simplex virus. J Gen Virol. 65(Pt 6):1053-68.
Brown, S. M., J. Harland, A. R. MacLean, J. Podlech, and J. B. Clements. 1994. Cell type and cell state determine differential in vitro growth of non- neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol. 75(Pt 9):2367-77.
Brown, C. S., S. Welling-Wester, M. Feijlbrief, J. W. Van Lent, and W. J. Spaan. 1994. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology. 198(2):477-88.
Brown, S. M., A. R. MacLean, E. A. McKie, and J. Harland. 1997. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. J Virol. 71(12):9442-9.
Browne, H. M., B. C. Bruun, and A. C. Minson. 1996. Characterization of herpes simplex virus type 1 recombinants with mutations in the cytoplasmic tail of glycoprotein H. J Gen Virol. 77(Pt 10):2569-73.
Browne, H., S. Bell, T. Minson, and D. W. Wilson. 1996. An endoplasmic reticulum-retained herpes simplex virus glycoprotein H is absent from secreted virions: evidence for reenvelopment during egress. J Virol. 70(7):4311-6.
Brunetti, C. R., R. L. Burke, S. Kornfeld, W. Gregory, F. R. Masiarz, K. S. Dingwell, and D. C. Johnson. 1994. Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. J Biol Chem. 269(25):17067-74.
Bruni, R., and B. Roizman. 1996. Open reading frame P--a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc Natl Acad Sci U S A. 93(19):10423-7.
Bruni, R., and B. Roizman. 1998. Herpes simplex virus 1 regulatory protein ICP22 interacts with a new cell cycle-regulated factor and accumulates in a cell cycle-dependent fashion in infected cells. J Virol. 72(11):8525-31.
Bruni, R., B. Fineschi, W. O. Ogle, and B. Roizman. 1999. A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type- specific manner and Is recruited to the nucleus after infection. J Virol. 73(5):3810-7.
Bruun, T., A. K. Kristoffersen, H. Rollag, S. Beck, and M. Degre. 1998. Herpes simplex virus type 1 inhibits in vitro differentiation and selected functions of human blood-derived monocytes. Apmis. 106(12):1194-203.
Bubley, G. J., J. Balzarini, C. S. Crumpacker, E. de Clercq, and L. E. Schnipper. 1987. The effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on DNA repair and mutagenesis of herpes simplex virus type 1. Virology. 161(1):242-4.
Buckmaster, E. A., U. Gompels, and A. Minson. 1984. Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight. Virology. 139(2):408-13.
Burck, P. J., D. H. Berg, T. P. Luk, L. M. Sassmannshausen, M. Wakulchik, D. P. Smith, H. M. Hsiung, G. W. Becker, W. Gibson, and E. C. Villarreal. 1994. Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites. J Virol. 68(5):2937-46.
Burgess, R. C., L. Michaels, J. F. Bale, Jr., and R. J. Smith. 1994. Polymerase chain reaction amplification of herpes simplex viral DNA from the geniculate ganglion of a patient with Bell's palsy. Ann Otol Rhinol Laryngol. 103(10):775-9.
Burioni, R., R. A. Williamson, P. P. Sanna, F. E. Bloom, and D. R. Burton. 1994. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci U S A. 91(1):355-9.
Burioni, R., P. Plaisant, F. Bugli, L. Solforosi, V. Delli Carri, P. E. Varaldo, and G. Fadda. 1998. A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries. Res Virol. 149(5):327-30.
Burkham, J., D. M. Coen, and S. K. Weller. 1998. ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol. 72(12):10100-7.
Bzik, D. J., B. A. Fox, N. A. DeLuca, and S. Person. 1984. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology. 137(1):185-90.
Bzik, D. J., B. A. Fox, N. A. DeLuca, and S. Person. 1984. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology. 133(2):301-14.
Bzik, D. J., C. Debroy, B. A. Fox, N. E. Pederson, and S. Person. 1986. The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1. Virology. 155(2):322-33.
Cai, W. Z., S. Person, C. DebRoy, and B. H. Gu. 1988. Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. An analysis of linker insertion mutants. J Mol Biol. 201(3):575-88.
Cai, W., T. L. Astor, L. M. Liptak, C. Cho, D. M. Coen, and P. A. Schaffer. 1993. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol. 67(12):7501-12.
Cai, J. S., H. K. Jang, Y. Izumiya, Y. Tsushima, K. Kato, A. M. Damiani, T. Miyazawa, C. Kai, E. Takahashi, and T. Mikami. 1999. Identification and structure of the Marek's disease virus serotype 2 glycoprotein M gene: comparison with glycoprotein M genes of Herpesviridae family. J Vet Med Sci. 61(5):503-11.
Calistri, A., C. Parolin, M. Pizzato, P. Calvi, I. Giaretta, and G. Palu. 1999. Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr. 21(2):90-8.
Cameron, I. R., M. Park, B. M. Dutia, A. Orr, and J. C. Macnab. 1985. Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state. J Gen Virol. 66(Pt 3):517-27.
Cameron, J. A. 1998. Headache and drowsiness. Aust Fam Physician. 27(8):725-6.
Campadelli-Fiume, G., S. Qi, E. Avitabile, L. Foa-Tomasi, R. Brandimarti, and B. Roizman. 1990. Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus. J Virol. 64(12):6070-9.
Campbell, M. E., and C. M. Preston. 1987. DNA sequences which regulate the expression of the pseudorabies virus major immediate early gene. Virology. 157(2):307-16.
Campbell, M. E., S. McCorkindale, R. D. Everett, and D. E. Onions. 1991. Activation of gene expression by human herpesvirus 6 is reporter gene- dependent. J Gen Virol. 72(Pt 5):1123-30.
Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol. 69(8):4898-905.
Carlucci, M. J., C. A. Pujol, M. Ciancia, M. D. Noseda, M. C. Matulewicz, E. B. Damonte, and A. S. Cerezo. 1997. Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. Int J Biol Macromol. 20(2):97-105.
Carmichael, E. P., M. J. Kosovsky, and S. K. Weller. 1988. Isolation and characterization of herpes simplex virus type 1 host range mutants defective in viral DNA synthesis. J Virol. 62(1):91-9.
Carr, D. J. 1998. Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J Neuroimmunol. 89(1-2):160-7.
Carr, D. J., and I. L. Campbell. 1999. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. J Neurovirol. 5(5):449-57.
Carreno, M., J. L. Llorente, F. Hidalgo, M. Ona, S. Melon, and C. Suarez. 1998. [Application of the polymerase chain reaction to an experimental model of infection by herpes simplex virus type 1]. Acta Otorrinolaringol Esp. 49(1):15-8.
Carreno, M., J. Llorente, S. Melon, M. Ona, and C. Suarez. 1999. [Use of double PCR in an experimental mode of HSV-1 infection of the facial nerve]. Acta Otorrinolaringol Esp. 50(7):512-8.
Carrozza, M. J., and N. A. DeLuca. 1996. Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol. 16(6):3085-93.
Carter, V. C., S. R. Jennings, P. L. Rice, and S. S. Tevethia. 1984. Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes. J Virol. 49(3):766-71.
Carter, K. L., P. L. Ward, and B. Roizman. 1996. Characterization of the products of the U(L)43 gene of herpes simplex virus 1: potential implications for regulation of gene expression by antisense transcription. J Virol. 70(11):7663-8.
Carter, K. L., and B. Roizman. 1996. The promoter and transcriptional unit of a novel herpes simplex virus 1 alpha gene are contained in, and encode a protein in frame with, the open reading frame of the alpha 22 gene. J Virol. 70(1):172-8.
Caruso, M., and A. Bank. 1997. Efficient retroviral gene transfer of a Tat-regulated herpes simplex virus thymidine kinase gene for HIV gene therapy. Virus Res. 52(2):133-43.
Casas, I., A. Tenorio, F. de Ory, A. Lozano, and J. M. Echevarria. 1996. Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis. J Med Virol. 50(1):82-92.
Cassady, K. A., M. Gross, and B. Roizman. 1998. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J Virol. 72(11):8620-6.
Cassady, K. A., M. Gross, and B. Roizman. 1998. The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol. 72(9):7005-11.
Cassinotti, P., H. Mietz, and G. Siegl. 1996. Suitability and clinical application of a multiplex nested PCR assay for the diagnosis of herpes simplex virus infections. J Med Virol. 50(1):75-81.
Cassinotti, P., and G. Siegl. 1998. A nested-PCR assay for the simultaneous amplification of HSV-1, HSV-2, and HCMV genomes in patients with presumed herpetic CNS infections. J Virol Methods. 71(1):105-14.
Cattani, P., P. Plaisant, S. Manzara, N. Capodicasa, R. Burioni, G. M. Rossolini, and G. Satta. 1995. Cloning and characterization of human recombinant antibody Fab fragments specific for types 1 and 2 herpes simplex virus. New Microbiol. 18(2):135-42.
Cattani, P., G. M. Rossolini, S. Cresti, R. Santangelo, D. R. Burton, R. A. Williamson, P. P. Sanna, and G. Fadda. 1997. Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria. J Clin Microbiol. 35(6):1504-9.
Cavalcoli, J. D., A. Baghian, F. L. Homa, and K. G. Kousoulas. 1993. Resolution of genotypic and phenotypic properties of herpes simplex virus type 1 temperature-sensitive mutant (KOS) tsZ47: evidence for allelic complementation in the UL28 gene. Virology. 197(1):23-34.
Celluzzi, C. N., and F. E. Farber. 1990. Role of the major capsid protein in herpes simplex virus type-1 capsid assembly. Acta Virol. 34(6):497-507.
Challberg, M. D. 1986. A method for identifying the viral genes required for herpesvirus DNA replication. Proc Natl Acad Sci U S A. 83(23):9094-8.
Chaney, S. M., K. G. Warren, and J. H. Subak-Sharpe. 1983. Variable restriction endonuclease sites of herpes simplex virus type 1 isolates from encephalitic, facial and genital lesions and ganglia. J Gen Virol. 64(Pt 12):2717-33.
Chang, Y. E., and B. Roizman. 1993. The product of the UL31 gene of herpes simplex virus 1 is a nuclear phosphoprotein which partitions with the nuclear matrix. J Virol. 67(11):6348-56.
Chang, Y. E., A. P. Poon, and B. Roizman. 1996. Properties of the protein encoded by the UL32 open reading frame of herpes simplex virus 1. J Virol. 70(6):3938-46.
Chang, Y. E., C. Van Sant, P. W. Krug, A. E. Sears, and B. Roizman. 1997. The null mutant of the U(L)31 gene of herpes simplex virus 1: construction and phenotype in infected cells. J Virol. 71(11):8307-15.
Chang, Y. E., L. Menotti, F. Filatov, G. Campadelli-Fiume, and B. Roizman. 1998. UL27.5 is a novel gamma2 gene antisense to the herpes simplex virus 1 gene encoding glycoprotein B. J Virol. 72(7):6056-64.
Chartrand, P., N. M. Wilkie, and M. C. Timbury. 1981. Physical mapping of temperature-sensitive mutations of herpes simplex virus type 2 by marker rescue. J Gen Virol. 52(Pt 1):121-33.
Chase, M., R. Y. Chung, and E. A. Chiocca. 1998. An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy. Nat Biotechnol. 16(5):444-8.
Chatzoulis, D. M., P. G. Theodosiadis, M. N. Apostolopoulos, N. Drakoulis, and N. N. Markomichelakis. 1997. Retinal perivasculitis in an immunocompetent patient with systemic herpes simplex infection. Am J Ophthalmol. 123(5):699-702.
Chen, J. X., X. X. Zhu, and S. Silverstein. 1991. Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology. 180(1):207-20.
Chen, J., and S. Silverstein. 1992. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J Virol. 66(5):2916-27.
Chen, S. H., J. E. Oakes, and R. N. Lausch. 1994. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 25(3-4):201-13.
Chen, D., E. C. Stabell, and P. D. Olivo. 1995. Varicella-zoster virus gene 51 complements a herpes simplex virus type 1 UL9 null mutant. J Virol. 69(7):4515-8.
Chen, X., M. C. Schmidt, W. F. Goins, and J. C. Glorioso. 1995. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol. 69(12):7899-908.
Chen, C. Y., Y. N. Chang, P. Ryan, M. Linscott, G. J. McGarrity, and Y. L. Chiang. 1995. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". Hum Gene Ther. 6(11):1467-76.
Chen, Y. M., and D. M. Knipe. 1996. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription. Virology. 221(2):281-90.
Chen, H., L. Teng, J. N. Li, R. Park, D. E. Mold, J. Gnabre, J. R. Hwu, W. N. Tseng, and R. C. Huang. 1998. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J Med Chem. 41(16):3001-7.
Chenal, V., and R. Griffais. 1994. Chemiluminescent and colorimetric detection of a fluorescein-labelled probe and a digoxigenin-labelled probe after a single hybridization step. Mol Cell Probes. 8(5):401-7.
Chenciner, N., L. Pedroza Martins, N. Hanania, L. Stratford Perricaudet, M. Perricaudet, and S. Wain-Hobson. 1995. Residual expression of reporter genes in constructs mimicking HIV genome organization. Res Virol. 146(3):171-8.
Chenet-Monte, C., F. Mohammad, C. M. Celluzzi, P. A. Schaffer, and F. E. Farber. 1986. Herpes simplex virus gene products involved in the induction of chromosomal aberrations. Virus Res. 6(3):245-60.
Cheung, A. K. 1989. DNA nucleotide sequence analysis of the immediate-early gene of pseudorabies virus. Nucleic Acids Res. 17(12):4637-46.
Cheung, P., B. Panning, and J. R. Smiley. 1997. Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells. J Virol. 71(3):1784-93.
Chi, J. H., and D. W. Wilson. 2000. ATP-Dependent localization of the herpes simplex virus capsid protein VP26 to sites of procapsid maturation. J Virol. 74(3):1468-76.
Chiang, H. Y., G. H. Cohen, and R. J. Eisenberg. 1994. Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol. 68(4):2529-43.
Chiba, A., T. Suzutani, M. Saijo, S. Koyano, and M. Azuma. 1998. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol. 42(6):401-7.
Chou, J., E. R. Kern, R. J. Whitley, and B. Roizman. 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science. 250(4985):1262-6.
Chou, J., and B. Roizman. 1990. The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J Virol. 64(3):1014-20.
Chou, J., A. P. Poon, J. Johnson, and B. Roizman. 1994. Differential response of human cells to deletions and stop codons in the gamma(1)34.5 gene of herpes simplex virus. J Virol. 68(12):8304-11.
Chou, J., and B. Roizman. 1994. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc Natl Acad Sci U S A. 91(12):5247-51.
Chou, J., J. J. Chen, M. Gross, and B. Roizman. 1995. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1. Proc Natl Acad Sci U S A. 92(23):10516-20.
Chowdhury, S. I., and W. Batterson. 1994. Transinhibition of herpes simplex virus replication by an inducible cell-resident gene encoding a dysfunctional VP19c capsid protein. Virus Res. 33(1):67-87.
Christians, F. C., L. Scapozza, A. Crameri, G. Folkers, and W. P. Stemmer. 1999. Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling. Nat Biotechnol. 17(3):259-64.
Chung, I. K., S. M. Soisson, and M. T. Muller. 1995. Clustering of Sp1 sites near the promoter region of ICP34.5 in herpes simplex virus type 1. J Biochem (Tokyo). 117(1):19-22.
Chung, R. Y., Y. Saeki, and E. A. Chiocca. 1999. B-myb promoter retargeting of herpes simplex virus gamma34.5 gene- mediated virulence toward tumor and cycling cells. J Virol. 73(9):7556-64.
Church, G. A., A. Dasgupta, and D. W. Wilson. 1998. Herpes simplex virus DNA packaging without measurable DNA synthesis. J Virol. 72(4):2745-51.
Cinatl, J., J. U. Vogel, H. Kabickova, B. Kornhuber, and H. W. Doerr. 1997. Antiviral effects of 6-diazo-5-oxo-L-norleucin on replication of herpes simplex virus type 1. Antiviral Res. 33(3):165-75.
Ciufo, D. M., M. A. Mullen, and G. S. Hayward. 1994. Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus. J Virol. 68(5):3267-82.
Clarke, P., and J. B. Clements. 1991. Mutagenesis occurring following infection with herpes simplex virus does not require virus replication. Virology. 182(2):597-606.
Claverie, J. M. 1993. Detecting frame shifts by amino acid sequence comparison. J Mol Biol. 234(4):1140-57.
Cleator, G. M., P. E. Klapper, C. Dennett, A. L. Sullivan, R. E. Bonshek, B. Marcyniuk, and A. B. Tullo. 1994. Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea. 13(4):294-304.
Clements, G. B., and N. D. Stow. 1989. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice. J Gen Virol. 70(Pt 9):2501-6.
Clusel, C., S. Meguenni, I. Elias, M. Vasseur, and M. Blumenfeld. 1995. Inhibition of HSV-1 proliferation by decoy phosphodiester oligonucleotides containing ICP4 recognition sequences. Gene Expr. 4(6):301-9.
Cocchi, F., M. Lopez, L. Menotti, M. Aoubala, P. Dubreuil, and G. Campadelli-Fiume. 1998. The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A. 95(26):15700-5.
Cocchi, F., L. Menotti, P. Mirandola, M. Lopez, and G. Campadelli-Fiume. 1998. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Virol. 72(12):9992-10002.
Cocchi, F., L. Menotti, P. Dubreuil, M. Lopez, and G. Campadelli-Fiume. 2000. Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB). J Virol. 74(8):3909-17.
Cockerham, G. C., A. E. Krafft, and I. W. McLean. 1997. Herpes simplex virus in primary graft failure. Arch Ophthalmol. 115(5):586-9.
Coffin, R. S., A. R. MacLean, D. S. Latchman, and S. M. Brown. 1996. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 3(10):886-91.
Coffin, R. S., S. K. Thomas, D. P. Thomas, and D. S. Latchman. 1998. The herpes simplex virus 2 kb latency associated transcript (LAT) leader sequence allows efficient expression of downstream proteins which is enhanced in neuronal cells: possible function of LAT ORFs. J Gen Virol. 79(Pt 12):3019-26.
Cohen, J. I., and K. Seidel. 1994. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J Virol. 68(12):7850-8.
Cohen, J. I., and K. E. Seidel. 1995. Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology. 206(2):835-42.
Cohen, J. L., O. Boyer, B. Salomon, R. Onclerco, D. Depetris, L. Lejeune, V. Dubus-Bonnet, S. Bruel, F. Charlotte, M. G. Mattei, and D. Klatzmann. 1998. Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene. Transgenic Res. 7(5):321-30.
Colbere-Garapin, F., F. Horodniceanu, P. Kourilsky, and A. C. Garapin. 1980. Cloning of the herpes simplex virus type 1 thymidine kinase gene in E. coli K 12: a selective marker for gene transfer into animal cells. Dev Biol Stand. 46:75-82.
Conner, J., J. Furlong, J. Murray, M. Meighan, A. Cross, H. Marsden, and J. B. Clements. 1993. Herpes simplex virus type 1 ribonucleotide reductase large subunit: regions of the protein essential for subunit interaction and dimerization. Biochemistry. 32(49):13673-80.
Conner, J., A. Cross, J. Murray, and H. Marsden. 1994. Identification of structural domains within the large subunit of herpes simplex virus ribonucleotide reductase. J Gen Virol. 75(Pt 12):3327-35.
Conner, J., J. Murray, A. Cross, J. B. Clements, and H. S. Marsden. 1995. Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells. Virology. 213(2):615-23.
Constantin, N., and M. S. Dodson. 1999. Two-hybrid analysis of the interaction between the UL52 and UL8 subunits of the herpes simplex virus type 1 helicase-primase. J Gen Virol. 80(Pt 9):2411-5.
Contreras, A., H. H. Zadeh, H. Nowzari, and J. Slots. 1999. Herpesvirus infection of inflammatory cells in human periodontitis. Oral Microbiol Immunol. 14(4):206-12.
Conway, J. E., S. Zolotukhin, N. Muzyczka, G. S. Hayward, and B. J. Byrne. 1997. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J Virol. 71(11):8780-9.
Conway, J. H., A. Weinberg, R. L. Ashley, J. Amer, and M. J. Levin. 1997. Viral meningitis in a preadolescent child caused by reactivation of latent herpes simplex (type 1). Pediatr Infect Dis J. 16(6):627-9.
Cook, M. L., R. L. Thompson, and J. G. Stevens. 1986. A herpes simplex virus mutant is temperature sensitive for reactivation from the latent state: evidence for selective restriction in neuronal cells. Virology. 155(1):293-6.
Cook, S. D., M. J. Paveloff, J. J. Doucet, A. J. Cottingham, F. Sedarati, and J. M. Hill. 1991. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci. 32(5):1558-61.
Cook, W. J., K. K. Wobbe, J. Boni, and D. M. Coen. 1996. Regulation of neighboring gene expression by the herpes simplex virus type 1 thymidine kinase gene. Virology. 218(1):193-203.
Cooper, J., J. Conner, and J. B. Clements. 1995. Characterization of the novel protein kinase activity present in the R1 subunit of herpes simplex virus ribonucleotide reductase. J Virol. 69(8):4979-85.
Cordingley, M. G., and C. M. Preston. 1981. Transcription and translation of the herpes simplex virus type 1 thymidine kinase gene after microinjection into Xenopus laevis oocytes. J Gen Virol. 54(Pt 2):409-14.
Corey, L., A. Hobson, and T. Schacker. 1996. Lack of detection of HSV DNA in PBMCs and lymph nodes of HIV-infected persons. J Med Virol. 48(1):47.
Corina, P., and T. Emanuil. 1998. [The polymerase reaction--PCR--a new diagnostic method in herpetic keratitis]. Oftalmologia. 44(3):36-9.
Cose, S. C., J. M. Kelly, and F. R. Carbone. 1995. Characterization of diverse primary herpes simplex virus type 1 gB- specific cytotoxic T-cell response showing a preferential V beta bias. J Virol. 69(9):5849-52.
Costa, R. H., B. G. Devi, K. P. Anderson, B. H. Gaylord, and E. K. Wagner. 1981. Characterization of a major late herpes simplex virus type 1 mRNA. J Virol. 38(2):483-96.
Costa, R. H., K. G. Draper, G. Devi-Rao, R. L. Thompson, and E. K. Wagner. 1985. Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5). J Virol. 56(1):19-30.
Couderc, B. C., S. de Neuville, V. Douin-Echinard, B. Serres, S. Manenti, J. M. Darbon, and F. Malecaze. 1999. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res. 19(6):472-82.
Coulter, L. J., H. W. Moss, J. Lang, and D. J. McGeoch. 1993. A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J Gen Virol. 74(Pt 3):387-95.
Cox, M., N. Maitland, and C. Scully. 1993. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Eur J Cancer B Oral Oncol. 29B(3):215-9.
Coyle, P. V., A. Desai, D. Wyatt, C. McCaughey, and H. J. O'Neill. 1999. A comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections. J Virol Methods. 83(1-2):75-82.
Coyle, P. V., S. Jain, D. Wyatt, C. McCaughey, and H. J. O'Neill. 2000. Description of a nonlethal herpes simplex virus type 1 glycoprotein D deletion mutant affecting a site frequently used for PCR. Clin Diagn Lab Immunol. 7(2):322-4.
Craig, A. M., O. Steward, and G. Banker. 1994. Use of HSV-1 amplicon vectors to study RNA and protein targeting in cultured hippocampal neurons. Gene Ther. 1(Suppl 1):S72.
Cress, A., and S. J. Triezenberg. 1991. Nucleotide and deduced amino acid sequences of the gene encoding virion protein 16 of herpes simplex virus type 2. Gene. 103(2):235-8.
Cribbs, D. H., B. Y. Azizeh, C. W. Cotman, and F. M. LaFerla. 2000. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. Biochemistry. 39(20):5988-94.
Cripe, T. P., T. H. Haugen, J. P. Turk, F. Tabatabai, P. G. d. Schmid, M. Durst, L. Gissmann, A. Roman, and L. P. Turek. 1987. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans- activator and repressor gene products: implications for cervical carcinogenesis. Embo J. 6(12):3745-53.
Crumpacker, C. S., L. E. Schnipper, P. N. Kowalsky, and D. M. Sherman. 1982. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2- bromovinyl)-2'-deoxyuridine: a physical analysis. J Infect Dis. 146(2):167-72.
Crumpacker, C. S., P. N. Kowalsky, S. A. Oliver, L. E. Schnipper, and A. K. Field. 1984. Resistance of herpes simplex virus to 9-[[2-hydroxy-1- (hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus. Proc Natl Acad Sci U S A. 81(5):1556-60.
Crute, J. J., I. R. Lehman, J. Gambino, T. F. Yang, P. Medveczky, M. Medveczky, N. N. Khan, C. Mulder, J. Monroe, and G. E. Wright. 1995. Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines. J Med Chem. 38(10):1820-5.
Cullen, B. R. 1996. Virology. New trick from an old foe [news; comment]. Nature. 379(6562):208-9.
Cunningham, C., and A. J. Davison. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology. 197(1):116-24.
Cunningham, E. T., Jr., G. A. Short, A. R. Irvine, J. S. Duker, and T. P. Margolis. 1996. Acquired immunodeficiency syndrome--associated herpes simplex virus retinitis. Clinical description and use of a polymerase chain reaction-- based assay as a diagnostic tool [published erratum appears in Arch Ophthalmol 1997 Apr;115(4):559]. Arch Ophthalmol. 114(7):834-40.
Cunningham, C., A. J. Davison, A. R. MacLean, N. S. Taus, and J. D. Baines. 2000. Herpes simplex virus type 1 gene UL14: phenotype of a null mutant and identification of the encoded protein. J Virol. 74(1):33-41.
Dabrowski, C. E., and P. A. Schaffer. 1991. Herpes simplex virus type 1 origin-specific binding protein: oriS- binding properties and effects of cellular proteins. J Virol. 65(6):3140-50.
Dabrowski, C. E., P. J. Carmillo, and P. A. Schaffer. 1994. Cellular protein interactions with herpes simplex virus type 1 oriS. Mol Cell Biol. 14(4):2545-55.
Daikoku, T., Y. Yamashita, T. Tsurumi, K. Maeno, and Y. Nishiyama. 1993. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2. Virology. 197(2):685-94.
Daikoku, T., K. Ikenoya, H. Yamada, F. Goshima, and Y. Nishiyama. 1998. Identification and characterization of the herpes simplex virus type 1 UL51 gene product. J Gen Virol. 79(Pt 12):3027-31.
Daksis, J. I., and V. L. Chan. 1987. Physical mapping of two herpes simplex virus type 1 host shutoff loci: rescue of each ts mutation occurs with two unique cloned regions of the viral genome. J Virol. 61(1):143-50.
Dalrymple, M. A., D. J. McGeoch, A. J. Davison, and C. M. Preston. 1985. DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters. Nucleic Acids Res. 13(21):7865-79.
Dalziel, R. G., and H. S. Marsden. 1984. Identification of two herpes simplex virus type 1-induced proteins (21K and 22K) which interact specifically with the a sequence of herpes simplex virus DNA. J Gen Virol. 65(Pt 9):1467-75.
Danaher, R. J., R. J. Jacob, M. D. Chorak, C. S. Freeman, and C. S. Miller. 1999. Heat stress activates production of herpes simplex virus type 1 from quiescently infected neurally differentiated PC12 cells. J Neurovirol. 5(4):374-83.
Danaher, R. J., R. J. Jacob, and C. S. Miller. 1999. Establishment of a quiescent herpes simplex virus type 1 infection in neurally-differentiated PC12 cells. J Neurovirol. 5(3):258-67.
Danovich, R. M., and N. Frenkel. 1988. Herpes simplex virus induces the replication of foreign DNA. Mol Cell Biol. 8(8):3272-81.
Darai, G., L. Zoller, B. Matz, A. Schwaier, R. M. Flugel, and K. Munk. 1980. Experimental infection and the state of viral latency of adult tupaia with herpes simplex virus type 1 and 2 and infection of juvenile Tupaia with temperature-sensitive mutants of HSV Type 2. Arch Virol. 65(3-4):311-8.
Dargan, D. J., and J. H. Subak-Sharpe. 1991. The difference in sensitivity to cicloxolone sodium between herpes simplex virus types 1 and 2 maps to the locations of genes UL22 (gH) and UL44 (gC). J Gen Virol. 72(Pt 2):377-84.
Dargan, D. J., A. H. Patel, and J. H. Subak-Sharpe. 1995. PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked. J Virol. 69(8):4924-32.
Darke, P. L., E. Chen, D. L. Hall, M. K. Sardana, C. A. Veloski, R. L. LaFemina, J. A. Shafer, and L. C. Kuo. 1994. Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J Biol Chem. 269(29):18708-11.
Das, C. M., S. Zhang, and E. J. Shillitoe. 1994. Expression of the mutagenic peptide of herpes simplex virus type 1 in virus-infected cells. Virus Res. 34(2):97-114.
Das, C. M., V. A. Murrah, S. Zhang, G. Wong, E. P. Gilchrist, and E. J. Shillitoe. 1995. The effect on cell phenotype of the mutagenic peptide of herpes simplex virus type-1. Eur J Cancer B Oral Oncol. 31B(4):267-74.
Dasika, G. K., and G. J. Letchworth, 3rd. 1999. Cellular expression of bovine herpesvirus 1 gD inhibits cell-to-cell spread of two closely related viruses without blocking their primary infection. Virology. 254(1):24-36.
Davido, D. J., and D. A. Leib. 1996. Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation. J Gen Virol. 77(Pt 8):1853-63.
Davido, D. J., and D. A. Leib. 1998. Analysis of the basal and inducible activities of the ICPO promoter of herpes simplex virus type 1. J Gen Virol. 79(Pt 9):2093-8.
Davidson, I., and N. D. Stow. 1985. Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA. Virology. 141(1):77-88.
Davis-Poynter, N., S. Bell, T. Minson, and H. Browne. 1994. Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion. J Virol. 68(11):7586-90.
Davison, A. J., and N. M. Wilkie. 1981. Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol. 55(Pt 2):315-31.
Davison, A. J., H. S. Marsden, and N. M. Wilkie. 1981. One functional copy of the long terminal repeat gene specifying the immediate-early polypeptide IE 110 suffices for a productive infection of human foetal lung cells by herpes simplex virus. J Gen Virol. 55(Pt 1):179-91.
Davison, A. J., and N. M. Wilkie. 1983. Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol. 64(Pt 9):1927-42.
Davison, A. J., and N. M. Wilkie. 1983. Inversion of the two segments of the herpes simplex virus genome in intertypic recombinants. J Gen Virol. 64(Pt 1):1-18.
Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 67(Pt 9):1759-816.
Davison, A. J., and D. J. McGeoch. 1986. Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J Gen Virol. 67(Pt 4):597-611.
Davison, A. J., and M. D. Davison. 1995. Identification of structural proteins of channel catfish virus by mass spectrometry. Virology. 206(2):1035-43.
Day, S. P., R. N. Lausch, and J. E. Oakes. 1987. Nucleotide sequences important in DNA replication are responsible for differences in the capacity of two herpes simplex virus strains to spread from cornea to central nervous system. Curr Eye Res. 6(1):19-26.
Day, S. P., R. N. Lausch, and J. E. Oakes. 1988. Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology. 163(1):166-73.
de Boer, J. H., C. Verhagen, M. Bruinenberg, A. Rothova, P. T. de Jong, G. S. Baarsma, A. Van der Lelij, F. M. Ooyman, J. G. Bollemeijer, P. J. Derhaag, and A. Kijlstra. 1996. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 121(6):650-8.
de Bruyn Kops, A., and D. M. Knipe. 1994. Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J Virol. 68(6):3512-26.
de Bruyn Kops, A., S. L. Uprichard, M. Chen, and D. M. Knipe. 1998. Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions. Virology. 252(1):162-78.
De Logu, A., R. A. Williamson, R. Rozenshteyn, F. Ramiro-Ibanez, C. D. Simpson, D. R. Burton, and P. P. Sanna. 1998. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential. J Clin Microbiol. 36(11):3198-204.
De Stasio, P. R., and M. W. Taylor. 1989. Trans-activation of herpes simplex virus type 1 immediate early genes is specifically inhibited by human recombinant interferons. Biochem Biophys Res Commun. 159(2):439-44.
De Wind, N., B. P. Peeters, A. Zuderveld, A. L. Gielkens, A. J. Berns, and T. G. Kimman. 1994. Mutagenesis and characterization of a 41-kilobase-pair region of the pseudorabies virus genome: transcription map, search for virulence genes, and comparison with homologs of herpes simplex virus type 1. Virology. 200(2):784-90.
Dean, H. J., and A. K. Cheung. 1993. A 3' coterminal gene cluster in pseudorabies virus contains herpes simplex virus UL1, UL2, and UL3 gene homologs and a unique UL3.5 open reading frame. J Virol. 67(10):5955-61.
Dean, H. J., M. S. Warner, S. S. Terhune, R. M. Johnson, and P. G. Spear. 1995. Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference. J Virol. 69(8):5171-6.
Deatly, A. M., J. G. Spivack, E. Lavi, and N. W. Fraser. 1987. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A. 84(10):3204-8.
Deatly, A. M., J. G. Spivack, E. Lavi, D. R. d. O'Boyle, and N. W. Fraser. 1988. Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J Virol. 62(3):749-56.
Deb, S., and S. P. Deb. 1989. Analysis of Ori-S sequence of HSV-1: identification of one functional DNA binding domain. Nucleic Acids Res. 17(7):2733-52.
Deb, S. P., S. Deb, and D. R. Brown. 1993. Analysis of the promoter sequences of the UL9 gene of herpes simplex virus type 1. Biochem Biophys Res Commun. 193(2):617-23.
Deb, S. P., S. Deb, and D. R. Brown. 1994. Cell-type-specific induction of the UL9 gene of HSV-1 by cell signaling pathway. Biochem Biophys Res Commun. 205(1):44-51.
Debinski, H. S., M. A. Kamm, I. C. Talbot, G. Khan, H. O. Kangro, and D. J. Jeffries. 1997. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut. 41(1):100-6.
Deckman, I. C., M. Hagen, and P. J. d. McCann. 1992. Herpes simplex virus type 1 protease expressed in Escherichia coli exhibits autoprocessing and specific cleavage of the ICP35 assembly protein. J Virol. 66(12):7362-7.
Degreve, B., M. Johansson, E. De Clercq, A. Karlsson, and J. Balzarini. 1998. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK. J Virol. 72(12):9535-43.
Degreve, B., R. Esnouf, E. De Clercq, and J. Balzarini. 1999. Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase. Biochem Biophys Res Commun. 264(2):338-42.
DeLuca, N., D. J. Bzik, V. C. Bond, S. Person, and W. Snipes. 1982. Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7). Virology. 122(2):411-23.
DeLuca, N. A., M. A. Courtney, and P. A. Schaffer. 1984. Temperature-sensitive mutants in herpes simplex virus type 1 ICP4 permissive for early gene expression. J Virol. 52(3):767-76.
DeLuca, N., S. Person, D. J. Bzik, and W. Snipes. 1984. Genome locations of temperature-sensitive mutants in glycoprotein gB of herpes simplex virus type 1. Virology. 137(2):382-9.
DeLuca, N. A., A. M. McCarthy, and P. A. Schaffer. 1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol. 56(2):558-70.
Demarchi, F., P. Bovenzi, D. Di Luca, and M. Giacca. 1996. Transcriptional activation of human immunodeficiency virus type 1 by herpesvirus infection: an in vivo footprinting study. Intervirology. 39(4):236-41.
Dennett, C., P. E. Klapper, and G. M. Cleator. 1996. Polymerase chain reaction in the investigation of "relapse" following herpes simplex encephalitis. J Med Virol. 48(2):129-32.
Dennett, C., G. M. Cleator, and P. E. Klapper. 1997. HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom. J Med Virol. 53(1):1-3.
Derby, M. L., M. Sena-Esteves, X. O. Breakefield, and D. P. Corey. 1999. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res. 134(1-2):1-8.
Desai, P., F. L. Homa, S. Person, and J. C. Glorioso. 1994. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses. Virology. 204(1):312-22.
Desai, P., S. C. Watkins, and S. Person. 1994. The size and symmetry of B capsids of herpes simplex virus type 1 are determined by the gene products of the UL26 open reading frame. J Virol. 68(9):5365-74.
Desai, P., and S. Person. 1996. Molecular interactions between the HSV-1 capsid proteins as measured by the yeast two-hybrid system. Virology. 220(2):516-21.
Desai, P., N. A. DeLuca, and S. Person. 1998. Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice. Virology. 247(1):115-24.
Desai, P., and S. Person. 1998. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J Virol. 72(9):7563-8.
Desai, P., and S. Person. 1999. Second site mutations in the N-terminus of the major capsid protein (VP5) overcome a block at the maturation cleavage site of the capsid scaffold proteins of herpes simplex virus type 1. Virology. 261(2):357-66.
Deshmane, S. L., B. Raengsakulrach, J. F. Berson, and N. W. Fraser. 1995. The replicating intermediates of herpes simplex virus type 1 DNA are relatively short [see comments]. J Neurovirol. 1(2):165-76.
Deshmane, S. L., T. Valyi-Nagy, T. Block, J. Maggioncalda, J. H. Wolfe, A. Dillner, and N. W. Fraser. 1995. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons. Gene Ther. 2(3):209-17.
Devi-Rao, G. B., D. C. Bloom, J. G. Stevens, and E. K. Wagner. 1994. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol. 68(3):1271-82.
Devi-Rao, G. B., J. S. Aguilar, M. K. Rice, H. H. Garza, Jr., D. C. Bloom, J. M. Hill, and E. K. Wagner. 1997. Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J Virol. 71(9):7039-47.
DeVincenzo, J. P., and G. Thorne. 1994. Mild herpes simplex encephalitis diagnosed by polymerase chain reaction: a case report and review. Pediatr Infect Dis J. 13(7):662-4.
Devireddy, L. R., and C. J. Jones. 2000. Olf-1, a neuron-specific transcription factor, can activate the herpes simplex virus type 1-infected cell protein 0 promoter. J Biol Chem. 275(1):77-81.
Dewey, R. A., G. Morrissey, C. M. Cowsill, D. Stone, F. Bolognani, N. J. Dodd, T. D. Southgate, D. Klatzmann, H. Lassmann, M. G. Castro, and P. R. Lowenstein. 1999. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat Med. 5(11):1256-63.
Dezelee, S., F. Bras, P. Vende, B. Simonet, X. Nguyen, A. Flamand, and M. J. Masse. 1996. The BamHI fragment 9 of pseudorabies virus contains genes homologous to the UL24, UL25, UL26, and UL 26.5 genes of herpes simplex virus type 1. Virus Res. 42(1-2):27-39.
Dhar, S., and J. P. Weir. 2000. Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line. Virology. 270(1):190-200.
Di Caro, A., E. Perola, B. Bartolini, M. Marzano, L. Liverani, G. Mascellani, A. Benedetto, and L. Cellai. 1999. Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus. Antivir Chem Chemother. 10(1):33-8.
Di Lazzaro, C., G. Campadelli-Fiume, and M. R. Torrisi. 1995. Intermediate forms of glycoconjugates are present in the envelope of herpes simplex virions during their transport along the exocytic pathway. Virology. 214(2):619-23.
Diaz, J. J., M. D. Dodon, N. Schaerer-Uthurralt, D. Simonin, K. Kindbeiter, L. Gazzolo, and J. J. Madjar. 1996. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein [see comments]. Nature. 379(6562):273-7.
Diaz-Latoud, C., J. J. Diaz, N. Fabre-Jonca, K. Kindbeiter, J. J. Madjar, and A. P. Arrigo. 1997. Herpes simplex virus Us11 protein enhances recovery of protein synthesis and survival in heat shock treated HeLa cells. Cell Stress Chaperones. 2(2):119-31.
Dick, J. W., and K. S. Rosenthal. 1995. A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1. Arch Virol. 140(12):2163-81.
Dicker, I. B., J. W. Blasecki, and S. Seetharam. 1995. Herpes simplex type1:lacZ recombinant viruses. II. Microtiter plate- based colorimetric assays for the discovery of new antiherpes agents and the points at which such agents disrupt the viral replication cycle. Antiviral Res. 28(3):213-24.
Dicker, I. B., and S. Seetharam. 1995. Herpes simplex type 1:lacZ recombinant viruses. I. Characterization and application to defining the mechanisms of action of known antiherpes agents. Antiviral Res. 28(3):191-212.
Dickman, S. 1998. Viral saboteurs caught in the act [news; comment]. Science. 279(5355):1305.
DiDonato, J. A., J. R. Spitzner, and M. T. Muller. 1991. A predictive model for DNA recognition by the herpes simplex virus protein ICP4. J Mol Biol. 219(3):451-70.
Digard, P., W. R. Bebrin, and D. M. Coen. 1995. Mutational analysis of DNA polymerase substrate recognition and subunit interactions using herpes simplex virus as prototype. Methods Enzymol. 262:303-22.
DiIanni, C. L., C. Mapelli, D. A. Drier, J. Tsao, S. Natarajan, D. Riexinger, S. M. Festin, M. Bolgar, G. Yamanaka, S. P. Weinheimer, and et al. 1993. In vitro activity of the herpes simplex virus type 1 protease with peptide substrates. J Biol Chem. 268(34):25449-54.
Dingwell, K. S., C. R. Brunetti, R. L. Hendricks, Q. Tang, M. Tang, A. J. Rainbow, and D. C. Johnson. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol. 68(2):834-45.
Dingwell, K. S., L. C. Doering, and D. C. Johnson. 1995. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol. 69(11):7087-98.
Disney, G. H., T. A. McKee, C. M. Preston, and R. D. Everett. 1990. The product of varicella-zoster virus gene 62 autoregulates its own promoter. J Gen Virol. 71(Pt 12):2999-3003.
Dixon, R. A., D. J. Sabourin, and P. A. Schaffer. 1983. Genetic analysis of temperature-sensitive mutants which define the genes for the major herpes simplex virus type 2 DNA-binding protein and a new late function. J Virol. 45(1):343-53.
do Nascimento, M. C., L. M. Sumita, V. A. de Souza, and C. S. Pannuti. 1998. Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR. J Clin Microbiol. 36(3):848-9.
Dobson, A. T., T. P. Margolis, W. A. Gomes, and L. T. Feldman. 1995. In vivo deletion analysis of the herpes simplex virus type 1 latency- associated transcript promoter. J Virol. 69(4):2264-70.
Docherty, J. J., J. H. Subak-Sharpe, and C. M. Preston. 1981. Identification of a virus-specific polypeptide associated with a transforming fragment (BglII-N) of herpes simplex virus type 2 DNA. J Virol. 40(1):126-32.
Docherty, J. J., M. M. Fu, B. S. Stiffler, R. J. Limperos, C. M. Pokabla, and A. L. DeLucia. 1999. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43(3):145-55.
Dodson, M. S., J. J. Crute, R. C. Bruckner, and I. R. Lehman. 1989. Overexpression and assembly of the herpes simplex virus type 1 helicase- primase in insect cells [published erratum appears in J Biol Chem 1990 Mar 15;265(8):4769]. J Biol Chem. 264(35):20835-8.
Dodson, M. S., and I. R. Lehman. 1993. The herpes simplex virus type I origin binding protein. DNA-dependent nucleoside triphosphatase activity. J Biol Chem. 268(2):1213-9.
Dolan, A., E. McKie, A. R. MacLean, and D. J. McGeoch. 1992. Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. J Gen Virol. 73(Pt 4):971-3.
Dolan, A., F. E. Jamieson, C. Cunningham, B. C. Barnett, and D. J. McGeoch. 1998. The genome sequence of herpes simplex virus type 2. J Virol. 72(3):2010-21.
Dolter, K. E., S. R. King, and T. C. Holland. 1993. Incorporation of CD4 into virions by a recombinant herpes simplex virus. J Virol. 67(1):189-95.
Dolter, K. E., R. Ramaswamy, and T. C. Holland. 1994. Syncytial mutations in the herpes simplex virus type 1 gK (UL53) gene occur in two distinct domains. J Virol. 68(12):8277-81.
Domingues, R. B., F. D. Lakeman, C. S. Pannuti, M. C. Fink, and A. M. Tsanaclis. 1997. Advantage of polymerase chain reaction in the diagnosis of herpes simplex encephalitis: presentation of 5 atypical cases. Scand J Infect Dis. 29(3):229-31.
Domingues, R. B., F. D. Lakeman, M. S. Mayo, and R. J. Whitley. 1998. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 36(8):2229-34.
Dorsky, D., P. Chatis, and C. Crumpacker. 1987. Functional expression of a cloned herpes simplex virus type 1 DNA polymerase gene. J Virol. 61(5):1704-7.
Dowbenko, D. J., and L. A. Lasky. 1984. Extensive homology between the herpes simplex virus type 2 glycoprotein F gene and the herpes simplex virus type 1 glycoprotein C gene. J Virol. 52(1):154-63.
Dracheva, S., E. V. Koonin, and J. J. Crute. 1995. Identification of the primase active site of the herpes simplex virus type 1 helicase-primase. J Biol Chem. 270(23):14148-53.
Draper, K. G., R. J. Frink, G. B. Devi, M. Swain, D. Galloway, and E. K. Wagner. 1984. Herpes simplex virus types 1 and 2 homology in the region between 0.58 and 0.68 map units. J Virol. 52(2):615-23.
Draper, K. G., G. Devi-Rao, R. H. Costa, E. D. Blair, R. L. Thompson, and E. K. Wagner. 1986. Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. J Virol. 57(3):1023-36.
Drescher, K. M., and J. A. Whittum-Hudson. 1996. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells. Invest Ophthalmol Vis Sci. 37(11):2302-12.
Drescher, K. M., and J. A. Whittum-Hudson. 1997. Evidence for induction of interferon-alpha and interferon-beta in retinal glial cells of Muller. Virology. 234(2):309-16.
Dressler, G. R., D. L. Rock, and N. W. Fraser. 1987. Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J Gen Virol. 68(Pt 6):1761-5.
Drolet, B. S., G. C. Perng, J. Cohen, S. M. Slanina, A. Yukht, A. B. Nesburn, and S. L. Wechsler. 1998. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology. 242(1):221-32.
Drolet, B. S., G. C. Perng, R. J. Villosis, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1999. Expression of the first 811 nucleotides of the herpes simplex virus type 1 latency-associated transcript (LAT) partially restores wild-type spontaneous reactivation to a LAT-null mutant. Virology. 253(1):96-106.
Drummond, C. W., R. P. Eglin, and M. M. Esiri. 1994. Herpes simplex virus encephalitis in a mouse model: PCR evidence for CNS latency following acute infection. J Neurol Sci. 127(2):159-63.
Duarte, R. G. 1995. [Gene therapy in neurology. State of the art and future prospects]. Neurologia. 10 Suppl 1:56-61.
Dube, D. K., J. D. Parker, D. C. French, D. S. Cahill, S. Dube, M. S. Horwitz, K. M. Munir, and L. A. Loeb. 1991. Artificial mutants generated by the insertion of random oligonucleotides into the putative nucleoside binding site of the HSV-1 thymidine kinase gene. Biochemistry. 30(51):11760-7.
Dubin, G., S. Basu, D. L. Mallory, M. Basu, R. Tal-Singer, and H. M. Friedman. 1994. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. J Virol. 68(4):2478-85.
Dubin, G., and H. Jiang. 1995. Expression of herpes simplex virus type 1 glycoprotein L (gL) in transfected mammalian cells: evidence that gL is not independently anchored to cell membranes. J Virol. 69(7):4564-8.
Duc Dodon, M., I. Mikaelian, A. Sergeant, and L. Gazzolo. 2000. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production. Virology. 270(1):43-53.
Dudas, K. C., and W. T. Ruyechan. 1998. Identification of a region of the herpes simplex virus single-stranded DNA-binding protein involved in cooperative binding. J Virol. 72(1):257-65.
Dutch, R. E., and I. R. Lehman. 1993. Renaturation of complementary DNA strands by herpes simplex virus type 1 ICP8. J Virol. 67(12):6945-9.
Dutch, R. E., B. V. Zemelman, and I. R. Lehman. 1994. Herpes simplex virus type 1 recombination: the Uc-DR1 region is required for high-level a-sequence-mediated recombination. J Virol. 68(6):3733-41.
Dutch, R. E., V. Bianchi, and I. R. Lehman. 1995. Herpes simplex virus type 1 DNA replication is specifically required for high-frequency homologous recombination between repeated sequences. J Virol. 69(5):3084-9.
Dyer, A. P., B. W. Banfield, D. Martindale, D. M. Spannier, and F. Tufaro. 1997. Dextran sulfate can act as an artificial receptor to mediate a type- specific herpes simplex virus infection via glycoprotein B. J Virol. 71(1):191-8.
Earnshaw, D. L., and R. L. Jarvest. 1994. Characterisation of the nucleotide and DNA coeffector binding sites of the herpes simplex virus type 1 (HSV-1) encoded helicase-primase complex and UL9 origin binding protein. Biochem Biophys Res Commun. 199(3):1333-40.
Eberle, J., and C. W. Knopf. 1996. Nonisotopic assays of viral polymerases and related proteins. Methods Enzymol. 275:257-76.
Eberle, R., B. Tanamachi, D. Black, E. L. Blewett, M. Ali, H. Openshaw, and E. M. Cantin. 1997. Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian alpha-herpesvirus homologs. Arch Virol. 142(4):721-36.
Ebert, S. N., D. Subramanian, S. S. Shtrom, I. K. Chung, D. S. Parris, and M. T. Muller. 1994. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. J Virol. 68(2):1010-20.
Ecob-Prince, M. S., K. Hassan, M. T. Denheen, and C. M. Preston. 1995. Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1. J Gen Virol. 76(Pt 6):1527-32.
Eeg-Olofsson, O., T. Bergstrom, C. K. Osterland, F. Andermann, and A. Olivier. 1995. Epilepsy etiology with special emphasis on immune dysfunction and neurovirology. Brain Dev. 17(Suppl):58-60.
Egal, M., M. Conrad, D. L. MacDonald, W. L. Maloy, M. Motley, and C. A. Genco. 1999. Antiviral effects of synthetic membrane-active peptides on herpes simplex virus, type 1. Int J Antimicrob Agents. 13(1):57-60.
Eide, T., H. S. Marsden, D. A. Leib, C. Cunningham, A. J. Davison, N. Langeland, and L. Haarr. 1998. Identification of the UL4 protein of herpes simplex virus type 1. J Gen Virol. 79(Pt 12):3033-8.
el Borai, N., M. Inoue, C. Lefevre, E. N. Naumova, B. Sato, and M. Yamamura. 1997. Detection of herpes simplex DNA in semen and menstrual blood of individuals attending an infertility clinic. J Obstet Gynaecol Res. 23(1):17-24.
El Borai, N., C. LeFevre, M. Inoue, E. N. Naumova, K. Sato, S. Suzuki, K. Tsuji, and M. Yamamura. 1998. Presence of HSV-1 DNA in semen and menstrual blood. J Reprod Immunol. 41(1-2):137-47.
Elliott, G., G. Mouzakitis, and P. O'Hare. 1995. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J Virol. 69(12):7932-41.
Elliott, G., D. O'Reilly, and P. O'Hare. 1996. Phosphorylation of the herpes simplex virus type 1 tegument protein VP22. Virology. 226(1):140-5.
Elliott, G., and P. O'Hare. 1997. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88(2):223-33.
Elliott, G., and P. O'Hare. 1998. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J Virol. 72(8):6448-55.
Elliott, G., and P. O'Hare. 1999. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J Virol. 73(5):4110-9.
Ellison, A. R., and J. O. Bishop. 1996. Initiation of herpes simplex virus thymidine kinase polypeptides. Nucleic Acids Res. 24(11):2073-9.
Ellison, A. R., L. Yang, C. Voytek, and T. P. Margolis. 2000. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology. 268(1):17-28.
Elnifro, E. M., R. J. Cooper, P. E. Klapper, A. C. Yeo, and A. B. Tullo. 2000. Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis. Invest Ophthalmol Vis Sci. 41(7):1818-22.
Endoh, D. 1996. Enhancement of gene expression by Marek's disease virus homologue of the herpes simplex virus-1 ICP4. Jpn J Vet Res. 44(2):136-7.
Engel, J. A., J. Zhang, T. Bergstrom, N. Conradi, C. Forkstam, A. Liljeroth, and L. Svensson. 2000. Neonatal herpes simplex virus type 1 brain infection affects the development of sensorimotor gating in rats. Brain Res. 863(1-2):233-40.
Enssle, J., W. Kugler, M. W. Hentze, and A. E. Kulozik. 1993. Determination of mRNA fate by different RNA polymerase II promoters. Proc Natl Acad Sci U S A. 90(21):10091-5.
Evans, J. S., K. P. Lock, B. A. Levine, J. N. Champness, M. R. Sanderson, W. C. Summers, and A. Buchan. 1997. Structure-specificity features of HSV-1 thymidine kinases. Biochem Soc Trans. 25(4):S621.
Evans, J. S., K. P. Lock, B. A. Levine, J. N. Champness, M. R. Sanderson, W. C. Summers, P. J. McLeish, and A. Buchan. 1998. Herpesviral thymidine kinases: laxity and resistance by design. J Gen Virol. 79(Pt 9):2083-92.
Everett, R. D. 1983. DNA sequence elements required for regulated expression of the HSV-1 glycoprotein D gene lie within 83 bp of the RNA capsites. Nucleic Acids Res. 11(19):6647-66.
Everett, R. D. 1984. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. Embo J. 3(13):3135-41.
Everett, R. D. 1984. A detailed analysis of an HSV-1 early promoter: sequences involved in trans-activation by viral immediate-early gene products are not early- gene specific. Nucleic Acids Res. 12(7):3037-56.
Everett, R. D. 1985. Activation of cellular promoters during herpes virus infection of biochemically transformed cells. Embo J. 4(8):1973-80.
Everett, R. D. 1986. The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J Gen Virol. 67(Pt 11):2507-13.
Everett, R. D. 1987. A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. Embo J. 6(7):2069-76.
Everett, R. D. 1988. Promoter sequence and cell type can dramatically affect the efficiency of transcriptional activation induced by herpes simplex virus type 1 and its immediate-early gene products Vmw175 and Vmw110. J Mol Biol. 203(3):739-51.
Everett, R. D. 1988. Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J Mol Biol. 202(1):87-96.
Everett, R. D. 1989. Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol. 70(Pt 5):1185-202.
Everett, R. D., and M. L. Fenwick. 1990. Comparative DNA sequence analysis of the host shutoff genes of different strains of herpes simplex virus: type 2 strain HG52 encodes a truncated UL41 product. J Gen Virol. 71(Pt 6):1387-90.
Everett, R. D., A. Orr, and M. Elliott. 1991. High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. Nucleic Acids Res. 19(22):6155-61.
Everett, R. D. 1991. Construction and characterization of herpes simplex type 1 viruses without introns in immediate early gene 1. J Gen Virol. 72(Pt 3):651-9.
Everett, R. D., and A. Orr. 1991. The Vmw175 binding site in the IE-1 promoter has no apparent role in the expression of Vmw110 during herpes simplex virus type 1 infection. Virology. 180(2):509-17.
Everett, R. D., A. Cross, and A. Orr. 1993. A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology. 197(2):751-6.
Everett, R. D., P. Barlow, A. Milner, B. Luisi, A. Orr, G. Hope, and D. Lyon. 1993. A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. J Mol Biol. 234(4):1038-47.
Everett, R. D., and G. G. Maul. 1994. HSV-1 IE protein Vmw110 causes redistribution of PML. Embo J. 13(21):5062-9.
Everett, R., A. Orr, and M. Elliott. 1995. The equine herpesvirus 1 gene 63 RING finger protein partially complements Vmw110, its herpes simplex virus type 1 counterpart. J Gen Virol. 76(Pt 9):2369-74.
Everett, R. D., G. G. Maul, A. Orr, and M. Elliott. 1995. The cellular RING finger protein PML is not a functional counterpart of the herpes simplex virus type 1 RING finger protein Vmw110. J Gen Virol. 76(Pt 4):791-8.
Everett, R. D., M. Meredith, A. Orr, A. Cross, M. Kathoria, and J. Parkinson. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein [corrected and republished article originally printed in EMBO J 1997 Feb 3;16(3):566-77]. Embo J. 16(7):1519-30.
Everett, R. D., P. Freemont, H. Saitoh, M. Dasso, A. Orr, M. Kathoria, and J. Parkinson. 1998. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol. 72(8):6581-91.
Everett, R. D., A. Orr, and C. M. Preston. 1998. A viral activator of gene expression functions via the ubiquitin- proteasome pathway. Embo J. 17(24):7161-9.
Everett, R. D., W. C. Earnshaw, J. Findlay, and P. Lomonte. 1999. Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. Embo J. 18(6):1526-38.
Everett, R. D., M. Meredith, and A. Orr. 1999. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J Virol. 73(1):417-26.
Everly, D. N., Jr., and G. S. Read. 1999. Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles. J Virol. 73(11):9117-29.
Falkenberg, M., D. A. Bushnell, P. Elias, and I. R. Lehman. 1997. The UL8 subunit of the heterotrimeric herpes simplex virus type 1 helicase-primase is required for the unwinding of single strand DNA- binding protein (ICP8)-coated DNA substrates. J Biol Chem. 272(36):22766-70.
Falkenberg, M., P. Elias, and I. R. Lehman. 1998. The herpes simplex virus type 1 helicase-primase. Analysis of helicase activity. J Biol Chem. 273(48):32154-7.
Fan, J., W. H. Zhang, and Y. Y. Wu. 1994. [Application of polymerase chain reaction for quick assay of herpes simplex viral acute ocular infection and ganglionic latent infection]. Chung Hua Yen Ko Tsa Chih. 30(4):298-300.
Fang, X. F., B. Song, Y. Y. Tu, J. Z. Tong, J. L. Faul, and H. Bai. 1999. Rapid detection of glycoprotein G gene for the diagnosis and typing of herpes simplex virus infection in genital herpes. Sex Transm Infect. 75(6):396-7.
Fareed, M. U., and J. G. Spivack. 1994. Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency- associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency. J Virol. 68(12):8071-81.
Fareed, M. U., A. R. Maclean, C. A. Maclean, A. Fu, and S. M. Brown. 1995. Isolation and characterization of two herpes simplex virus type 1 variants containing duplication of sequences within the unique long component of their genomes. Acta Virol. 39(2):69-77.
Fareed, M. U., and S. M. Brown. 1997. Use of site-directed mutagenesis to generate a herpes simplex virus type 1 strain 17+ mutant lacking seven HindIII restriction endonuclease cleavage sites. J Virol Methods. 68(1):17-32.
Farkas, D. H., T. M. Block, P. B. Hart, and R. G. Hughes, Jr. 1987. Sequences of herpes simplex virus type 1 that inhibit formation of stable TK+ transformants. J Virol. 61(10):2989-96.
Farrell, M. J., T. P. Margolis, W. A. Gomes, and L. T. Feldman. 1994. Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol. 68(9):5337-43.
Fath, T., J. Eidenmuller, T. Maas, and R. Brandt. 2000. Herpes simplex virus-mediated expression of the axonal protein tau in human model neurons (NT2-N cells). Microsc Res Tech. 48(2):85-96.
Fawaz, L. M., E. Sharif-Askari, and J. Menezes. 1999. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol. 163(8):4473-80.
Felser, J. M., P. R. Kinchington, G. Inchauspe, S. E. Straus, and J. M. Ostrove. 1988. Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J Virol. 62(6):2076-82.
Feng, C. P., M. Kulka, C. Smith, and L. Aurelian. 1996. Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3. Antisense Nucleic Acid Drug Dev. 6(1):25-35.
Fennewald, S. M., S. Mustain, J. Ojwang, and R. F. Rando. 1995. Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine. Antiviral Res. 26(1):37-54.
Fenwick, M. L., and J. Clark. 1982. Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol. 61(Pt l):121-5.
Fenwick, M. L., and R. D. Everett. 1990. Inactivation of the shutoff gene (UL41) of herpes simplex virus types 1 and 2. J Gen Virol. 71(Pt 12):2961-7.
Fenwick, M. L., and R. D. Everett. 1990. Transfer of UL41, the gene controlling virion-associated host cell shutoff, between different strains of herpes simplex virus. J Gen Virol. 71(Pt 2):411-8.
Ferrante, P., R. Mancuso, E. Pagani, F. R. Guerini, M. G. Calvo, M. Saresella, L. Speciale, and D. Caputo. 2000. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol. 6 Suppl 2:S109-14.
Fetzer, J., G. Folkers, I. Muller, and G. M. Keil. 1993. Site-directed mutagenesis in the active site of the herpes simplex virus type 1 thymidine kinase gene. Virus Genes. 7(2):205-9.
Fetzer, J., M. Michael, T. Bohner, R. Hofbauer, and G. Folkers. 1994. A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase. Protein Expr Purif. 5(5):432-41.
Feyzi, E., E. Trybala, T. Bergstrom, U. Lindahl, and D. Spillmann. 1997. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem. 272(40):24850-7.
Fierer, D. S., and M. D. Challberg. 1995. The stoichiometry of binding of the herpes simplex virus type 1 origin binding protein, UL9, to OriS. J Biol Chem. 270(13):7330-4.
Flanagan, W. M., A. G. Papavassiliou, M. Rice, L. B. Hecht, S. Silverstein, and E. K. Wagner. 1991. Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol. 65(2):769-86.
Fleck, M., J. Podlech, K. Weise, and D. Falke. 1994. A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice. Med Microbiol Immunol (Berl). 183(2):87-94.
Fletcher, T. M. d., and W. L. Gray. 1993. DNA sequence and genetic organization of the unique short (US) region of the simian varicella virus genome. Virology. 193(2):762-73.
Flowers, C. C., and D. J. O'Callaghan. 1992. The equine herpesvirus type 1 (EHV-1) homolog of herpes simplex virus type 1 US9 and the nature of a major deletion within the unique short segment of the EHV-1 KyA strain genome. Virology. 190(1):307-15.
Fluit, A. C., J. A. van Strijp, L. A. Miltenburg, C. P. van Kessel, H. Snippe, and J. Verhoef. 1989. The use of a hybridization assay for the study of host defences against herpes simplex virus. J Virol Methods. 26(3):269-78.
Foa-Tomasi, L., E. Avitabile, A. Boscaro, R. Brandimarti, R. Gualandri, R. Manservigi, F. Dall'Olio, F. Serafini-Cessi, and G. C. Fiume. 1991. Herpes simplex virus (HSV) glycoprotein H is partially processed in a cell line that expresses the glycoprotein and fully processed in cells infected with deletion or ts mutants in the known HSV glycoproteins. Virology. 180(2):474-82.
Focher, F., G. Maga, A. Bendiscioli, M. Capobianco, F. Colonna, A. Garbesi, and S. Spadari. 1995. Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing D- and L-thymidine 5'-triphosphate as substrate. Nucleic Acids Res. 23(15):2840-7.
Font, M., C. Sanmartin, M. L. Alonso, L. Gracia, M. J. Losa, B. Marquiegui, I. Merino, E. Nadal, I. Ruiz, A. Monge, M. T. Bengoechea, F. Cabodevilla, S. Elena, J. J. Martinez-Irujo, L. Odriozola, I. Penuelas, E. Santiago, F. Homa, and M. W. Wathen. 2000. New antiherpetic 1,3-phenylene derivatives, inhibitors of the interaction of the HSV-1 origin binding protein (OBP) with DNA. Drug Des Discov. 16(4):295-315.
Foster, T. P., G. V. Rybachuk, and K. G. Kousoulas. 1998. Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication. J Virol Methods. 75(2):151-60.
Foster, T. P., and K. G. Kousoulas. 1999. Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress. J Virol. 73(10):8457-68.
Foster, T. P., V. N. Chouljenko, and K. G. Kousoulas. 1999. Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein. Virology. 258(2):365-74.
Fraefel, C., S. Song, F. Lim, P. Lang, L. Yu, Y. Wang, P. Wild, and A. I. Geller. 1996. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol. 70(10):7190-7.
Fraefel, C., D. R. Jacoby, C. Lage, H. Hilderbrand, J. Y. Chou, F. W. Alt, X. O. Breakefield, and J. A. Majzoub. 1997. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol Med. 3(12):813-25.
Frame, M. C., H. S. Marsden, and D. J. McGeoch. 1986. Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J Gen Virol. 67(Pt 4):745-51.
Frame, M. C., F. C. Purves, D. J. McGeoch, H. S. Marsden, and D. P. Leader. 1987. Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J Gen Virol. 68(Pt 10):2699-704.
Franz, C., F. J. Kuhn, and C. W. Knopf. 1999. DNA and protein interactions of the small subunit of herpes simplex virus type 1 DNA polymerase. Virology. 253(1):55-64.
Fraser, N. W., W. C. Lawrence, Z. Wroblewska, D. H. Gilden, and H. Koprowski. 1981. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A. 78(10):6461-5.
Frazier, D. P., D. Cox, E. M. Godshalk, and P. A. Schaffer. 1996. Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells. J Virol. 70(11):7433-44.
Frazier, D. P., D. Cox, E. M. Godshalk, and P. A. Schaffer. 1996. The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells. J Virol. 70(11):7424-32.
Freese, A., M. Stern, M. G. Kaplitt, W. M. O'Connor, M. V. Abbey, M. J. O'Connor, and M. J. During. 1996. Prospects for gene therapy in Parkinson's disease. Mov Disord. 11(5):469-88.
Freiman, R. N., and W. Herr. 1997. Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev. 11(23):3122-7.
French, S. W., M. C. Schmidt, and J. C. Glorioso. 1996. Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol Cell Biol. 16(10):5393-9.
Friedman, H. M., L. Wang, N. O. Fishman, J. D. Lambris, R. J. Eisenberg, G. H. Cohen, and J. Lubinski. 1996. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol. 70(7):4253-60.
Frink, R. J., K. P. Anderson, and E. K. Wagner. 1981. Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol. 39(2):559-72.
Frink, R. J., R. Eisenberg, G. Cohen, and E. K. Wagner. 1983. Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol. 45(2):634-47.
Fu, T. M., R. H. Bonneau, M. Epler, M. J. Tevethia, S. Alam, K. Verner, and S. S. Tevethia. 1996. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Virology. 222(1):269-74.
Fujii, S., T. Akaike, and H. Maeda. 1999. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology. 256(2):203-12.
Fujiwara, M., N. Ashida, M. Okamoto, T. Mizuta, T. Ide, Y. Hanasaki, K. Katsuura, H. Sawada, S. Shigeta, K. Konno, T. Yokota, and M. Baba. 1998. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses. Antiviral Res. 38(2):141-9.
Fukuda, S., Y. Furuta, T. Takasu, S. Suzuki, Y. Inuyama, and K. Nagashima. 1994. The significance of herpes viral latency in the spiral ganglia. Acta Otolaryngol Suppl. 514:108-10.
Fukuda, S., and Y. Yoshita. 1998. [Molecular biology and molecular genetics in otorhinolaryngology--virus infections in inner ears]. Nippon Jibiinkoka Gakkai Kaiho. 101(6):856-9.
Furuta, Y., S. Fukuda, E. Chida, T. Takasu, F. Ohtani, Y. Inuyama, and K. Nagashima. 1998. Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J Med Virol. 54(3):162-6.
Gaffney, D. F., J. McLauchlan, J. L. Whitton, and J. B. Clements. 1985. A modular system for the assay of transcription regulatory signals: the sequence TAATGARAT is required for herpes simplex virus immediate early gene activation. Nucleic Acids Res. 13(21):7847-63.
Galdiero, M., A. Whiteley, B. Bruun, S. Bell, T. Minson, and H. Browne. 1997. Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H. J Virol. 71(3):2163-70.
Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1995. Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus. Adv Exp Med Biol. 5:1581-5.
Gallinari, P., K. Wiebauer, M. C. Nardi, and J. Jiricny. 1994. Localization of a 34-amino-acid segment implicated in dimerization of the herpes simplex virus type 1 ICP4 polypeptide by a dimerization trap. J Virol. 68(6):3809-20.
Gallo, M. L., D. I. Dorsky, C. S. Crumpacker, and D. S. Parris. 1989. The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase. J Virol. 63(12):5023-9.
Galvan, V., R. Brandimarti, and B. Roizman. 1999. Herpes simplex virus 1 blocks caspase-3-independent and caspase- dependent pathways to cell death. J Virol. 73(4):3219-26.
Galvan, V., R. Brandimarti, J. Munger, and B. Roizman. 2000. Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J Virol. 74(4):1931-8.
Gambhir, S. S., J. R. Barrio, L. Wu, M. Iyer, M. Namavari, N. Satyamurthy, E. Bauer, C. Parrish, D. C. MacLaren, A. R. Borghei, L. A. Green, S. Sharfstein, A. J. Berk, S. R. Cherry, M. E. Phelps, and H. R. Herschman. 1998. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med. 39(11):2003-11.
Gambhir, S. S., J. R. Barrio, M. E. Phelps, M. Iyer, M. Namavari, N. Satyamurthy, L. Wu, L. A. Green, E. Bauer, D. C. MacLaren, K. Nguyen, A. J. Berk, S. R. Cherry, and H. R. Herschman. 1999. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A. 96(5):2333-8.
Ganatra, J. B., D. Chandler, C. Santos, B. Kuppermann, and T. P. Margolis. 2000. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 129(2):166-72.
Gangappa, S., S. P. Deshpande, and B. T. Rouse. 2000. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Invest Ophthalmol Vis Sci. 41(2):453-9.
Gao, M., L. Matusick-Kumar, W. Hurlburt, S. F. DiTusa, W. W. Newcomb, J. C. Brown, P. J. McCann, 3rd, I. Deckman, and R. J. Colonno. 1994. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J Virol. 68(6):3702-12.
Gao, M., B. J. Robertson, P. J. McCann, D. R. O'Boyle, S. K. Weller, W. W. Newcomb, J. C. Brown, and S. P. Weinheimer. 1998. Functional conservations of the alkaline nuclease of herpes simplex type 1 and human cytomegalovirus. Virology. 249(2):460-70.
Garber, D. A., P. A. Schaffer, and D. M. Knipe. 1997. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol. 71(8):5885-93.
Garcia-Corbeira, P., W. Hogrefe, L. Aguilar, J. Garcia-de-Lomas, A. Gil, J. M. Bayas, A. Vilella, and R. Dal-Re. 1999. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2- based immunoassays for HSV-2 seroprevalence studies. J Med Virol. 59(4):502-6.
Garcin, D., Y. Michal, F. Jault, M. Lyon, G. Lenoir, and B. Jacquemont. 1990. Inhibition of HSV-1 multiplication in rat embryo fibroblasts constitutively expressing the EJ-ras oncogene. Virology. 179(1):208-16.
Gariglio, M., P. Foresta, C. Sacchi, M. Lembo, L. Hertel, and S. Landolfo. 1997. Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. J Gen Virol. 78(Pt 3):665-70.
Garrido, J. J., M. T. Alonso, F. Lim, J. Represa, F. Giraldez, and T. Schimmang. 1996. Using herpes simplex virus type 1 (HSV-1) mediated gene transfer to study neurotrophins in cochlear neurons. Int J Dev Biol. Suppl(1):149S-150S.
Garrido, J. J., E. Carnicero, F. Lim, and T. Schimmang. 1999. Differential effects on the survival of neuronal and non-neuronal cells after infection by herpes simplex virus type 1 mutants. J Neurovirol. 5(3):280-8.
Garweg, J., T. Fenner, M. Bohnke, and H. Schmitz. 1993. An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous. Graefes Arch Clin Exp Ophthalmol. 231(9):508-13.
Garweg, J., and M. Bohnke. 1996. Slow viral replication of HSV-1 is responsible for early recurrence of herpetic keratitis after corneal grafting. Graefes Arch Clin Exp Ophthalmol. 234 Suppl 1:S133-8.
Garweg, J. G., and M. Boehnke. 1997. Low rate shedding of HSV-1 DNA, but not of infectious virus from human donor corneae into culture media. J Med Virol. 52(3):320-5.
Gattuso, J. M., H. S. Debinski, H. O. Kangro, D. Jeffries, and M. A. Kamm. 1998. Evaluation of specific herpes DNA viruses in idiopathic megarectum and idiopathic megacolon. Int J Colorectal Dis. 13(3):131-3.
Gaudio, A. C., Y. Takahata, and W. G. Richards. 1998. Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase. J Comput Aided Mol Des. 12(1):15-25.
Gebhardt, B. M., and H. E. Kaufman. 1995. Propranolol suppresses reactivation of herpesvirus. Antiviral Res. 27(3):255-61.
Gebhardt, B. M., G. E. Wright, H. Xu, F. Focher, S. Spadari, and H. E. Kaufman. 1996. 9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antiviral Res. 30(2-3):87-94.
Geiger, K. D., D. Gurushanthaiah, E. L. Howes, G. A. Lewandowski, J. C. Reed, F. E. Bloom, and N. E. Sarvetnick. 1995. Cytokine-mediated survival from lethal herpes simplex virus infection: role of programmed neuronal death. Proc Natl Acad Sci U S A. 92(8):3411-5.
Geller, A. I. 1991. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters. J Neurosci Methods. 36(1):91-103.
Geller, A. I. 1993. Herpesviruses: expression of genes in postmitotic brain cells. Curr Opin Genet Dev. 3(1):81-5.
Gelman, I. H., and S. Silverstein. 1985. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A. 82(16):5265-9.
Georgopoulou, U., A. Kakkanas, V. Miriagou, A. Michaelidou, and P. Mavromara. 1995. Characterization of the US8.5 protein of herpes simplex virus. Arch Virol. 140(12):2227-41.
Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 280(5369):1618-20.
Gerber, S. I., B. J. Belval, and B. C. Herold. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology. 214(1):29-39.
Geschwind, M. D., J. A. Kessler, A. I. Geller, and H. J. Federoff. 1994. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. Brain Res Mol Brain Res. 24(1-4):327-35.
Gesser, R. M., T. Valyi-Nagy, S. M. Altschuler, and N. W. Fraser. 1994. Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia). J Gen Virol. 75(Pt 9):2379-86.
Gesser, R. M., T. Valyi-Nagy, and N. W. Fraser. 1994. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology. 200(2):791-5.
Gesser, R. M., and S. C. Koo. 1997. Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol. 71(5):4103-6.
Ghiasi, H., S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1994. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. J Virol. 68(4):2347-54.
Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. 1994. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol. 68(4):2118-26.
Ghiasi, H., S. Cai, S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1995. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28(2):147-57.
Ghiasi, H., G. C. Perng, S. Cai, A. B. Nesburn, and S. L. Wechsler. 1996. The UL3 open reading frame of herpes simplex virus type 1 codes for a phosphoprotein. Virus Res. 44(2):137-42.
Ghiasi, H., A. B. Nesburn, S. Cai, and S. L. Wechsler. 1998. The US5 open reading frame of herpes simplex virus type 1 does encode a glycoprotein (gJ). Intervirology. 41(2-3):91-7.
Ghiasi, H., G. C. Pemg, F. M. Hofman, S. Cai, A. B. Nesburn, and S. L. Wechsler. 1999. Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge. Virology. 258(2):208-16.
Gibson, M. G., and P. G. Spear. 1983. Insertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D. J Virol. 48(2):396-404.
Gieroba, Z. J., B. S. Zhu, W. W. Blessing, and S. L. Wesselingh. 1995. Herpes simplex virus induces Fos expression in rat brainstem neurons. Brain Res. 675(1-2):329-32.
Gilbert, R., K. Ghosh, L. Rasile, and H. P. Ghosh. 1994. Membrane anchoring domain of herpes simplex virus glycoprotein gB is sufficient for nuclear envelope localization. J Virol. 68(4):2272-85.
Gius, D., and L. A. Laimins. 1989. Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester. J Virol. 63(2):555-63.
Glebov, O. K., and D. S. Abramian. 1985. [Genetic transformation of somatic cells. VI. Transfer of the trait of the rate of loss of transformant phenotype by means of DNA from cells containing the thymidine kinase gene of the herpes simplex virus]. Tsitologiia. 27(6):678-87.
Glebov, O. K., D. S. Abramian, and T. M. Smirnova. 1985. [Genetic transformation of somatic cells. V. Inheritability of the rate of loss of the trait and the stabilization of the transformant phenotype]. Tsitologiia. 27(6):670-7.
Glebov, O. K., D. S. Abramian, and N. V. Tomilin. 1985. [Genetic transformation of somatic cells. IV. The rate of loss of transformant phenotype depends on the structure of the transforming DNA and changes when the cells are treated with the tumor promotor 12-o- tetradecanoyl-phorbol-13-acetate]. Tsitologiia. 27(5):572-81.
Glorioso, J. C., N. A. DeLuca, and D. J. Fink. 1995. Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol. 49:675-710.
Goade, D. E., R. Bell, T. Yamada, G. J. Mertz, and S. Jenison. 1996. Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies. J Virol. 70(5):2950-6.
Godefroy, S., and C. Guenet. 1995. Autoprocessing of HSV-1 protease: effect of deletions on autoproteolysis. FEBS Lett. 357(2):168-72.
Goins, W. F., L. R. Sternberg, K. D. Croen, P. R. Krause, R. L. Hendricks, D. J. Fink, S. E. Straus, M. Levine, and J. C. Glorioso. 1994. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol. 68(4):2239-52.
Goins, W. F., K. A. Lee, J. D. Cavalcoli, M. E. O'Malley, S. T. DeKosky, D. J. Fink, and J. C. Glorioso. 1999. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol. 73(1):519-32.
Goldenberg, D., N. Mador, A. Panet, and I. Steiner. 1998. Tissue specific distribution of the herpes simplex virus type 1 latency- associated transcripts on polyribosomes during latent infection. J Neurovirol. 4(4):426-32.
Goldin, A. L., R. M. Sandri-Goldin, M. Levine, and J. C. Glorioso. 1981. Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol. 38(1):50-8.
Goldstein, J. N., and S. K. Weller. 1998. In vitro processing of herpes simplex virus type 1 DNA replication intermediates by the viral alkaline nuclease, UL12. J Virol. 72(11):8772-81.
Goldstein, J. N., and S. K. Weller. 1998. The exonuclease activity of HSV-1 UL12 is required for in vivo function. Virology. 244(2):442-57.
Gompels, U., and A. Minson. 1986. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology. 153(2):230-47.
Gonzalez-Villasenor, L. I. 1999. A duplex PCR assay for detection and genotyping of Herpes simplex virus in cerebrospinal fluid. Mol Cell Probes. 13(4):309-14.
Goodman, J. L., M. L. Cook, F. Sederati, K. Izumi, and J. G. Stevens. 1989. Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regions. J Virol. 63(3):1153-61.
Goshima, F., D. Watanabe, H. Takakuwa, K. Wada, T. Daikoku, M. Yamada, and Y. Nishiyama. 2000. Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells. Arch Virol. 145(2):417-26.
Goto, T., Y. Yamaguchi, M. Hashido, H. Yoshikawa, and T. Kawana. 1993. Diagnosis of genital herpes by polymerase chain reaction amplification. Microbiol Immunol. 37(12):987-90.
Gottlieb, J., A. I. Marcy, D. M. Coen, and M. D. Challberg. 1990. The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity. J Virol. 64(12):5976-87.
Gottlieb, J., and M. D. Challberg. 1994. Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template. J Virol. 68(8):4937-45.
Gowans, E. J., K. Blight, J. Arthur, and G. D. Higgins. 1994. Detection of virus nucleic acids by radioactive and nonisotopic in situ hybridization. Methods Mol Biol. 33:243-56.
Goya, R. G., J. Rowe, Y. E. Sosa, P. Tomasec, P. R. Lowenstein, and M. G. Castro. 1998. Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cells. Mol Cell Endocrinol. 139(1-2):199-207.
Grabowska, A., C. Jameson, P. Laing, S. Jeansson, E. Sjogren-Jansson, J. Taylor, A. Cunningham, and W. L. Irving. 1999. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol. 80(Pt 7):1789-98.
Graves-Woodward, K. L., and S. K. Weller. 1996. Replacement of gly815 in helicase motif V alters the single-stranded DNA-dependent ATPase activity of the herpes simplex virus type 1 helicase-primase. J Biol Chem. 271(23):13629-35.
Gray, C. P., and H. C. Kaerner. 1984. Sequence of the putative origin of replication in the UL region of herpes simplex virus type 1 ANG DNA. J Gen Virol. 65(Pt 12):2109-19.
Greco, A., D. Simonin, J. J. Diaz, L. Barjhoux, K. Kindbeiter, J. J. Madjar, and T. Masse. 1994. The DNA sequence coding for the 5' untranslated region of herpes simplex virus type 1 ICP22 mRNA mediates a high level of gene expression. J Gen Virol. 75(Pt 7):1693-702.
Greco, A., A. M. Laurent, and J. J. Madjar. 1997. Repression of beta-actin synthesis and persistence of ribosomal protein synthesis after infection of HeLa cells by herpes simplex virus type 1 infection are under translational control. Mol Gen Genet. 256(3):320-7.
Green, M. T., H. B. Qavi, and G. K. SeGall. 1987. Isolation and characterization of HSV-1 DNA from trigeminal ganglion neurons during suppressed infection in vitro. Invest Ophthalmol Vis Sci. 28(2):391-4.
Greenaway, P. J., and G. W. Wilkinson. 1987. Nucleotide sequence of the most abundantly transcribed early gene of human cytomegalovirus strain AD169. Virus Res. 7(1):17-31.
Griffiths, A., S. Renfrey, and T. Minson. 1998. Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non- polarized cells. J Gen Virol. 79(Pt 4):807-12.
Grodzicker, T., and D. F. Klessig. 1980. Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 tk gene and adenovirus 2 DNA. Cell. 21(2):453-63.
Groh, M. J., B. Seitz, S. Schumacher, and G. O. Naumann. 1999. Detection of herpes simplex virus in aqueous humor in iridocorneal endothelial (ICE) syndrome. Cornea. 18(3):359-60.
Grundy, F. J., R. P. Baumann, and D. J. O'Callaghan. 1989. DNA sequence and comparative analyses of the equine herpesvirus type 1 immediate early gene. Virology. 172(1):223-36.
Gu, B., R. Rivera-Gonzalez, C. A. Smith, and N. A. DeLuca. 1993. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter. Proc Natl Acad Sci U S A. 90(20):9528-32.
Gu, B., and N. DeLuca. 1994. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J Virol. 68(12):7953-65.
Gu, M., G. G. Haraszthy, A. R. Collins, and E. J. Bergey. 1995. Identification of salivary proteins inhibiting herpes simplex virus 1 replication. Oral Microbiol Immunol. 10(1):54-9.
Gupta, R., A. Emili, G. Pan, H. Xiao, M. Shales, J. Greenblatt, and C. J. Ingles. 1996. Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. Nucleic Acids Res. 24(12):2324-30.
Gustafson, E. A., A. C. Chillemi, D. R. Sage, and J. D. Fingeroth. 1998. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob Agents Chemother. 42(11):2923-31.
Gustafson, E. A., R. F. Schinazi, and J. D. Fingeroth. 2000. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J Virol. 74(2):684-92.
Guzowski, J. F., and E. K. Wagner. 1993. Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation. J Virol. 67(9):5098-108.
Guzowski, J. F., J. Singh, and E. K. Wagner. 1994. Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor. J Virol. 68(12):7774-89.
Haanes, E. J., C. M. Nelson, C. L. Soule, and J. L. Goodman. 1994. The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion. J Virol. 68(9):5825-34.
Haanes, E. J., D. R. Thomsen, S. Martin, F. L. Homa, and D. E. Lowery. 1995. The bovine herpesvirus 1 maturational proteinase and scaffold proteins can substitute for the homologous herpes simplex virus type 1 proteins in the formation of hybrid type B capsids. J Virol. 69(11):7375-9.
Haanes, E. J., C. C. Chen, and D. E. Lowery. 1997. Nucleotide sequence and transcriptional analysis of a portion of the bovine herpesvirus genome encoding genes homologous to HSV-1, UL25, UL26 and UL26.5. Virus Res. 48(1):19-26.
Haas, J., U. Meyding-Lamade, A. Fath, K. Stingele, B. Storch-Hagenlocher, and B. Wildemann. 1999. Acyclovir treatment of experimentally induced herpes simplex virus encephalitis: monitoring the changes in immunologic NO synthase expression and viral load within brain tissue of SJL mice. Neurosci Lett. 264(1-3):129-32.
Halford, W. P., B. M. Gebhardt, and D. J. Carr. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol. 157(8):3542-9.
Halford, W. P., B. M. Gebhardt, and D. J. Carr. 1997. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology. 238(1):53-63.
Halford, W. P., L. A. Veress, B. M. Gebhardt, and D. J. Carr. 1997. Innate and acquired immunity to herpes simplex virus type 1. Virology. 236(2):328-37.
Hall, J. D., J. S. Gibbs, D. M. Coen, and D. W. Mount. 1986. Structural organization and unusual codon usage in the DNA polymerase gene from herpes simplex virus type 1. Dna. 5(4):281-8.
Hall, D. L., and P. L. Darke. 1995. Activation of the herpes simplex virus type 1 protease. J Biol Chem. 270(39):22697-700.
Hall, M. R. T., and W. Gibson. 1997. Assemblin homolog of herpes simplex virus type 1 retains proteolytic activity when expressed as a recombinant two-chain enzyme. Virology. 227(1):160-7.
Halliday, K. E., R. C. McKenzie, and M. Norval. 1997. Expression of interleukin-10 mRNA in herpes simplex virus-infected keratinocytes in vivo and in vitro. Biochem Soc Trans. 25(2):282S.
Hamatake, R. K., M. Bifano, D. J. Tenney, W. W. Hurlburt, and M. G. Cordingley. 1993. The herpes simplex virus type 1 DNA polymerase accessory protein, UL42, contains a functional protease-resistant domain. J Gen Virol. 74(Pt 10):2181-9.
Hamatake, R. K., M. Bifano, W. W. Hurlburt, and D. J. Tenney. 1997. A functional interaction of ICP8, the herpes simplex virus single- stranded DNA-binding protein, and the helicase-primase complex that is dependent on the presence of the UL8 subunit. J Gen Virol. 78(Pt 4):857-65.
Hammarsten, O., X. Yao, and P. Elias. 1996. Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1. J Virol. 70(7):4523-9.
Hammarsten, O., P. Elias, and N. D. Stow. 1996. Characterization of a binding site for the herpes simplex virus type 1 UL9 origin-binding protein within the UL9 gene. J Gen Virol. 77(Pt 5):969-76.
Hammerschmidt, W., F. Conraths, J. Mankertz, G. Pauli, H. Ludwig, and H. J. Buhk. 1988. Conservation of a gene cluster including glycoprotein B in bovine herpesvirus type 2 (BHV-2) and herpes simplex virus type 1 (HSV-1). Virology. 165(2):388-405.
Hamouda, T., R. McPhee, S. C. Hsia, G. S. Read, T. C. Holland, and S. R. King. 1997. Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein. J Virol. 71(7):5521-7.
Hampar, B., J. G. Derge, A. L. Boyd, M. A. Tainsky, and S. D. Showalter. 1981. Herpes simplex virus (type 1) thymidine kinase gene does not transform cells morphologically. Proc Natl Acad Sci U S A. 78(4):2616-9.
Hamzaoui, K., A. Hamzaoui, L. Zakraoui, and A. Chabbou. 1999. Expression of Bcl-2 in inflammatory sites from patients with active Behcet's disease. Mediators Inflamm. 8(2):101-6.
Handler, C. G., G. H. Cohen, and R. J. Eisenberg. 1996. Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry. J Virol. 70(9):6076-82.
Hara, K., M. Toba, Y. Yogo, and F. Taguchi. 1994. Growth inhibition of herpes simplex virus-1 in the cells expressing abundant 2.0-kilobase latency-associated transcripts. Jpn J Med Sci Biol. 47(5-6):281-8.
Hara, Y., T. Kimoto, Y. Okuno, and Y. Minekawa. 1997. Effect of herpes simplex virus on the DNA of human papillomavirus 18. J Med Virol. 53(1):4-12.
Harada, Y., M. Iwai, S. Tanaka, T. Okanoue, K. Kashima, H. Maruyama-Tabata, H. Hirai, E. Satoh, J. Imanishi, and O. Mazda. 2000. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther. 7(1):27-36.
Hardwicke, M. A., P. J. Vaughan, R. E. Sekulovich, R. O'Conner, and R. M. Sandri-Goldin. 1989. The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule. J Virol. 63(11):4590-602.
Hardwicke, M. A., and P. A. Schaffer. 1995. Cloning and characterization of herpes simplex virus type 1 oriL: comparison of replication and protein-DNA complex formation by oriL and oriS. J Virol. 69(3):1377-88.
Hardwicke, M. A., and P. A. Schaffer. 1997. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells. J Virol. 71(5):3580-7.
Hardy, W. R., and R. M. Sandri-Goldin. 1994. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol. 68(12):7790-9.
Harland, J., and S. M. Brown. 1988. Generation of a herpes simplex virus type 2 variant devoid of XbaI sites: removal of the 0.91 map coordinate site results in impaired synthesis of glycoprotein G-2. J Gen Virol. 69(Pt 1):113-24.
Harland, J., and S. M. Brown. 1991. Abolition of the RL neurovirulence phenotype of herpes simplex virus type 2 strain HG52 does not require deletion of the DR1 element of the 'a' sequence. J Gen Virol. 72(Pt 11):2777-9.
Harms, J. S., X. Ren, S. C. Oliveira, and G. A. Splitter. 2000. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol. 74(7):3301-12.
Harrington, L., L. V. Wall, and D. C. Kelly. 1992. Molecular cloning and physical mapping of the genome of simian herpes B virus and comparison of genome organization with that of herpes simplex virus type 1. J Gen Virol. 73(Pt 5):1217-26.
Hatama, S., H. K. Jang, Y. Izumiya, J. S. Cai, Y. Tsushima, K. Kato, T. Miyazawa, C. Kai, E. Takahashi, and T. Mikami. 1999. Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the herpes simplex virus type 1 UL20 and UL21. J Vet Med Sci. 61(6):587-93.
Haubner, R., N. Avril, P. A. Hantzopoulos, B. Gansbacher, and M. Schwaiger. 2000. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. Eur J Nucl Med. 27(3):283-91.
Haugen, T. H., B. Alden, S. Matthey, and D. Nicholson. 1993. Restriction enzyme fragment length polymorphisms of amplified herpes simplex virus type-1 DNA provide epidemiologic information. Diagn Microbiol Infect Dis. 17(2):129-33.
Hayashi, K., and S. Niwayama. 1993. Effects of gangliosides on the growth of herpes simplex virus type 1- infected cells derived from neurons and on viral replication. Intervirology. 36(3):134-43.
Hayward, G. S., R. Ambinder, D. Ciufo, S. D. Hayward, and R. L. LaFemina. 1984. Structural organization of human herpesvirus DNA molecules. J Invest Dermatol. 83(1 Suppl):29s-41s.
He, B., J. Chou, D. A. Liebermann, B. Hoffman, and B. Roizman. 1996. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J Virol. 70(1):84-90.
He, B., M. Gross, and B. Roizman. 1997. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A. 94(3):843-8.
He, B., M. Gross, and B. Roizman. 1998. The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J Biol Chem. 273(33):20737-43.
He, X., and I. R. Lehman. 2000. Unwinding of a herpes simplex virus type 1 origin of replication (Ori(S)) by a complex of the viral origin binding protein and the single-stranded DNA binding protein. J Virol. 74(12):5726-8.
Heilbronn, R., G. Jahn, A. Burkle, U. K. Freese, B. Fleckenstein, and H. zur Hausen. 1987. Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol. 61(1):119-24.
Heiligenhaus, A., P. A. Wells, and C. S. Foster. 1995. Immunisation against HSV-1 keratitis with a synthetic gD peptide. Eye. 9(( Pt 1)):89-95.
Heiligenhaus, A., and D. Bauer. 1999. Herpes simplex virus type 1 infection of the cornea. Dev Ophthalmol. 30:141-66.
Heiligenhaus, A., D. Bauer, M. Zheng, S. Mrzyk, and K. P. Steuhl. 1999. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol. 237(5):399-406.
Henderson, J. O., L. J. Ball-Goodrich, and D. S. Parris. 1998. Structure-function analysis of the herpes simplex virus type 1 UL12 gene: correlation of deoxyribonuclease activity in vitro with replication function. Virology. 243(1):247-59.
Hennes-Stegmann, B., and C. H. Schroder. 1982. Low infectivity of HSV-1 DNA caused by defective-interfering genomes. J Gen Virol. 63(2):307-14.
Herold, B. C., R. J. Visalli, N. Susmarski, C. R. Brandt, and P. G. Spear. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol. 75(Pt 6):1211-22.
Herold, B. C., and P. G. Spear. 1994. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry. Virology. 203(1):166-71.
Herold, B. C., S. I. Gerber, T. Polonsky, B. J. Belval, P. N. Shaklee, and K. Holme. 1995. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology. 206(2):1108-16.
Hibbard, M. K., and R. M. Sandri-Goldin. 1995. Arginine-rich regions succeeding the nuclear localization region of the herpes simplex virus type 1 regulatory protein ICP27 are required for efficient nuclear localization and late gene expression. J Virol. 69(8):4656-67.
Hidaka, Y., Y. Sakai, Y. Toh, and R. Mori. 1991. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J Gen Virol. 72(Pt 4):915-21.
Hilbert, A., F. Hudecz, G. Mezo, I. Mucsi, J. Kajtar, I. Kurucz, J. Gergely, and E. Rajnavolgyi. 1994. The influence of branched polypeptide carriers on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D. Scand J Immunol. 40(6):609-17.
Hill, T. M., R. R. Sinden, and J. R. Sadler. 1983. Herpes simplex virus types 1 and 2 induce shutoff of host protein synthesis by different mechanisms in Friend erythroleukemia cells. J Virol. 45(1):241-50.
Hill, A. B., B. C. Barnett, A. J. McMichael, and D. J. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol. 152(6):2736-41.
Hill, J. M., W. P. Halford, R. Wen, L. S. Engel, L. C. Green, and B. M. Gebhardt. 1996. Quantitative analysis of polymerase chain reaction products by dot blot. Anal Biochem. 235(1):44-8.
Hill, J. M., J. B. Maggioncalda, H. H. Garza, Jr., Y. H. Su, N. W. Fraser, and T. M. Block. 1996. In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5' end of the 2.0 kilobase latency-associated transcript. J Virol. 70(10):7270-4.
Hill, J. M., H. H. Garza, Jr., Y. H. Su, R. Meegalla, L. A. Hanna, J. M. Loutsch, H. W. Thompson, E. D. Varnell, D. C. Bloom, and T. M. Block. 1997. A 437-base-pair deletion at the beginning of the latency-associated transcript promoter significantly reduced adrenergically induced herpes simplex virus type 1 ocular reactivation in latently infected rabbits. J Virol. 71(9):6555-9.
Hill, J. M., H. H. Garza, Jr., M. F. Helmy, S. D. Cook, P. A. Osborne, E. M. Johnson, Jr., H. W. Thompson, L. C. Green, R. J. O'Callaghan, and B. M. Gebhardt. 1997. Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits. J Neurovirol. 3(3):206-11.
Hilliard, J. K., D. Black, and R. Eberle. 1989. Simian alphaherpesviruses and their relation to the human herpes simplex viruses. Arch Virol. 109(1-2):83-102.
Hilton, M. J., D. Mounghane, T. McLean, N. V. Contractor, J. O'Neil, K. Carpenter, and S. L. Bachenheimer. 1995. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor. Virology. 213(2):624-38.
Hirai, H., E. Satoh, M. Osawa, T. Inaba, C. Shimazaki, S. Kinoshita, M. Nakagawa, O. Mazda, and J. Imanishi. 1997. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Biochem Biophys Res Commun. 241(1):112-8.
Hiraki, A., Y. Ikuno, J. Kim, and S. Ueda. 1996. Suppression of enveloped virus production with a substance from silkworm faeces. Cell Struct Funct. 21(6):501-14.
Hirano, M., S. Nakamura, M. Okada, M. Ueda, and R. Mukai. 2000. Rapid discrimination of monkey B virus from human herpes simplex viruses by PCR in the presence of betaine. J Clin Microbiol. 38(3):1255-7.
Ho, D. Y., and E. S. Mocarski. 1989. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A. 86(19):7596-600.
Hobbs, W. E., 2nd, and N. A. DeLuca. 1999. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol. 73(10):8245-55.
Hodgman, T. C., and A. C. Minson. 1986. The herpes simplex virus type 2 equivalent of the herpes simplex virus type 1 US7 gene and its flanking sequences. Virology. 153(1):1-11.
Holden, V. R., R. R. Yalamanchili, R. N. Harty, and D. J. O'Callaghan. 1992. Identification and characterization of an equine herpesvirus 1 late gene encoding a potential zinc finger. Virology. 188(2):704-13.
Homa, F. L., T. M. Otal, J. C. Glorioso, and M. Levine. 1986. Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol. 6(11):3652-66.
Homa, F. L., J. C. Glorioso, and M. Levine. 1988. A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev. 2(1):40-53.
Homer, E. G., A. Rinaldi, M. J. Nicholl, and C. M. Preston. 1999. Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J Virol. 73(10):8512-8.
Hong, Z., M. Beaudet-Miller, J. Durkin, R. Zhang, and A. D. Kwong. 1996. Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein. J Virol. 70(1):533-40.
Hoog, S. S., W. W. Smith, X. Qiu, C. A. Janson, B. Hellmig, M. S. McQueney, K. O'Donnell, D. O'Shannessy, A. G. DiLella, C. Debouck, and S. S. Abdel-Meguid. 1997. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex. Biochemistry. 36(46):14023-9.
Hooks, J. J., and C. Kupfer. 1995. Herpes simplex virus in iridocorneal endothelial syndrome [letter; comment]. Arch Ophthalmol. 113(10):1226-8.
Hope, R. G., J. Palfreyman, M. Suh, and H. S. Marsden. 1982. Sulphated glycoproteins induced by herpes simplex virus. J Gen Virol. 58(Pt 2):399-415.
Hope, R. G., and H. S. Marsden. 1983. Processing of glycoproteins induced by herpes simplex virus type 1: sulphation and nature of the oligosaccharide linkages. J Gen Virol. 64(Pt 9):1943-53.
Horsburgh, B. C., M. M. Hubinette, D. Qiang, M. L. MacDonald, and F. Tufaro. 1999. Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 6(5):922-30.
Hostetler, K. Y., G. D. Kini, J. R. Beadle, K. A. Aldern, M. F. Gardner, R. Border, R. Kumar, L. Barshak, C. N. Sridhar, C. J. Wheeler, and D. D. Richman. 1996. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV- infected cells, in vitro. Antiviral Res. 31(1-2):59-67.
Hu, M. C., and N. Davidson. 1988. The inducible lac operator-repressor system is functional for control of expression of injected DNA in Xenopus oocytes. Gene. 62(2):301-13.
Huang, C. J., S. A. Goodart, M. K. Rice, J. F. Guzowski, and E. K. Wagner. 1993. Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter. J Virol. 67(9):5109-16.
Huang, Q. S., S. L. Deshmane, and N. W. Fraser. 1994. An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1. Gene Ther. 1(5):300-6.
Huang, C. J., and E. K. Wagner. 1994. The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression. J Virol. 68(9):5738-47.
Huang, C. C., and W. Herr. 1996. Differential control of transcription by homologous homeodomain coregulators. Mol Cell Biol. 16(6):2967-76.
Huang, C. J., M. D. Petroski, N. T. Pande, M. K. Rice, and E. K. Wagner. 1996. The herpes simplex virus type 1 VP5 promoter contains a cis-acting element near the cap site which interacts with a cellular protein. J Virol. 70(3):1898-904.
Huard, J., G. Akkaraju, S. C. Watkins, M. Pike-Cavalcoli, and J. C. Glorioso. 1997. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Hum Gene Ther. 8(4):439-52.
Huebner, K., A. Linnenbach, S. Weidner, G. Glenn, and C. M. Croce. 1981. Deoxyribonuclease I sensitivity of plasmid genomes in teratocarcinoma- derived stem and differentiated cells. Proc Natl Acad Sci U S A. 78(8):5071-5.
Hufert, F. T., T. Diebold, B. Ermisch, D. Von Laer, U. Meyer-Konig, and D. Neumann-Haefelin. 1995. Liver failure due to disseminated HSV-1 infection in a newborn twin. Scand J Infect Dis. 27(6):627-9.
Hukin, J., K. Farrell, L. M. MacWilliam, M. Colbourne, E. Waida, R. Tan, L. Mroz, and E. Thomas. 1998. Case-control study of primary human herpesvirus 6 infection in children with febrile seizures. Pediatrics. 101(2):E3.
Hummel, M., M. Arsenakis, A. Marchini, L. Lee, B. Roizman, and E. Kieff. 1986. Herpes simplex virus expressing Epstein-Barr virus nuclear antigen 1. Virology. 148(2):337-48.
Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol. 66(4):2240-50.
Hutchinson, L., and D. C. Johnson. 1995. Herpes simplex virus glycoprotein K promotes egress of virus particles. J Virol. 69(9):5401-13.
Hwang, C. B., B. Horsburgh, E. Pelosi, S. Roberts, P. Digard, and D. M. Coen. 1994. A net +1 frameshift permits synthesis of thymidine kinase from a drug- resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A. 91(12):5461-5.
Hwang, J. J., Z. Scuric, and W. F. Anderson. 1996. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline- responsive expression system. J Virol. 70(11):8138-41.
Hwang, Y. T., J. F. Smith, L. Gao, and C. B. Hwang. 1998. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities. Virology. 246(2):298-305.
Hwang, Y. T., B. Y. Liu, C. Y. Hong, E. J. Shillitoe, and C. B. Hwang. 1999. Effects of exonuclease activity and nucleotide selectivity of the herpes simplex virus DNA polymerase on the fidelity of DNA replication in vivo. J Virol. 73(7):5326-32.
Ikeda, T., J. Ando, A. Miyazono, X. H. Zhu, H. Tsumagari, T. Nohara, K. Yokomizo, and M. Uyeda. 2000. Anti-herpes virus activity of Solanum steroidal glycosides. Biol Pharm Bull. 23(3):363-4.
Imbalzano, A. N., D. M. Coen, and N. A. DeLuca. 1991. Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J Virol. 65(2):565-74.
Ingram, A., A. Phelan, J. Dunlop, and J. B. Clements. 1996. Immediate early protein IE63 of herpes simplex virus type 1 binds RNA directly. J Gen Virol. 77(Pt 8):1847-51.
Inoue, N., T. R. Dambaugh, J. C. Rapp, and P. E. Pellett. 1994. Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses. J Virol. 68(7):4126-36.
Irie, H., H. Koyama, H. Kubo, A. Fukuda, K. Aita, T. Koike, A. Yoshimura, T. Yoshida, J. Shiga, and T. Hill. 1998. Herpes simplex virus hepatitis in macrophage-depleted mice: the role of massive, apoptotic cell death in pathogenesis. J Gen Virol. 79(Pt 5):1225-31.
Israel, B. A., K. T. Schultz, and C. J. Murphy. 1998. Lack of detectable interaction between HSV-1 and integrins or tachykinins. Intervirology. 41(2-3):132-4.
Ito, M., W. Koide, M. Watanabe, H. Kamiya, and M. Sakurai. 1997. Apoptosis of cord blood T lymphocytes by herpes simplex virus type 1. J Gen Virol. 78(Pt 8):1971-5.
Ito, M., M. Watanabe, H. Kamiya, and M. Sakurai. 1997. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes. J Infect Dis. 175(5):1220-4.
Itoh, N., N. Matsumura, A. Ogi, T. Nishide, Y. Imai, H. Kanai, and S. Ohno. 2000. High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. Am J Ophthalmol. 129(3):404-5.
Itzhaki, R. F., W. R. Lin, D. Shang, G. K. Wilcock, B. Faragher, and G. A. Jamieson. 1997. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease [see comments]. Lancet. 349(9047):241-4.
Ivanova, L., S. Schlesinger, and P. D. Olivo. 1999. Regulated expression of a Sindbis virus replicon by herpesvirus promoters. J Virol. 73(3):1998-2005.
Izumi, K. M., and J. G. Stevens. 1990. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J Exp Med. 172(2):487-96.
Izumiya, Y., H. K. Jang, H. Kashiwase, J. S. Cai, Y. Nishimura, Y. Tsushima, K. Kato, T. Miyazawa, C. Kai, and T. Mikami. 1998. Identification and transcriptional analysis of the homologues of the herpes simplex virus type 1 UL41 to UL51 genes in the genome of nononcogenic Marek's disease virus serotype 2. J Gen Virol. 79(Pt 8):1997-2001.
Izumiya, Y., H. K. Jang, M. Sugawara, Y. Ikeda, R. Miura, Y. Nishimura, K. Nakamura, T. Miyazawa, C. Kai, and T. Mikami. 1999. Identification and transcriptional analysis of the homologues of the herpes simplex virus type 1 UL30 to UL40 genes in the genome of nononcogenic Marek's disease virus serotype 2. J Gen Virol. 80(Pt 9):2417-22.
Izumiya, Y., H. K. Jang, J. S. Cai, Y. Nishimura, K. Nakamura, Y. Tsushima, K. Kato, T. Miyazawa, C. Kai, and T. Mikami. 1999. Identification and sequence analysis of the Marek's disease virus serotype 2 gene homologous to the herpes simplex virus type 1 UL52 protein. J Vet Med Sci. 61(6):683-7.
Jacobs, J. J., E. Folkers, and J. Vreeswijk. 1999. Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers. J Virol Methods. 83(1-2):155-67.
Jacobson, J. G., S. H. Chen, W. J. Cook, M. F. Kramer, and D. M. Coen. 1998. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice. Virology. 242(1):161-9.
Jacquemont, B., B. Verrier, A. L. Epstein, and I. Machuca. 1984. Expression of immediate-early genes in herpes simplex virus type 1- infected XC cells: lack of ICP22 (68K) polypeptide. J Gen Virol. 65(Pt 8):1331-40.
Jahedi, S., N. S. Markovitz, F. Filatov, and B. Roizman. 1999. Colocalization of the herpes simplex virus 1 UL4 protein with infected cell protein 22 in small, dense nuclear structures formed prior to onset of DNA synthesis. J Virol. 73(6):5132-8.
Jamieson, D. R., L. H. Robinson, J. I. Daksis, M. J. Nicholl, and C. M. Preston. 1995. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J Gen Virol. 76(Pt 6):1417-31.
Jankowski, J. M., and G. H. Dixon. 1984. Transcription of a trout protamine gene in vitro: the effects of alteration of promoters. Can J Biochem Cell Biol. 62(5):291-300.
Jarman, R. G., E. K. Wagner, and D. C. Bloom. 1999. LAT expression during an acute HSV infection in the mouse. Virology. 262(2):384-97.
Javier, R. T., J. G. Stevens, V. B. Dissette, and E. K. Wagner. 1988. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology. 166(1):254-7.
Jay, V., L. E. Becker, S. Blaser, P. Hwang, H. J. Hoffman, R. Humphreys, and M. Zielenska. 1995. Pathology of chronic herpes infection associated with seizure disorder: a report of two cases with tissue detection of herpes simplex virus 1 by the polymerase chain reaction. Pediatr Pathol Lab Med. 15(1):131-46.
Jay, V., L. E. Becker, H. Otsubo, M. Cortez, P. Hwang, H. J. Hoffman, and M. Zielenska. 1995. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology. 45(1):108-17.
Jayachandra, S., A. Baghian, and K. G. Kousoulas. 1997. Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space. J Virol. 71(7):5012-24.
Jenkins, F. J., M. J. Casadaban, and B. Roizman. 1985. Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome. Proc Natl Acad Sci U S A. 82(14):4773-7.
Jensen, H. L., and B. Norrild. 1999. Easy and reliable double-immunogold labelling of herpes simplex virus type-1 infected cells using primary monoclonal antibodies and studied by cryosection electron microscopy. Histochem J. 31(8):525-33.
Jerome, K. R., J. F. Tait, D. M. Koelle, and L. Corey. 1998. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol. 72(1):436-41.
Jerome, K. R., R. Fox, Z. Chen, A. E. Sears, H. Lee, and L. Corey. 1999. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol. 73(11):8950-7.
Jia, W. W., L. Gatzke, X. Wu, Y. Wang, F. Tufaro, and M. Cynader. 1994. A recombinant herpes simplex type 1 virus expressing antisense 5-HT2 receptors. Gene Ther. 1(Suppl 1):S75.
Jin, B. K., M. Belloni, B. Conti, H. J. Federoff, R. Starr, J. H. Son, H. Baker, and T. H. Joh. 1996. Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum Gene Ther. 7(16):2015-24.
Johnson, P. A., and R. D. Everett. 1986. The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Res. 14(21):8247-64.
Johnson, P. A., and R. D. Everett. 1986. DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Res. 14(9):3609-25.
Johnson, P. A., C. MacLean, H. S. Marsden, R. G. Dalziel, and R. D. Everett. 1986. The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene. J Gen Virol. 67(Pt 5):871-83.
Johnson, D. C., M. C. Frame, M. W. Ligas, A. M. Cross, and N. D. Stow. 1988. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol. 62(4):1347-54.
Johnson, P. A., M. G. Best, T. Friedmann, and D. S. Parris. 1991. Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J Virol. 65(2):700-10.
Johnson, P. A., K. Yoshida, F. H. Gage, and T. Friedmann. 1992. Effects of gene transfer into cultured CNS neurons with a replication- defective herpes simplex virus type 1 vector. Brain Res Mol Brain Res. 12(1-3):95-102.
Johnson, P. A., M. J. Wang, and T. Friedmann. 1994. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol. 68(10):6347-62.
Johnston, K. M., D. Jacoby, P. A. Pechan, C. Fraefel, P. Borghesani, D. Schuback, R. J. Dunn, F. I. Smith, and X. O. Breakefield. 1997. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum Gene Ther. 8(3):359-70.
Jones, C. M., S. C. Cose, and F. R. Carbone. 1997. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. Int Immunol. 9(9):1319-28.
Jordan, R., J. Pepe, and P. A. Schaffer. 1998. Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage. J Virol. 72(7):5373-82.
Jordan, R., L. Schang, and P. A. Schaffer. 1999. Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases. J Virol. 73(10):8843-7.
Jugovic, P., A. M. Hill, R. Tomazin, H. Ploegh, and D. C. Johnson. 1998. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol. 72(6):5076-84.
Jun, P. Y., L. I. Strelow, R. C. Herman, H. S. Marsden, T. Eide, L. Haarr, and D. A. Leib. 1998. The UL4 gene of herpes simplex virus type 1 is dispensable for latency, reactivation and pathogenesis in mice. J Gen Virol. 79(Pt 7):1603-11.
Junejo, F., and S. M. Brown. 1995. Latent phenotype analysis of three deletion variants of herpes simplex virus type 1 (HSV-1) in mouse model. JPMA J Pak Med Assoc. 45(4):99-104.
Junejo, F., and S. M. Brown. 1995. Deletions and duplication in internal inverted repeat sequence of long region/unique sequence of long region (IRL/UL) of herpes simplex virus type-1 (HSV-1) genome are not evidently associated with intracranial and foot-pad pathogenicity in mouse model. JPMA J Pak Med Assoc. 45(4):95-8.
Kakkanas, A., H. Papadogeorgaki, R. Manservigi, V. Miriagou, U. Georgopoulou, and P. Mavromara. 1995. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays. Intervirology. 38(6):346-51.
Kalinowska, E., and M. Chorazy. 1992. Carrier DNA affects the integration of HSV-1 TK gene in the genome of L929TK- cells. Cell Biol Int Rep. 16(1):11-8.
Kanangat, S., J. S. Babu, D. M. Knipe, and B. T. Rouse. 1996. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology. 219(1):295-300.
Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol. 156(3):1110-6.
Kanzaki, Y., M. Eura, K. Chikamatsu, M. Yoshida, K. Masuyama, H. Nishimura, and T. Ishikawa. 1997. Angioimmunoblastic lymphadenopathy-like T-cell lymphoma. A case report and immunologic study. Auris Nasus Larynx. 24(2):199-206.
Karem, K. L., J. Bowen, N. Kuklin, and B. T. Rouse. 1997. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J Gen Virol. 78(Pt 2):427-34.
Karlen, S., E. A. Offord, and P. Beard. 1993. Herpes simplex virions interfere with the expression of human papillomavirus type 18 genes. J Gen Virol. 74(Pt 6):965-73.
Karupiah, G., and N. Harris. 1995. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med. 181(6):2171-9.
Kasamatsu, H., and A. Nakanishi. 1998. How do animal DNA viruses get to the nucleus? Annu Rev Microbiol. 52:627-86.
Kato, K., H. K. Jang, Y. Izumiya, J. S. Cai, Y. Tsushima, T. Miyazawa, C. Kai, and T. Mikami. 1999. Identification of the Marek's disease virus serotype 2 genes homologous to the glycoprotein B (UL27), ICP18.5 (UL28) and major DNA-binding protein (UL29) genes of herpes simplex virus type 1. J Vet Med Sci. 61(10):1161-5.
Kaufman, P. L., W. W. Jia, J. Tan, Z. Chen, B. T. Gabelt, V. Booth, F. Tufaro, and M. Cynader. 1999. A perspective of gene therapy in the glaucomas. Surv Ophthalmol. 43 Suppl 1:S91-7.
Kawa, D., J. Wang, Y. Yuan, and F. Liu. 1998. Inhibition of viral gene expression by human ribonuclease P. Rna. 4(11):1397-406.
Kawaguchi, Y., K. Maeda, T. Miyazawa, M. Ono, K. Tsubota, K. Tomonaga, and T. Mikami. 1994. Inhibition of feline immunodeficiency virus gene expression and replication by alphaherpesvirus ICP4 homologues. J Gen Virol. 75(Pt 10):2783-7.
Kawaguchi, Y., C. Van Sant, and B. Roizman. 1997. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol. 71(10):7328-36.
Kawaguchi, Y., R. Bruni, and B. Roizman. 1997. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol. 71(2):1019-24.
Kawaguchi, Y., C. Van Sant, and B. Roizman. 1998. Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1. J Virol. 72(3):1731-6.
Keadle, T. L., N. Usui, K. A. Laycock, J. K. Miller, J. S. Pepose, and P. M. Stuart. 2000. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 41(1):96-102.
Kehm, R., E. Lorentzen, A. Rosen-Wolff, and G. Darai. 1994. In vitro expression of UL56 gene of herpes simplex virus type 1; detection of UL56 gene product in infected cells and in virions. Virus Res. 33(1):55-66.
Kehm, R., A. Rosen-Wolff, and G. Darai. 1996. Restitution of the UL56 gene expression of HSV-1 HFEM led to restoration of virulent phenotype; deletion of the amino acids 217 to 234 of the UL56 protein abrogates the virulent phenotype. Virus Res. 40(1):17-31.
Kehm, E., M. Goksu, S. Bayer, and C. W. Knopf. 1998. Herpes simplex virus type 1 DNase: functional analysis of the enzyme expressed by recombinant baculovirus. Intervirology. 41(2-3):110-9.
Kehm, E., M. A. Goksu, and C. W. Knopf. 1998. Expression analysis of recombinant herpes simplex virus type 1 DNase. Virus Genes. 17(2):129-38.
Keir, S. D., W. J. Mitchell, L. T. Feldman, and J. R. Martin. 1995. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J Neurovirol. 1(3-4):259-67.
Keller, P. M., A. J. Davison, R. S. Lowe, C. D. Bennett, and R. W. Ellis. 1986. Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology. 152(1):181-91.
Kemble, G. W., and E. S. Mocarski. 1989. A host cell protein binds to a highly conserved sequence element (pac- 2) within the cytomegalovirus a sequence. J Virol. 63(11):4715-28.
Kemp, L. M., J. K. Estridge, A. Brennan, D. R. Katz, and D. S. Latchman. 1990. Mononuclear phagocytes and HSV-1 infection: increased permissivity in differentiated U937 cells is mediated by post-transcriptional regulation of viral immediate-early gene expression. J Leukoc Biol. 47(6):483-9.
Kennard, J., F. J. Rixon, I. M. McDougall, J. D. Tatman, and V. G. Preston. 1995. The 25 amino acid residues at the carboxy terminus of the herpes simplex virus type 1 UL26.5 protein are required for the formation of the capsid shell around the scaffold. J Gen Virol. 76(Pt 7):1611-21.
Kennedy, P. G., and I. Steiner. 1993. The use of herpes simplex virus vectors for gene therapy in neurological diseases. Q J Med. 86(11):697-702.
Kenny, J. J., F. C. Krebs, H. T. Hartle, A. E. Gartner, B. Chatton, J. M. Leiden, J. P. Hoeffler, P. C. Weber, and B. Wigdahl. 1994. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology. 200(1):220-35.
Kenny, J. J., S. Millhouse, M. Wotring, and B. Wigdahl. 1997. Upstream stimulatory factor family binds to the herpes simplex virus type 1 latency-associated transcript promoter. Virology. 230(2):381-91.
Kesari, S., T. M. Lasner, K. R. Balsara, B. P. Randazzo, V. M. Lee, J. Q. Trojanowski, and N. W. Fraser. 1998. A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system. J Gen Virol. 79(Pt 3):525-36.
Kessler, J., J. Muller, and J. P. Weir. 1998. Expression of the human immunodeficiency virus gag gene products by a replication-incompetent herpes simplex virus vector. Virus Res. 54(1):31-8.
Khadr, A., S. K. Tikoo, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 1996. Sequence and expression of a bovine herpesvirus-1 gene homologous to the glycoprotein K-encoding gene of herpes simplex virus-1. Gene. 168(2):189-93.
Khattar, S. K., S. van Drunen Littel-van den Hurk, L. A. Babiuk, and S. K. Tikoo. 1995. Identification and transcriptional analysis of a 3'-coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1. Virology. 213(1):28-37.
Kibler, P. K., J. Duncan, B. D. Keith, T. Hupel, and J. R. Smiley. 1991. Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template. J Virol. 65(12):6749-60.
Kienzle, T. E., J. S. Henkel, J. Y. Ling, M. C. Banks, D. R. Beers, B. Jones, and W. G. Stroop. 1995. Cloning and restriction endonuclease mapping of herpes simplex virus type-1 strains H129 and +GC. Arch Virol. 140(9):1663-75.
Kilani, A. F., P. Trang, S. Jo, A. Hsu, J. Kim, E. Nepomuceno, K. Liou, and F. Liu. 2000. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J Biol Chem. 275(14):10611-22.
Killeen, A. M., L. Harrington, L. V. Wall, and D. C. Kelly. 1992. Nucleotide sequence analysis of a homologue of herpes simplex virus type 1 gene US9 found in the genome of simian herpes B virus. J Gen Virol. 73(Pt 1):195-9.
Kim, M., S. K. Kim, B. N. Park, K. H. Lee, G. H. Min, J. Y. Seoh, C. G. Park, E. S. Hwang, C. Y. Cha, and Y. H. Kook. 1999. Antiviral effects of 28-deacetylsendanin on herpes simplex virus-1 replication. Antiviral Res. 43(2):103-12.
Kinchington, P. R., J. P. Vergnes, P. Defechereux, J. Piette, and S. E. Turse. 1994. Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J Virol. 68(6):3570-81.
Kirkitadze, M. D., P. N. Barlow, N. C. Price, S. M. Kelly, C. J. Boutell, F. J. Rixon, and D. A. McClelland. 1998. The herpes simplex virus triplex protein, VP23, exists as a molten globule. J Virol. 72(12):10066-72.
Kit, S., M. Hazen, H. Qavi, D. R. Dubbs, and S. Pathak. 1980. Integration site(s) of herpes simplex virus type 1 thymidine kinase gene and regional assignment of the gene for aminoacylase-1 in human chromosomes. Cytogenet Cell Genet. 26(2-4):93-103.
Kit, S., H. Otsuka, H. Qavi, D. R. Dubbs, and D. Trkula. 1980. Biochemical transformation of mouse cells by a purified fragment of marmoset herpesvirus DNA. Intervirology. 13(2):110-21.
Kit, S., M. Hazen, H. Otsuka, H. Qavi, D. Trkula, and D. R. Dubbs. 1981. The site of integration of the herpes simplex virus type 1 thymidine kinase gene in human cells transformed by an HSV-1 DNA fragment. Int J Cancer. 28(6):767-76.
Kit, S., H. Otsuka, H. Qavi, D. Trkula, and D. R. Dubbs. 1981. Expression of SV40 T antigen polypeptides in cells biochemically transformed by plasmids containing the herpes simplex virus thymidine kinase gene and the genome of an SV40tsA mutant. Int J Cancer. 28(4):485-96.
Kit, S., H. Otsuka, H. Qavi, and M. Hazen. 1981. Herpes simplex virus thymidine kinase activity of thymidine kinase- deficient Escherichia coli K-12 mutant transformed by hybrid plasmids. Proc Natl Acad Sci U S A. 78(1):582-6.
Klauck, S. M., W. Hampl, and A. K. Kleinschmidt. 1995. HSV type 1 genome variants from persistently productive infections in Raji and BJAB cell lines. Arch Virol. 140(7):1195-213.
Klessig, D. F., M. P. Quinlan, and T. Grodzicker. 1982. Proteins containing only half of the coding information of early region 1b of adenovirus are functional in human cells transformed with the herpes simplex virus type 1 thymidine kinase gene and adenovirus type 2 DNA. J Virol. 41(2):423-34.
Klessig, D. F., T. Grodzicker, and V. Cleghon. 1984. Construction of human cell lines which contain and express the adenovirus DNA binding protein gene by cotransformation with the HSV-1 tk gene. Virus Res. 1(2):169-88.
Klinedinst, D. K., and M. D. Challberg. 1994. Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity. J Virol. 68(6):3693-701.
Klotzbucher, A., S. Mittnacht, H. Kirchner, and H. Jacobsen. 1990. Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1. Virology. 179(1):487-91.
Klupp, B. G., and T. C. Mettenleiter. 1991. Sequence and expression of the glycoprotein gH gene of pseudorabies virus. Virology. 182(2):732-41.
Klupp, B. G., H. Kern, and T. C. Mettenleiter. 1992. The virulence-determining genomic BamHI fragment 4 of pseudorabies virus contains genes corresponding to the UL15 (partial), UL18, UL19, UL20, and UL21 genes of herpes simplex virus and a putative origin of replication. Virology. 191(2):900-8.
Klupp, B. G., J. Baumeister, A. Karger, N. Visser, and T. C. Mettenleiter. 1994. Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. J Virol. 68(6):3868-78.
Knopf, K. W., E. R. Kaufman, and C. Crumpacker. 1981. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme. J Virol. 39(3):746-57.
Knopf, C., G. Strauss, A. Ott-Hartmann, R. Schatten, and H. C. Kaerner. 1983. Herpes simplex virus defective genomes: structure of HSV-1 ANG defective DNA of class II and encoded polypeptides. J Gen Virol. 64(Pt 11):2455-70.
Knopf, C. W., B. Spies, and H. C. Kaerner. 1986. The DNA replication origins of herpes simplex virus type 1 strain Angelotti. Nucleic Acids Res. 14(21):8655-67.
Knox, C. M., D. Chandler, G. A. Short, and T. P. Margolis. 1998. Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. Ophthalmology. 105(1):37-44; discussion 44-5.
Kobayashi, K., E. Ohgitani, Y. Tanaka, M. Kita, and J. Imanishi. 1994. Herpes simplex virus-induced expression of 70 kDa heat shock protein (HSP70) requires early protein synthesis but not viral DNA replication. Microbiol Immunol. 38(4):321-5.
Koch, H. G., A. Rosen, F. Ernst, Y. Becker, and G. Darai. 1987. Determination of the nucleotide sequence flanking the deletion (0.762 to 0.789 map units) in the genome of an intraperitoneally avirulent HSV- 1 strain HFEM. Virus Res. 7(2):105-15.
Kock, J., E. M. Borst, and H. J. Schlicht. 1996. Uptake of duck hepatitis B virus into hepatocytes occurs by endocytosis but does not require passage of the virus through an acidic intracellular compartment. J Virol. 70(9):5827-31.
Koelle, D. M., L. Corey, R. L. Burke, R. J. Eisenberg, G. H. Cohen, R. Pichyangkura, and S. J. Triezenberg. 1994. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol. 68(5):2803-10.
Kokoris, M. S., P. Sabo, E. T. Adman, and M. E. Black. 1999. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Ther. 6(8):1415-26.
Kokoris, M. S., P. Sabo, and M. E. Black. 2000. In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy. Anticancer Res. 20(2A):959-63.
Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J Neuroimmunol. 68(1-2):101-8.
Kong, Y., T. Yang, and A. I. Geller. 1999. An efficient in vivo recombination cloning procedure for modifying and combining HSV-1 cosmids. J Virol Methods. 80(2):129-36.
Kongsuwan, K., C. T. Prideaux, M. A. Johnson, M. Sheppard, and S. Rhodes. 1995. Nucleotide sequence analysis of an infectious laryngotracheitis virus gene corresponding to the US3 of HSV-1 and a unique gene encoding a 67 kDa protein. Arch Virol. 140(1):27-39.
Koop, K. E., J. Duncan, and J. R. Smiley. 1993. Binding sites for the herpes simplex virus immediate-early protein ICP4 impose an increased dependence on viral DNA replication on simple model promoters located in the viral genome. J Virol. 67(12):7254-63.
Koslowski, K. M., P. R. Shaver, X. Y. Wang, D. J. Tenney, and N. E. Pederson. 1997. The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. J Virol. 71(12):9118-23.
Koslowski, K. M., P. R. Shaver, J. T. Casey, 2nd, T. Wilson, G. Yamanaka, A. K. Sheaffer, D. J. Tenney, and N. E. Pederson. 1999. Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. J Virol. 73(2):1704-7.
Kosovsky, J., A. Vojvodova, I. Oravcova, M. Kudelova, J. Matis, and J. Rajcani. 2000. Herpes simplex virus 1 (HSV-1) strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence. Virus Genes. 20(1):27-33.
Kostal, M., I. Bacik, J. Rajcani, and H. C. Kaerner. 1994. Replacement of glycoprotein B gene in the herpes simplex virus type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus. Acta Virol. 38(2):77-88.
Kostavasili, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol. 158(4):1763-71.
Kosz-Vnenchak, M., J. Jacobson, D. M. Coen, and D. M. Knipe. 1993. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol. 67(9):5383-93.
Kotronias, D., and N. Kapranos. 1998. Detection of herpes simplex virus DNA in human spermatozoa by in situ hybridization technique. In Vivo. 12(4):391-4.
Kotronias, D., and N. Kapranos. 1999. Detection of herpes simplex virus DNA in maternal breast milk by in situ hybridization with tyramide signal amplification. In Vivo. 13(6):463-6.
Kousoulas, K. G., P. E. Pellett, L. Pereira, and B. Roizman. 1984. Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology. 135(2):379-94.
Kousoulas, K., M. Arsenakis, and L. Pereira. 1989. A subset of type-specific epitopes map in the amino terminus of herpes simplex virus type 1 glycoprotein B. J Gen Virol. 70(Pt 3):735-41.
Koyama, A. H., and T. Uchida. 1994. Inhibition by Brefeldin A of the envelopment of nucleocapsids in herpes simplex virus type 1-infected Vero cells. Arch Virol. 135(3-4):305-17.
Koyama, A. H., and Y. Miwa. 1997. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J Virol. 71(3):2567-71.
Koyama, A. H., H. Akari, A. Adachi, F. Goshima, and Y. Nishiyama. 1998. Induction of apoptosis in HEp-2 cells by infection with herpes simplex virus type 2. Arch Virol. 143(12):2435-41.
Kramer, M. F., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol. 69(3):1389-99.
Kramm, C. M., M. Chase, U. Herrlinger, A. Jacobs, P. A. Pechan, N. G. Rainov, M. Sena-Esteves, M. Aghi, F. H. Barnett, E. A. Chiocca, and X. O. Breakefield. 1997. Therapeutic efficiency and safety of a second-generation replication- conditional HSV1 vector for brain tumor gene therapy. Hum Gene Ther. 8(17):2057-68.
Krause, P. R., J. M. Ostrove, and S. E. Straus. 1991. The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency- associated transcript. J Virol. 65(10):5619-23.
Krisky, D. M., P. C. Marconi, T. Oligino, R. J. Rouse, D. J. Fink, and J. C. Glorioso. 1997. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4(10):1120-5.
Krisky, D. M., D. Wolfe, W. F. Goins, P. C. Marconi, R. Ramakrishnan, M. Mata, R. J. Rouse, D. J. Fink, and J. C. Glorioso. 1998. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5(12):1593-603.
Krummenacher, C., A. V. Nicola, J. C. Whitbeck, H. Lou, W. Hou, J. D. Lambris, R. J. Geraghty, P. G. Spear, G. H. Cohen, and R. J. Eisenberg. 1998. Herpes simplex virus glycoprotein D can bind to poliovirus receptor- related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol. 72(9):7064-74.
Kuddus, R., B. Gu, and N. A. DeLuca. 1995. Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. J Virol. 69(9):5568-75.
Kudelova, M., M. Muranyiova, O. Kudela, J. Rajcani, M. Lehtinen, J. Stankovic, M. Arvaja, and O. Balint. 1995. Detection of herpes simplex virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients with viral meningoencephalitis using primers for the glycoprotein D gene. Acta Virol. 39(1):11-7.
Kudelova, M., M. Dragun, J. Kosovsky, J. Matis, and J. Rajcani. 1996. Determination of the DNA target sequence of poorly reactivable strain HSZP of herpes simplex virus type 1 by polymerase chain reaction. Acta Virol. 40(1):15-21.
Kudelova, M., A. Vojvodova, and J. Rajcani. 1998. Syn strains HSZP and ANGpath [correction of ANG] of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation [published erratum appears in Acta Virol 1998 Apr;42(2):124]. Acta Virol. 42(1):41-5.
Kudo, E., H. Shiota, Y. Kinouchi, Y. Mimura, and M. Itakura. 1996. Detection of herpes simplex virus DNA in tear fluid of stromal herpetic keratitis patients by nested polymerase chain reaction. Jpn J Ophthalmol. 40(3):390-6.
Kudo, E., H. Shiota, T. Naito, K. Satake, and M. Itakura. 1998. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains. J Med Virol. 56(2):151-8.
Kugler, W., J. Enssle, M. W. Hentze, and A. E. Kulozik. 1995. Nuclear degradation of nonsense mutated beta-globin mRNA: a post- transcriptional mechanism to protect heterozygotes from severe clinical manifestations of beta-thalassemia? Nucleic Acids Res. 23(3):413-8.
Kuhn, F. J. P., and C. W. Knopf. 1996. Herpes simplex virus type 1 DNA polymerase. Mutational analysis of the 3'-5'-exonuclease domain. J Biol Chem. 271(46):29245-54.
Kukhanova, M. K., E. V. Kuznetsova, A. A. Kraevskii, B. O'Hara, J. Bekker, J. Morin, and I. Gluzman. 1994. [Inhibitory analysis of DNA polymerases from human viruses using modified substrates]. Mol Biol (Mosk). 28(3):530-41.
Kuklin, N., M. Daheshia, K. Karem, E. Manickan, and B. T. Rouse. 1997. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol. 71(4):3138-45.
Kulka, M., M. Wachsman, S. Miura, R. Fishelevich, P. S. Miller, P. O. Ts'o, and L. Aurelian. 1993. Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5. Antiviral Res. 20(2):115-30.
Kulka, M., C. C. Smith, J. Levis, R. Fishelevich, J. C. Hunter, C. D. Cushman, P. S. Miller, P. O. Ts'o, and L. Aurelian. 1994. Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1. Antimicrob Agents Chemother. 38(4):675-80.
Kulka, M., and L. Aurelian. 1995. Antiviral activity of an oligo(nucleoside methylphosphonate) that targets HSV-1 immediate-early pre-mRNA 4,5 is augmented by cotreatment with replication-defective adenovirus. Antisense Res Dev. 5(4):243-9.
Kumano, Y., J. Manabe, M. Hamamoto, Y. Kawano, H. Minagawa, Y. Fukumaki, and H. Inomata. 1995. Detection of varicella-zoster virus genome having a PstI site in the ocular sample from a patient with acute retinal necrosis. Ophthalmic Res. 27(5):310-6.
Kumar, S., P. C. McDonnell, R. Lehr, L. Tierney, M. N. Tzimas, D. E. Griswold, E. A. Capper, R. Tal-Singer, G. I. Wells, M. L. Doyle, and P. R. Young. 2000. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem. 275(14):10308-14.
Kuo, Y. C., W. T. Liu, and C. Y. Lin. 1993. Herpes simplex virus type 1 genes in human mononuclear cells and affecting cell-mediated immunity. J Med Virol. 41(2):138-45.
Kurokawa, M., M. Nakano, H. Ohyama, T. Hozumi, S. Kageyama, T. Namba, and K. Shiraki. 1997. Prophylactic efficacy of traditional herbal medicines against recurrent herpes simplex virus type 1 infection from latently infected ganglia in mice. J Dermatol Sci. 14(1):76-84.
Kurokawa, M., T. Hozumi, P. Basnet, M. Nakano, S. Kadota, T. Namba, T. Kawana, and K. Shiraki. 1998. Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther. 284(2):728-35.
Kussmann-Gerber, S., O. Kuonen, G. Folkers, B. D. Pilger, and L. Scapozza. 1998. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase. Eur J Biochem. 255(2):472-81.
Kwong, A. D., and N. Frenkel. 1989. The herpes simplex virus virion host shutoff function. J Virol. 63(11):4834-9.
Kwun, H. J., S. W. Yim, D. H. Lee, and K. L. Jang. 1999. Activation of the thymidine kinase promoter by herpes simplex virus type 1 immediate early proteins. Mol Cells. 9(3):277-80.
Lachmann, R. H., C. Brown, and S. Efstathiou. 1996. A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection. J Gen Virol. 77(Pt 10):2575-82.
Lachmann, R. H., and S. Efstathiou. 1997. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J Virol. 71(4):3197-207.
Lagunoff, M., and B. Roizman. 1994. Expression of a herpes simplex virus 1 open reading frame antisense to the gamma(1)34.5 gene and transcribed by an RNA 3' coterminal with the unspliced latency-associated transcript. J Virol. 68(9):6021-8.
Lagunoff, M., and B. Roizman. 1995. The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome. J Virol. 69(6):3615-23.
Lagunoff, M., G. Randall, and B. Roizman. 1996. Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene. J Virol. 70(3):1810-7.
Lamberti, C., and S. K. Weller. 1996. The herpes simplex virus type 1 UL6 protein is essential for cleavage and packaging but not for genomic inversion. Virology. 226(2):403-7.
Lamberti, C., and S. K. Weller. 1998. The herpes simplex virus type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments. J Virol. 72(3):2463-73.
Lang, J. C., D. A. Spandidos, and N. M. Wilkie. 1984. Transcriptional regulation of a herpes simplex virus immediate early gene is mediated through an enhancer-type sequence. Embo J. 3(2):389-95.
Langeland, N., A. M. Oyan, H. S. Marsden, A. Cross, J. C. Glorioso, L. J. Moore, and L. Haarr. 1990. Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol. 64(3):1271-7.
Laquerre, S., S. Person, and J. C. Glorioso. 1996. Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain. J Virol. 70(3):1640-50.
Laquerre, S., D. B. Anderson, D. B. Stolz, and J. C. Glorioso. 1998. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J Virol. 72(12):9683-97.
Laquerre, S., R. Argnani, D. B. Anderson, S. Zucchini, R. Manservigi, and J. C. Glorioso. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol. 72(7):6119-30.
Larcher, C., H. Recheis, R. Sgonc, W. Gottinger, H. P. Huemer, and E. U. Irschick. 1997. Influence of viral infection on expression of cell surface antigens in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 235(11):709-16.
Larder, B. A., and G. Darby. 1985. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology. 146(2):262-71.
Larsen, N. B., H. W. Kestler, and J. J. Docherty. 1998. Mice transgenic for simian immunodeficiency virus nef are immunologically compromised. J Biomed Sci. 5(4):260-6.
Larsson, C., C. Bernstrom-Lundberg, S. Edstrom, and T. Bergstrom. 1998. Tumor necrosis factor-alpha response and herpesvirus infection in Bell's palsy. Laryngoscope. 108(8 Pt 1):1171-6.
Laurent, A. M., J. J. Madjar, and A. Greco. 1998. Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J Gen Virol. 79(Pt 11):2765-75.
Lausch, R. N., J. D. Lee, and J. E. Oakes. 1987. Failure of intertypic recombinant constructed from HSV-1 x HSV-2 virulent parents to induce ocular pathology. Curr Eye Res. 6(1):27-32.
Lavie, A., M. Konrad, R. Brundiers, R. S. Goody, I. Schlichting, and J. Reinstein. 1998. Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation. Biochemistry. 37(11):3677-86.
Le Gac, N. T., G. Villani, and P. E. Boehmer. 1998. Herpes simplex virus type-1 single-strand DNA-binding protein (ICP8) enhances the ability of the viral DNA helicase-primase to unwind cisplatin-modified DNA. J Biol Chem. 273(22):13801-7.
Leary, K., J. R. Connor, and P. S. Morahan. 1985. Comparison of herpes simplex virus type 1 DNA replication and virus production in murine bone marrow-derived and resident peritoneal macrophages. J Gen Virol. 66(Pt 5):1123-9.
Lechanteur, C., F. Princen, S. Lo Bue, B. Detroz, G. Fillet, J. Gielen, V. Bours, and M. P. Merville. 1997. HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma- derived peritoneal carcinomatosis. Gene Ther. 4(11):1189-94.
Lee, S. S., Q. Dong, T. S. Wang, and I. R. Lehman. 1995. Interaction of herpes simplex virus 1 origin-binding protein with DNA polymerase alpha. Proc Natl Acad Sci U S A. 92(17):7882-6.
Lee, S. K., T. Compton, and R. Longnecker. 1997. Failure to complement infectivity of EBV and HSV-1 glycoprotein B (gB) deletion mutants with gBs from different human herpesvirus subfamilies. Virology. 237(1):170-81.
Lee, S. S., and I. R. Lehman. 1997. Unwinding of the box I element of a herpes simplex virus type 1 origin by a complex of the viral origin binding protein, single-strand DNA binding protein, and single-stranded DNA. Proc Natl Acad Sci U S A. 94(7):2838-42.
Lee, L. Y., and P. A. Schaffer. 1998. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts. J Virol. 72(5):4250-64.
Lee, J. B., T. Hayashi, K. Hayashi, U. Sankawa, M. Maeda, T. Nemoto, and H. Nakanishi. 1998. Further purification and structural analysis of calcium spirulan from Spirulina platensis. J Nat Prod. 61(9):1101-4.
Lee, S. S., and I. R. Lehman. 1999. The interaction of herpes simplex type 1 virus origin-binding protein (UL9 protein) with Box I, the high affinity element of the viral origin of DNA replication. J Biol Chem. 274(26):18613-7.
Leenen, P. J., K. Radosevic, J. S. Voerman, B. Salomon, N. van Rooijen, D. Klatzmann, and W. van Ewijk. 1998. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol. 160(5):2166-73.
Lees-Miller, S. P., M. C. Long, M. A. Kilvert, V. Lam, S. A. Rice, and C. A. Spencer. 1996. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol. 70(11):7471-7.
Lehman, I. R., and P. E. Boehmer. 1999. Replication of herpes simplex virus DNA. J Biol Chem. 274(40):28059-62.
Leib, D. A., M. A. Machalek, B. R. Williams, R. H. Silverman, and H. W. Virgin. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene [see comments]. Proc Natl Acad Sci U S A. 97(11):6097-101.
Lekstrom-Himes, J. A., K. Wang, L. Pesnicak, P. R. Krause, and S. E. Straus. 1998. The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice. J Neurovirol. 4(1):27-37.
Lekstrom-Himes, J. A., L. Pesnicak, and S. E. Straus. 1998. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol. 72(4):2760-4.
Lentine, A. F., and S. L. Bachenheimer. 1990. Intracellular organization of herpes simplex virus type 1 DNA assayed by staphylococcal nuclease sensitivity. Virus Res. 16(3):275-92.
Leopardi, R., N. Michael, and B. Roizman. 1995. Repression of the herpes simplex virus 1 alpha 4 gene by its gene product (ICP4) within the context of the viral genome is conditioned by the distance and stereoaxial alignment of the ICP4 DNA binding site relative to the TATA box. J Virol. 69(5):3042-8.
Leopardi, R., and B. Roizman. 1996. Functional interaction and colocalization of the herpes simplex virus 1 major regulatory protein ICP4 with EAP, a nucleolar-ribosomal protein. Proc Natl Acad Sci U S A. 93(10):4572-6.
Leopardi, R., C. Van Sant, and B. Roizman. 1997. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci U S A. 94(15):7891-6.
Leslie, J., F. J. Rixon, and J. McLauchlan. 1996. Overexpression of the herpes simplex virus type 1 tegument protein VP22 increases its incorporation into virus particles. Virology. 220(1):60-8.
LeVatte, M. A., L. C. Weaver, J. R. Smiley, and G. A. Dekaban. 1994. Generation of recombinant herpes simplex virus type 1 to be used for automatic tract tracing. Gene Ther. 1(Suppl 1):S77.
Levatte, M. A., L. C. Weaver, I. A. York, D. Johnson, and G. A. Dekaban. 1995. Delivery of a foreign gene to sympathetic preganglionic neurons using recombinant herpes simplex virus. Neuroscience. 66(3):737-50.
Levatte, M. A., P. J. Mabon, L. C. Weaver, and G. A. Dekaban. 1998. Simultaneous identification of two populations of sympathetic preganglionic neurons using recombinant herpes simplex virus type 1 expressing different reporter genes. Neuroscience. 82(4):1253-67.
Levi, M., U. Ruden, and B. Wahren. 1996. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagn Lab Immunol. 3(3):265-9.
Levine, M., A. Krikos, J. C. Glorioso, and F. L. Homa. 1990. Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Adv Exp Med Biol. 278:151-64.
Levine, F., and T. Friedmann. 1993. Gene therapy. Am J Dis Child. 147(11):1167-74.
Levinson, R. D., J. J. Hooks, Y. Wang, M. T. Chiu, J. Kellaway, and C. C. Chan. 1998. Triple viral retinitis diagnosed by polymerase chain reaction of the vitreous biopsy in a patient with Richter syndrome. Am J Ophthalmol. 126(5):732-3.
Lewandowski, G., M. V. Hobbs, and F. E. Bloom. 1994. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol. 55(1):23-34.
Lewis, M. E., S. M. Brown, K. G. Warren, and J. H. Subak-Sharpe. 1984. Recovery of herpes simplex virus genetic information from human trigeminal ganglion cells following superinfection with herpes simplex virus type 2 temperature-sensitive mutants. J Gen Virol. 65(Pt 1):215-9.
Lewis, J. B., Y. G. Thompson, and G. B. Caughman. 1993. Transcriptional control of the equine herpesvirus 1 immediate early gene. Virology. 197(2):788-92.
Lewis, J. B., Y. G. Thompson, A. C. Jenkins, and G. B. Caughman. 1995. Characterization and localization of the equine herpesvirus 1 major DNA binding protein. Virology. 207(2):380-91.
Li, S., L. Xie, and X. Dong. 1995. A study on HSV-1 corneal potential infection by in situ nucleic acid hybridization. Yen Ko Hsueh Pao. 11(3):117-9.
Li, S., L. Xie, and X. Dong. 1995. [An experimental study on HSV-1 corneal latency by in situ nucleic acid hybridization]. Chung Hua Yen Ko Tsa Chih. 31(5):366-9.
Li, Q., M. Feldman, C. Harmon, and P. Fitzgerald-Bocarsly. 1996. Role of tyrosine kinases, protein kinase C, and protein kinase A in the regulation of interferon-alpha production induced by herpes simplex virus type 1. J Interferon Cytokine Res. 16(2):109-18.
Liang, G. S., G. L. Daikos, U. Serfling, W. Y. Zhu, M. Pecoraro, C. L. Leonardi, M. A. Fischl, and N. S. Penneys. 1993. An evaluation of oral ulcers in patients with AIDS and AIDS-related complex. J Am Acad Dermatol. 29(4):563-8.
Liedtke, W., B. Opalka, C. W. Zimmermann, and E. Lignitz. 1993. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci. 116(1):6-11.
Lieu, P. T., and E. K. Wagner. 2000. Two leaky-late HSV-1 promoters differ significantly in structural architecture. Virology. 272(1):191-203.
Lieu, P. T., and E. K. Wagner. 2000. The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells. J Virol. 74(6):2770-6.
Lieu, P. T., N. T. Pande, M. K. Rice, and E. K. Wagner. 2000. The exchange of cognate TATA boxes results in a corresponding change in the strength of two HSV-1 early promoters. Virus Genes. 20(1):5-10.
Lim, F., D. Hartley, P. Starr, S. Song, P. Lang, L. Yu, Y. Wang, and A. I. Geller. 1997. Use of defective herpes-derived plasmid vectors. Methods Mol Biol. 62:223-32.
Lin, W. R., D. Shang, G. K. Wilcock, and R. F. Itzhaki. 1995. Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem Soc Trans. 23(4):594S.
Lin, L. S., L. H. Ro, M. S. Lo, W. L. Huang, J. Ma, T. H. Chang, C. H. Shu, K. C. Chow, W. T. Liu, K. Y. Chen, and et al. 1995. Expression of the Epstein-Barr virus DNA polymerase in Escherichia coli for use as antigen for the diagnosis of nasopharyngeal carcinoma. J Med Virol. 45(1):99-105.
Lin, X. H., M. A. Ali, H. Openshaw, and E. M. Cantin. 1996. Deletion of the carboxy-terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B does not affect oligomerization, heparin-binding activity, or its ability to protect against HSV challenge. Arch Virol. 141(6):1153-65.
Lin, W. R., I. Casas, G. K. Wilcock, and R. F. Itzhaki. 1997. Neurotropic viruses and Alzheimer's disease: a search for varicella zoster virus DNA by the polymerase chain reaction. J Neurol Neurosurg Psychiatry. 62(6):586-9.
Lin, Y., T. Lukacsovich, and A. S. Waldman. 1999. Multiple pathways for repair of DNA double-strand breaks in mammalian chromosomes. Mol Cell Biol. 19(12):8353-60.
Ling, P., P. R. Kinchington, W. T. Ruyechan, and J. Hay. 1991. A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V). Virology. 184(2):625-35.
Ling, J. Y., T. E. Kienzle, and W. G. Stroop. 1996. An improved rapid method for purification of herpes simplex virus DNA using cesium trifluoroacetate. J Virol Methods. 58(1-2):193-8.
Ling, J. Y., T. E. Kienzle, T. M. Chen, J. S. Henkel, G. C. Wright, and W. G. Stroop. 1997. Comparative analyses of the latency-associated transcript promoters from herpes simplex virus type 1 strains H129, +GC and KOS-63. Virus Res. 50(1):95-106.
Lingen, M., T. Seck, K. Weise, and D. Falke. 1995. Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1. J Gen Virol. 76(Pt 7):1843-9.
Lingen, M., T. Seck, K. Weise, and D. Falke. 1996. Two mutations in gB-1 and gD-1 of herpes simplex virus type 1 are involved in the "fusion from without" phenotype in different cell types. Virus Genes. 13(3):221-8.
Lingen, M., F. Hengerer, and D. Falke. 1997. Mixed vaginal infections of Balb/c mice with low virulent herpes simplex type 1 strains result in restoration of virulence properties: vaginitis/vulvitis and neuroinvasiveness. Med Microbiol Immunol (Berl). 185(4):217-22.
Linnenbach, A., K. Huebner, and C. M. Croce. 1980. DNA-transformed murine teratocarcinoma cells: regulation of expression of simian virus 40 tumor antigen in stem versus differentiated cells. Proc Natl Acad Sci U S A. 77(8):4875-9.
Linnik, M. D., P. Zahos, M. D. Geschwind, and H. J. Federoff. 1995. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26(9):1670-4; discussion 1675.
Liptak, L. M., S. L. Uprichard, and D. M. Knipe. 1996. Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures. J Virol. 70(3):1759-67.
Little, S. P., and P. A. Schaffer. 1981. Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology. 112(2):686-702.
Littler, E., J. Zeuthen, A. A. McBride, E. Trost Sorensen, K. L. Powell, J. E. Walsh-Arrand, and J. R. Arrand. 1986. Identification of an Epstein-Barr virus-coded thymidine kinase. Embo J. 5(8):1959-66.
Litwinska, B., A. Biesiadecka, W. Gut, and M. Kantoch. 1996. Comparative analysis of HSV-1 temperature mutants proteins and their reactivity. Acta Microbiol Pol. 45(2):155-60.
Liu, F. Y., and B. Roizman. 1991. The promoter, transcriptional unit, and coding sequence of herpes simplex virus 1 family 35 proteins are contained within and in frame with the UL26 open reading frame. J Virol. 65(1):206-12.
Liu, F., and B. Roizman. 1993. Characterization of the protease and other products of amino-terminus- proximal cleavage of the herpes simplex virus 1 UL26 protein. J Virol. 67(3):1300-9.
Lium, E. K., C. A. Panagiotidis, X. Wen, and S. Silverstein. 1996. Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection. J Virol. 70(6):3488-96.
Lium, E. K., and S. Silverstein. 1997. Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene. J Virol. 71(11):8602-14.
Liuzzi, M., R. Deziel, N. Moss, P. Beaulieu, A. M. Bonneau, C. Bousquet, J. G. Chafouleas, M. Garneau, J. Jaramillo, R. L. Krogsrud, and et al. 1994. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo. Nature. 372(6507):695-8.
Llorente, J. L., M. Ona, C. Suarez, S. Melon, F. Hidalgo, M. Carreno, and J. A. Fernandez. 1997. Identification of the HSV-1 genome by "Dot Blot hybridization" in the geniculate ganglion of rabbits. Rev Laryngol Otol Rhinol. 118(3):163-5.
Lo, K., S. B. Hwang, R. Duncan, M. Trousdale, and M. M. Lai. 1998. Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA. Virology. 250(1):94-105.
Logvinoff, C., and A. L. Epstein. 2000. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Virology. 267(1):102-10.
Lokensgard, J. R., H. Berthomme, and L. T. Feldman. 1997. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. J Virol. 71(9):6714-9.
Lomonte, P., and R. D. Everett. 1999. Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. J Virol. 73(11):9456-67.
Long, M. C., V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J Virol. 73(7):5593-604.
Longnecker, R., and B. Roizman. 1987. Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome. Science. 236(4801):573-6.
Lopez, M., F. Cocchi, L. Menotti, E. Avitabile, P. Dubreuil, and G. Campadelli-Fiume. 2000. Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J Virol. 74(3):1267-74.
Loregian, A., E. Papini, B. Satin, H. S. Marsden, T. R. Hirst, and G. Palu. 1999. Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A. 96(9):5221-6.
Loutsch, J. M., G. C. Perng, J. M. Hill, X. Zheng, M. E. Marquart, T. M. Block, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1999. Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes. J Virol. 73(1):767-71.
Lowe, D. M., W. K. Alderton, M. R. Ellis, V. Parmar, W. H. Miller, G. B. Roberts, J. A. Fyfe, R. Gaillard, P. Ertl, W. Snowden, and et al. 1995. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses. Antimicrob Agents Chemother. 39(8):1802-8.
Lowenstein, P. R., S. Fournel, D. Bain, P. Tomasec, P. Clissold, M. G. Castro, and A. L. Epstein. 1994. Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in glia. Neuroreport. 5(13):1625-30.
Lowenstein, P. R., E. E. Morrison, D. Bain, P. Hodge, C. M. Preston, P. Clissold, N. D. Stow, T. A. McKee, and M. G. Castro. 1994. Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro. Neuroscience. 60(4):1059-77.
Lowenstein, P. R., S. Fournel, D. Bain, P. Tomasec, P. M. Clissold, M. G. Castro, and A. L. Epstein. 1995. Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. Brain Res Mol Brain Res. 30(1):169-75.
Lowry, P. W., C. M. Koropchak, C. Y. Choi, E. S. Mocarski, E. R. Kern, P. R. Kinchington, and A. M. Arvin. 1997. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1. Antiviral Res. 33(3):187-200.
Lu, B., S. Gupta, and H. Federoff. 1995. Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Hepatology. 21(3):752-9.
Lu, R., and V. Misra. 2000. Potential role for luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency. J Virol. 74(2):934-43.
Lubinski, J., L. Wang, D. Mastellos, A. Sahu, J. D. Lambris, and H. M. Friedman. 1999. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC [published erratum appears in J Exp Med 2000 Feb 21;191(4):following 746]. J Exp Med. 190(11):1637-46.
Lucotte, G., C. Bathelier, V. Lespiaux, C. Bali, and T. Champenois. 1995. Detection and genotyping of herpes simplex virus types 1 and 2 by polymerase chain reaction. Mol Cell Probes. 9(5):287-90.
Lukonis, C. J., and S. K. Weller. 1996. Characterization of nuclear structures in cells infected with herpes simplex virus type 1 in the absence of viral DNA replication. J Virol. 70(3):1751-8.
Lukonis, C. J., and S. K. Weller. 1996. The herpes simplex virus type 1 transactivator ICPO mediates aberrant intracellular localization of the viral helicase/primase complex subunits. Virology. 220(2):495-501.
Lukonis, C. J., J. Burkham, and S. K. Weller. 1997. Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments. J Virol. 71(6):4771-81.
Lukonis, C. J., and S. K. Weller. 1997. Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10. J Virol. 71(3):2390-9.
Lusso, P., M. Malnati, A. De Maria, C. Balotta, S. E. DeRocco, P. D. Markham, and R. C. Gallo. 1991. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol. 147(2):685-91.
Lycke, E. 1985. Virological aspects on herpesvirus infections. Scand J Infect Dis Suppl. 47:9-15.
Lynas, C., K. A. Laycock, S. D. Cook, T. J. Hill, W. A. Blyth, and N. J. Maitland. 1989. Detection of herpes simplex virus type 1 gene expression in latently and productively infected mouse ganglia using the polymerase chain reaction. J Gen Virol. 70(Pt 9):2345-55.
Machuca, I., B. Jacquemont, and A. Epstein. 1986. Multiple adjacent or overlapping loci affecting the level of gC and cell fusion mapped by intratypic recombinants of HSV-1. Virology. 150(1):117-25.
Mackem, S., and B. Roizman. 1980. Regulation of herpesvirus macromolecular synthesis: transcription- initiation sites and domains of alpha genes. Proc Natl Acad Sci U S A. 77(12):7122-6.
MacLean, C. A., B. Clark, and D. J. McGeoch. 1989. Gene UL11 of herpes simplex virus type 1 encodes a virion protein which is myristylated. J Gen Virol. 70(Pt 12):3147-57.
Madhavan, H. N., K. Priya, A. R. Anand, and K. L. Therese. 1999. Detection of herpes simplex virus (HSV) genome using polymerase chain reaction (PCR) in clinical samples comparison of PCR with standard laboratory methods for the detection of HSV. J Clin Virol. 14(2):145-51.
Mador, N., D. Goldenberg, O. Cohen, A. Panet, and I. Steiner. 1998. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol. 72(6):5067-75.
Maeda, K., T. Horimoto, J. Norimine, Y. Kawaguchi, K. Tomonaga, M. Niikura, C. Kai, E. Takahashi, and T. Mikami. 1992. Identification and nucleotide sequence of a gene in feline herpesvirus type 1 homologous to the herpes simplex virus gene encoding the glycoprotein B. Arch Virol. 127(1-4):387-97.
Maertzdorf, J., L. Remeijer, A. Van Der Lelij, J. Buitenwerf, H. G. Niesters, A. D. Osterhaus, and G. M. Verjans. 1999. Amplification of reiterated sequences of herpes simplex virus type 1 (HSV-1) genome to discriminate between clinical HSV-1 isolates. J Clin Microbiol. 37(11):3518-23.
Maggioncalda, J., A. Mehta, N. W. Fraser, and T. M. Block. 1994. Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript. J Virol. 68(12):7816-24.
Maggioncalda, J., A. Mehta, Y. H. Su, N. W. Fraser, and T. M. Block. 1996. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology. 225(1):72-81.
Maggioncalda, J., A. Mehta, O. Bagasra, N. W. Fraser, and T. M. Block. 1996. A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics [see comments]. J Neurovirol. 2(4):268-78.
Maggs, D. J., E. Chang, M. P. Nasisse, and W. J. Mitchell. 1998. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol. 72(11):9166-72.
Mahalingam, R., G. Cabirac, M. Wellish, D. Gilden, and A. Vafai. 1990. In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase. Virus Genes. 4(2):105-20.
Maidji, E., S. Tugizov, T. Jones, Z. Zheng, and L. Pereira. 1996. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol. 70(12):8402-10.
Maidment, N. T., A. M. Tan, D. C. Bloom, B. Anton, L. T. Feldman, and J. G. Stevens. 1996. Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector. Exp Neurol. 139(1):107-14.
Makarova, O., G. Gorneva, F. Wu, V. Farutin, B. Villeponteau, L. Poliani, D. Fink, and M. Levine. 1996. Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency. Gene Ther. 3(9):829-33.
Makhov, A. M., P. E. Boehmer, I. R. Lehman, and J. D. Griffith. 1996. The herpes simplex virus type 1 origin-binding protein carries out origin specific DNA unwinding and forms stem-loop structures. Embo J. 15(7):1742-50.
Malik, A. K., and S. K. Weller. 1996. Use of transdominant mutants of the origin-binding protein (UL9) of herpes simplex virus type 1 to define functional domains. J Virol. 70(11):7859-66.
Malik, A. K., L. Shao, J. D. Shanley, and S. K. Weller. 1996. Intracellular localization of the herpes simplex virus type-1 origin binding protein, UL9 [published erratum appears in Virology 1997 Jan 6;227(1):268]. Virology. 224(2):380-9.
Manickan, E., Z. Yu, R. J. Rouse, W. S. Wire, and B. T. Rouse. 1995. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. 8(2):53-61.
Mannini-Palenzona, A., A. M. Bartoletti, L. Foa-Tomasi, F. Costanzo, M. Borgatti, M. Tognon, and E. Cassai. 1985. Study of herpes simplex virus type 1 populations obtained from recurrences and primary infections. J Med Virol. 15(1):17-28.
Manns, M. P. 1994. Autoantibodies in chronic hepatitis: diagnostic reagents and scientific tools to study etiology, pathogenesis, and cell biology. Prog Liver Dis. 12:137-56.
Manservigi, R., M. P. Grossi, R. Gualandri, P. G. Balboni, A. Marchini, A. Rotola, P. Rimessi, D. Di Luca, E. Cassai, and G. Barbanti-Brodano. 1990. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J Virol. 64(1):431-6.
Mao, H., and K. S. Rosenthal. 1999. Synthesis of radioactive single-stranded DNA probes using asymmetrical PCR and oligonucleotide random priming. Biotechniques. 27(4):674-6, 678.
Mapelli, M., and P. A. Tucker. 1999. Crystallization and preliminary X-ray crystallographic studies on the herpes simplex virus 1 single-stranded DNA binding protein. J Struct Biol. 128(2):219-22.
Marcello, A., and I. Giaretta. 1998. Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector. Res Virol. 149(6):419-31.
Marchetti, M., P. Mastromarino, S. Rieti, L. Seganti, and N. Orsi. 1995. Inhibition of herpes simplex, rabies and rubella viruses by lectins with different specificities. Res Virol. 146(3):211-5.
Marconi, P., D. Krisky, T. Oligino, P. L. Poliani, R. Ramakrishnan, W. F. Goins, D. J. Fink, and J. C. Glorioso. 1996. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A. 93(21):11319-20.
Markoulatos, P., P. Fountoucidou, G. Marinakis, V. Krikelis, N. Spyrou, N. Vamvakopoulos, and M. L. Moncany. 1997. Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods-- capture ELISA, restriction enzymes, and polymerase chain reaction. J Clin Lab Anal. 11(3):146-53.
Markovitz, N. S., F. Filatov, and B. Roizman. 1999. The U(L)3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications. J Virol. 73(10):8010-8.
Markovitz, N. S., and B. Roizman. 2000. Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present. J Virol. 74(1):523-8.
Marquez, V. E., M. A. Siddiqui, A. Ezzitouni, P. Russ, J. Wang, R. W. Wagner, and M. D. Matteucci. 1996. Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides? J Med Chem. 39(19):3739-47.
Marsden, H. S., J. Lang, A. J. Davison, R. G. Hope, and D. M. MacDonald. 1982. Genomic location and lack of phosphorylation of the HSV immediate-early polypeptide IE 12. J Gen Virol. 62(Pt 1):17-27.
Marsden, H. S., M. E. Campbell, L. Haarr, M. C. Frame, D. S. Parris, M. Murphy, R. G. Hope, M. T. Muller, and C. M. Preston. 1987. The 65,000-Mr DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1. J Virol. 61(8):2428-37.
Marsden, H. S., M. Murphy, G. L. McVey, K. A. MacEachran, A. M. Owsianka, and N. D. Stow. 1994. Role of the carboxy terminus of herpes simplex virus type 1 DNA polymerase in its interaction with UL42. J Gen Virol. 75(Pt 11):3127-35.
Marsden, H. S., A. M. Cross, G. J. Francis, A. H. Patel, K. MacEachran, M. Murphy, G. McVey, D. Haydon, A. Abbotts, and N. D. Stow. 1996. The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells. J Gen Virol. 77(Pt 9):2241-9.
Marsden, H. S., G. W. McLean, E. C. Barnard, G. J. Francis, K. MacEachran, M. Murphy, G. McVey, A. Cross, A. P. Abbotts, and N. D. Stow. 1997. The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primase complex. J Virol. 71(9):6390-7.
Marshall, K. R., R. H. Lachmann, S. Efstathiou, A. Rinaldi, and C. M. Preston. 2000. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression. J Virol. 74(2):956-64.
Martin, S., E. Cantin, and B. T. Rouse. 1989. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins. J Gen Virol. 70(Pt 6):1359-70.
Martin, D. W., R. M. Munoz, D. Oliver, M. A. Subler, and S. Deb. 1994. Analysis of the DNA-binding domain of the HSV-1 origin-binding protein. Virology. 198(1):71-80.
Martin, D. W., and P. C. Weber. 1996. The a sequence is dispensable for isomerization of the herpes simplex virus type 1 genome. J Virol. 70(12):8801-12.
Martin, D. W., and P. C. Weber. 1998. Role of the DR2 repeat array in the regulation of the ICP34.5 gene promoter of herpes simplex virus type 1 during productive infection. J Gen Virol. 79(Pt 3):517-23.
Martin, R. E., J. M. Loutsch, H. H. Garza, Jr., D. J. Boedeker, and J. M. Hill. 1999. Iontophoresis of lysophosphatidic acid into rabbit cornea induces HSV-1 reactivation: evidence that neuronal signaling changes after infection. Mol Vis. 5:36.
Martinez, R., R. T. Sarisky, P. C. Weber, and S. K. Weller. 1996. Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates. J Virol. 70(4):2075-85.
Martinez, R., L. Shao, J. C. Bronstein, P. C. Weber, and S. K. Weller. 1996. The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant. Virology. 215(2):152-64.
Martuza, R. L. 2000. Conditionally replicating herpes vectors for cancer therapy. J Clin Invest. 105(7):841-6.
Mason, A., R. Sallie, R. Perrillo, A. Rayner, L. Xu, D. E. Dohner, M. Dehner, N. Naoumov, L. Gelb, B. Saha, J. O'Grady, and R. Williams. 1996. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology. 24(6):1361-5.
Matsumura, T., R. H. Smith, and D. J. O'Callaghan. 1993. DNA sequence and transcriptional analyses of the region of the equine herpesvirus type 1 Kentucky A strain genome encoding glycoprotein C. Virology. 193(2):910-23.
Matthews, J. T., R. D. Carroll, J. T. Stevens, and M. L. Haffey. 1989. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme. J Virol. 63(11):4913-8.
Matusick-Kumar, L., W. Hurlburt, S. P. Weinheimer, W. W. Newcomb, J. C. Brown, and M. Gao. 1994. Phenotype of the herpes simplex virus type 1 protease substrate ICP35 mutant virus. J Virol. 68(9):5384-94.
Matz, B., J. H. Subak-Sharpe, and V. G. Preston. 1983. Physical mapping of temperature-sensitive mutations of herpes simplex virus type 1 using cloned restriction endonuclease fragments. J Gen Virol. 64(Pt 10):2261-70.
Maul, G. G., H. H. Guldner, and J. G. Spivack. 1993. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol. 74(Pt 12):2679-90.
Maul, G. G., A. M. Ishov, and R. D. Everett. 1996. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology. 217(1):67-75.
Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8(1):21-30.
Mazure, G., J. E. Grundy, G. Nygard, M. Hudson, K. Khan, K. Srai, A. P. Dhillon, R. E. Pounder, and A. J. Wakefield. 1994. Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro. J Gen Virol. 75(Pt 11):2863-71.
McCann, P. J., 3rd, D. R. O'Boyle, 2nd, and I. C. Deckman. 1994. Investigation of the specificity of the herpes simplex virus type 1 protease by point mutagenesis of the autoproteolysis sites. J Virol. 68(1):526-9.
McCormick, L., K. Igarashi, and B. Roizman. 1999. Posttranscriptional regulation of US11 in cells infected with a herpes simplex virus 1 recombinant lacking both 222-bp domains containing S- component origins of DNA synthesis. Virology. 259(2):286-98.
McGeoch, D. J., H. W. Moss, D. McNab, and M. C. Frame. 1987. DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J Gen Virol. 68(Pt 1):19-38.
McGeoch, D. J. 1987. The genome of herpes simplex virus: structure, replication and evolution. J Cell Sci Suppl. 7:67-94.
McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 69(Pt 7):1531-74.
McGeoch, D. J., M. A. Dalrymple, A. Dolan, D. McNab, L. J. Perry, P. Taylor, and M. D. Challberg. 1988. Structures of herpes simplex virus type 1 genes required for replication of virus DNA. J Virol. 62(2):444-53.
McGeoch, D. J., C. Cunningham, G. McIntyre, and A. Dolan. 1991. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J Gen Virol. 72(Pt 12):3057-75.
McGregor, F., A. Phelan, J. Dunlop, and J. B. Clements. 1996. Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch. J Virol. 70(3):1931-40.
McKay, E. M., B. McVey, H. S. Marsden, S. M. Brown, and A. R. MacLean. 1993. The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M(r) 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F. J Gen Virol. 74(Pt 11):2493-7.
McKercher, G., P. R. Bonneau, L. Lagace, D. Thibeault, M. J. Massariol, R. Krogsrud, C. Lawetz, P. C. McDonald, and M. G. Cordingley. 1997. Improved purification protocol of the HSV-1 protease catalytic domain, using immunoaffinity. Biochem Cell Biol. 75(6):795-801.
McKie, E. A., R. G. Hope, S. M. Brown, and A. R. MacLean. 1994. Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. J Gen Virol. 75(Pt 4):733-41.
McKie, E. A., A. R. MacLean, A. D. Lewis, G. Cruickshank, R. Rampling, S. C. Barnett, P. G. Kennedy, and S. M. Brown. 1996. Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy. Br J Cancer. 74(5):745-52.
McKie, E. A., S. M. Brown, A. R. MacLean, and D. I. Graham. 1998. Histopathological responses in the CNS following inoculation with a non- neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy. Neuropathol Appl Neurobiol. 24(5):367-72.
McKnight, J. L., M. Doerr, and Y. Zhang. 1994. An 85-kilodalton herpes simplex virus type 1 alpha trans-induction factor (VP16)-VP13/14 fusion protein retains the transactivation and structural properties of the wild-type molecule during virus infection. J Virol. 68(3):1750-7.
McLauchlan, J., and J. B. Clements. 1983. DNA sequence homology between two co-linear loci on the HSV genome which have different transforming abilities. Embo J. 2(11):1953-61.
McLauchlan, J., K. Liefkens, and N. D. Stow. 1994. The herpes simplex virus type 1 UL37 gene product is a component of virus particles. J Gen Virol. 75(Pt 8):2047-52.
McLauchlan, J. 1997. The abundance of the herpes simplex virus type 1 UL37 tegument protein in virus particles is closely controlled. J Gen Virol. 78(Pt 1):189-94.
McLean, G., F. Rixon, N. Langeland, L. Haarr, and H. Marsden. 1990. Identification and characterization of the virion protein products of herpes simplex virus type 1 gene UL47. J Gen Virol. 71(Pt 12):2953-60.
McNabb, D. S., and R. J. Courtney. 1992. Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1. J Virol. 66(12):7581-4.
McNally, J. M., D. Dempsey, R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1999. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection. J Immunol. 163(2):675-81.
McVoy, M. A., D. E. Nixon, S. P. Adler, and E. S. Mocarski. 1998. Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol. 72(1):48-56.
Mears, W. E., and S. A. Rice. 1996. The RGG box motif of the herpes simplex virus ICP27 protein mediates an RNA-binding activity and determines in vivo methylation. J Virol. 70(11):7445-53.
Mears, W. E., and S. A. Rice. 1998. The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm. Virology. 242(1):128-37.
Meijer, A., J. A. van der Vliet, L. M. Schouls, A. de Vries, P. J. Roholl, and J. M. Ossewaarde. 1998. Detection of microorganisms in vessel wall specimens of the abdominal aorta: development of a PCR assay in the absence of a gold standard. Res Microbiol. 149(8):577-83.
Mendez-Samperio, P., M. Hernandez, and H. E. Ayala. 2000. Induction of transforming growth factor-beta 1 production in human cells by herpes simplex virus. J Interferon Cytokine Res. 20(3):273-80.
Mercadal, C. M., M. Slaoui, S. M. Brown, and B. T. Rouse. 1993. Efficacy of the herpes simplex virus types 1 and 2 mutant viruses to confer protection against zosteriform spread in mice. Viral Immunol. 6(1):35-42.
Meredith, M., A. Orr, and R. Everett. 1994. Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology. 200(2):457-69.
Meredith, M., A. Orr, M. Elliott, and R. Everett. 1995. Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology. 209(1):174-87.
Mertens, G., M. Ieven, D. Ursi, S. R. Pattyn, J. J. Martin, and P. M. Parizel. 1993. Detection of herpes simplex virus in the cerebrospinal fluid of patients with encephalitis using the polymerase chain reaction. J Neurol Sci. 118(2):213-6.
Mesri, E. A., H. J. Federoff, and M. Brownlee. 1995. Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ Res. 76(2):161-7.
Messerle, M., G. M. Keil, K. Schneider, and U. H. Koszinowski. 1992. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. Virology. 191(1):355-67.
Mettenleiter, T. C., and P. G. Spear. 1994. Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J Virol. 68(1):500-4.
Metzger, B., J. Podlech, S. Muller, and D. Falke. 1988. Suppression of humoral immune response against herpes simplex virus induced by defective strains, ts- and TK- mutants. Arch Virol. 99(3-4):143-52.
Meyding-Lamade, U., W. Lamade, R. Kehm, K. W. Knopf, T. Hess, G. Gosztonyi, O. Degen, and W. Hacke. 1998. Herpes simplex virus encephalitis: cranial magnetic resonance imaging and neuropathology in a mouse model. Neurosci Lett. 248(1):13-6.
Meyer, G. A., and K. D. Radsak. 2000. Identification of a novel signal sequence that targets transmembrane proteins to the nuclear envelope inner membrane. J Biol Chem. 275(6):3857-66.
Michael, M., J. Fetzer, and G. Folkers. 1994. Site-directed mutagenesis clarifies the substrate position within the three-dimensional model of the active site of herpes simplex virus type- 1 thymidine kinase. Eur J Biochem. 226(1):219-26.
Michael, M., J. Fetzer, and G. Folkers. 1995. Site-directed mutagenesis of herpes simplex virus type 1 thymidine kinase opposes the importance of amino acid positions 251, 321 and 348 for selective recognition of substrate analogs. Biochem Biophys Res Commun. 209(3):966-73.
Michael, M., S. Gerber, J. Fetzer, and G. Folkers. 1997. Oligonucleotide-directed mutagenesis and subsequent expression of the corresponding recombinant proteins without changing the bacterial vector system. Pharm Acta Helv. 72(3):139-43.
Mietz, H., P. Cassinotti, G. Siegl, B. Kirchhof, and G. K. Krieglstein. 1995. Detection of herpes simplex virus after penetrating keratoplasty by polymerase chain reaction: correlation of clinical and laboratory findings. Graefes Arch Clin Exp Ophthalmol. 233(11):714-6.
Mikloska, Z., A. M. Kesson, M. E. Penfold, and A. L. Cunningham. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J Infect Dis. 173(1):7-17.
Mikloska, Z., and A. L. Cunningham. 1998. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol. 79(Pt 2):353-61.
Miller, C. S., R. J. Danaher, and R. J. Jacob. 1998. Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Crit Rev Oral Biol Med. 9(4):541-62.
Millhouse, S., J. J. Kenny, P. G. Quinn, V. Lee, and B. Wigdahl. 1998. ATF/CREB elements in the herpes simplex virus type 1 latency-associated transcript promoter interact with members of the ATF/CREB and AP-1 transcription factor families. J Biomed Sci. 5(6):451-64.
Millhouse, S., and B. Wigdahl. 2000. Molecular circuitry regulating herpes simplex virus type 1 latency in neurons. J Neurovirol. 6(1):6-24.
Mills, L. K., Y. Shi, and R. L. Millette. 1994. YY1 is the cellular factor shown previously to bind to regulatory regions of several leaky-late (beta gamma, gamma 1) genes of herpes simplex virus type 1. J Virol. 68(2):1234-8.
Minagawa, H., S. Tanaka, Y. Toh, and R. Mori. 1994. Detection of herpes simplex virus type 1-encoded RNA by polymerase chain reaction: different pattern of viral RNA detection in latently infected murine trigeminal ganglia following in vitro or in vivo reactivation. J Gen Virol. 75(Pt 3):647-50.
Mineta, T., K. Tabuchi, and R. L. Martuza. 1995. [Gene therapy for brain tumors: experimental treatment of malignant brain tumors using recombinant herpes simplex virus type 1 (series 7)]. No Shinkei Geka. 23(4):285-92.
Minjolle, S., C. Michelet, I. Jusselin, M. Joannes, F. Cartier, and R. Colimon. 1999. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR. J Clin Microbiol. 37(4):950-3.
Minson, A., S. E. Bell, and K. Bastow. 1982. Correlation of the virus sequence content and biological properties of cells carrying the herpes simplex virus type 2 thymidine kinase gene. J Gen Virol. 58 Pt 1:127-38.
Miranda-Saksena, M., P. Armati, R. A. Boadle, D. J. Holland, and A. L. Cunningham. 2000. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J Virol. 74(4):1827-39.
Miriagou, V., R. Argnani, A. Kakkanas, U. Georgopoulou, R. Manservigi, and P. Mavromara. 1995. Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice. J Gen Virol. 76(Pt 12):3137-43.
Miriagou, V., L. Stevanato, R. Manservigi, and P. Mavromara. 2000. The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins. J Gen Virol. 81 Pt 4:1027-31.
Mishra, L., and J. A. Rose. 1990. Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis. Virology. 179(2):632-9.
Misra, V., R. Nelson, and M. Smith. 1988. Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for the glycoprotein gB. Virology. 166(2):542-9.
Misra, V., and E. L. Blewett. 1991. Construction of herpes simplex viruses that are pseudodiploid for the glycoprotein B gene: a strategy for studying the function of an essential herpesvirus gene. J Gen Virol. 72(Pt 2):385-92.
Misra, V., S. Walker, S. Hayes, and P. O'Hare. 1995. The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16. J Virol. 69(9):5209-16.
Misra, V., S. Walter, P. Yang, S. Hayes, and P. O'Hare. 1996. Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators. Mol Cell Biol. 16(8):4404-13.
Mitchell, W. J., P. Gressens, J. R. Martin, and R. DeSanto. 1994. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J Gen Virol. 75(Pt 6):1201-10.
Mitchell, C., J. A. Blaho, and B. Roizman. 1994. Casein kinase II specifically nucleotidylylates in vitro the amino acid sequence of the protein encoded by the alpha 22 gene of herpes simplex virus 1. Proc Natl Acad Sci U S A. 91(25):11864-8.
Mitchell, W. J. 1995. Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice. J Virol. 69(12):7942-50.
Mitchell, C., J. A. Blaho, A. L. McCormick, and B. Roizman. 1997. The nucleotidylylation of herpes simplex virus 1 regulatory protein alpha22 by human casein kinase II. J Biol Chem. 272(40):25394-400.
Miyao, Y., K. Shimizu, S. Moriuchi, M. Yamada, K. Nakahira, K. Nakajima, J. Nakao, S. Kuriyama, T. Tsujii, K. Mikoshiba, and et al. 1993. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J Neurosci Res. 36(4):472-9.
Miyao, Y., K. Shimizu, M. Tamura, H. Akita, K. Ikeda, E. Mabuchi, H. Kishima, T. Hayakawa, and K. Ikenaka. 1997. Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells. Jpn J Cancer Res. 88(7):678-86.
Miyatake, S., A. Iyer, R. L. Martuza, and S. D. Rabkin. 1997. Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol. 71(7):5124-32.
Mohr, I., and Y. Gluzman. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. Embo J. 15(17):4759-66.
Monahan, S. J., L. A. Grinstead, W. Olivieri, and D. S. Parris. 1998. Interaction between the herpes simplex virus type 1 origin-binding and DNA polymerase accessory proteins. Virology. 241(1):122-30.
Montanha, J. A., M. Amoros, J. Boustie, and L. Girre. 1995. Anti-herpes virus activity of aporphine alkaloids. Planta Med. 61(5):419-24.
Mori, Y., Y. Inoue, Y. Shimomura, T. Kase, and Y. Tano. 1998. Detection of HSV mRNA using reverse transcription-polymerase chain reaction for diagnosis in murine herpetic keratitis model. Jpn J Ophthalmol. 42(1):8-11.
Morin, K. W., E. D. Atrazheva, E. E. Knaus, and L. I. Wiebe. 1997. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2- [125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy. J Med Chem. 40(14):2184-90.
Morioka, H., K. Kobayashi, M. Tachibana, and J. Imanishi. 1999. Co-localization of HSV-1 DNA and ICP35 protein by in situ hybridization and immunocytochemistry. J Electron Microsc. 48(5):621-8.
Moriuchi, H., M. Moriuchi, H. A. Smith, S. E. Straus, and J. I. Cohen. 1992. Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0 [published erratum appears in J Virol 1995 Apr;69(4):2723]. J Virol. 66(12):7303-8.
Moriuchi, H., M. Moriuchi, H. Dean, A. K. Cheung, and J. I. Cohen. 1995. Pseudorabies virus EPO is functionally homologous to varicella-zoster virus ORF61 protein and herpes simplex virus type 1 ICPO. Virology. 209(1):281-3.
Morrison, L. A., and D. M. Knipe. 1994. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J Virol. 68(2):689-96.
Morrison, L. A., and D. M. Knipe. 1996. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology. 220(2):402-13.
Morrison, E. E., Y. F. Wang, and D. M. Meredith. 1998. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J Virol. 72(9):7108-14.
Morrow, J. A., and F. J. Rixon. 1994. Analysis of sequences important for herpes simplex virus type 1 latency- associated transcript promoter activity during lytic infection of tissue culture cells. J Gen Virol. 75(Pt 2):309-16.
Mosca, J. D., D. P. Bednarik, N. B. Raj, C. A. Rosen, J. G. Sodroski, W. A. Haseltine, G. S. Hayward, and P. M. Pitha. 1987. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc Natl Acad Sci U S A. 84(21):7408-12.
Moss, N., R. Deziel, J. Adams, N. Aubry, M. Bailey, M. Baillet, P. Beaulieu, J. DiMaio, J. S. Duceppe, J. M. Ferland, and et al. 1993. Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives. J Med Chem. 36(20):3005-9.
Mossman, K. L., and J. R. Smiley. 1999. Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0. J Virol. 73(12):9726-33.
Mossman, K. L., H. A. Saffran, and J. R. Smiley. 2000. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol. 74(4):2052-6.
Mousavi-Jazi, M., L. Bostrom, C. Lovmark, A. Linde, M. Brytting, and V. A. Sundqvist. 1998. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol. 25(4):623-8.
Moyal, M., I. Raibstein, A. Rosen, G. Darai, and Y. Becker. 1988. Heterogeneity of BamHi DNA fragments B and E in several HSV-1 strains and recombinants. Virus Genes. 1(2):165-74.
Moyal, M., Y. Asher, G. Darai, A. Rosen-Wolff, A. Vafai, and Y. Becker. 1991. In vitro transcription and translation of proteins encoded by the BamHI- B genomic fragment of herpes simplex virus-1. Virus Genes. 5(2):133-46.
Moyal, M., C. Berkowitz, A. Rosen-Wolff, G. Darai, and Y. Becker. 1992. Mutations in the UL53 gene of HSV-1 abolish virus neurovirulence to mice by the intracerebral route of infection. Virus Res. 26(2):99-112.
Moyal, M., and Y. Becker. 1994. Analysis of the transcription pattern of HSV-1 UL52 and UL53 genes. Virus Genes. 9(1):15-21.
Muggeridge, M. I., T. T. Wu, D. C. Johnson, J. C. Glorioso, R. J. Eisenberg, and G. H. Cohen. 1990. Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology. 174(2):375-87.
Mullen, M. A., D. M. Ciufo, and G. S. Hayward. 1994. Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus. J Virol. 68(5):3250-66.
Muller-Breitkreutz, K., and H. Mohr. 1997. Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light. Beitr Infusionsther Transfusionsmed. 34:37-42.
Murakami, S., N. Hato, M. Mizobuchi, T. Doi, and N. Yanagihara. 1996. Role of herpes simplex virus infection in the pathogenesis of facial paralysis in mice. Ann Otol Rhinol Laryngol. 105(1):49-53.
Murakami, S., M. Mizobuchi, Y. Nakashiro, T. Doi, N. Hato, and N. Yanagihara. 1996. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle [see comments]. Ann Intern Med. 124(1 Pt 1):27-30.
Murata, L. B., and M. S. Dodson. 1999. The herpes simplex virus type 1 origin-binding protein. sequence- specific activation of adenosine triphosphatase activity by a double- stranded DNA containing box I. J Biol Chem. 274(52):37079-86.
Murphy, C., P. Zacchi, R. G. Parton, M. Zerial, and F. Lim. 1997. HSV infection of polarized epithelial cells on filter supports: implications for transport assays and protein localization. Eur J Cell Biol. 72(3):278-81.
Muyombwe, A., M. Olivier, M. Ouellette, and B. Papadopoulou. 1997. Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene. Exp Parasitol. 85(1):35-42.
Nagesha, H. S., B. S. Crabb, and M. J. Studdert. 1993. Analysis of the nucleotide sequence of five genes at the left end of the unique short region of the equine herpesvirus 4 genome. Arch Virol. 128(1-2):143-54.
Nalwanga, D., S. Rempel, B. Roizman, and J. D. Baines. 1996. The UL 16 gene product of herpes simplex virus 1 is a virion protein that colocalizes with intranuclear capsid proteins. Virology. 226(2):236-42.
Namba, T., M. Kurokawa, S. Kadota, and K. Shiraki. 1998. [Development of antiviral therapeutic agents from traditional medicines]. Yakugaku Zasshi. 118(9):383-400.
Nash, T. C., and J. G. Spivack. 1994. The UL55 and UL56 genes of herpes simplex virus type 1 are not required for viral replication, intraperitoneal virulence, or establishment of latency in mice. Virology. 204(2):794-8.
Nass, P. H., K. L. Elkins, and J. P. Weir. 1998. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. J Infect Dis. 178(3):611-7.
Neufeld, M. V., T. L. Steinemann, L. M. Merin, W. G. Stroop, and M. F. Brown. 1999. Identification of a herpes simplex virus-induced dendrite in an eye- bank donor cornea. Cornea. 18(4):489-92.
Newcomb, W. W., and J. C. Brown. 1994. Induced extrusion of DNA from the capsid of herpes simplex virus type 1. J Virol. 68(1):433-40.
Newcomb, W. W., F. L. Homa, D. R. Thomsen, F. P. Booy, B. L. Trus, A. C. Steven, J. V. Spencer, and J. C. Brown. 1996. Assembly of the herpes simplex virus capsid: characterization of intermediates observed during cell-free capsid formation. J Mol Biol. 263(3):432-46.
Newcomb, W. W., F. L. Homa, D. R. Thomsen, B. L. Trus, N. Cheng, A. Steven, F. Booy, and J. C. Brown. 1999. Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J Virol. 73(5):4239-50.
Newcomb, W. W., B. L. Trus, N. Cheng, A. C. Steven, A. K. Sheaffer, D. J. Tenney, S. K. Weller, and J. C. Brown. 2000. Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virus. J Virol. 74(4):1663-73.
Ng, T. I., Y. E. Chang, and B. Roizman. 1997. Infected cell protein 22 of herpes simplex virus 1 regulates the expression of virion host shutoff gene U(L)41. Virology. 234(2):226-34.
Ng, T. I., W. O. Ogle, and B. Roizman. 1998. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology. 241(1):37-48.
Nguyen, L., D. M. Knipe, and R. W. Finberg. 1994. Mechanism of virus-induced Ig subclass shifts. J Immunol. 152(2):478-84.
Nguyen-Huynh, A. T., and P. A. Schaffer. 1998. Cellular transcription factors enhance herpes simplex virus type 1 oriS- dependent DNA replication. J Virol. 72(5):3635-45.
Nicholl, M. J., and C. M. Preston. 1996. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific. J Virol. 70(9):6336-9.
Nicholson, P., C. Addison, A. M. Cross, J. Kennard, V. G. Preston, and F. J. Rixon. 1994. Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a. J Gen Virol. 75(Pt 5):1091-9.
Nicola, A. V., C. Peng, H. Lou, G. H. Cohen, and R. J. Eisenberg. 1997. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection. J Virol. 71(4):2940-6.
Nicola, A. V., M. Ponce de Leon, R. Xu, W. Hou, J. C. Whitbeck, C. Krummenacher, R. I. Montgomery, P. G. Spear, R. J. Eisenberg, and G. H. Cohen. 1998. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol. 72(5):3595-601.
Nicoll, J. A., S. Love, P. A. Burton, and P. J. Berry. 1994. Autopsy findings in two cases of neonatal herpes simplex virus infection: detection of virus by immunohistochemistry, in situ hybridization and the polymerase chain reaction. Histopathology. 24(3):257-64.
Nicolson, L., and D. E. Onions. 1990. The nucleotide sequence of the equine herpesvirus 4 gC gene homologue. Virology. 179(1):378-87.
Nicosia, M., S. L. Deshmane, J. M. Zabolotny, T. Valyi-Nagy, and N. W. Fraser. 1993. Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region. J Virol. 67(12):7276-83.
Nicosia, M., J. M. Zabolotny, R. P. Lirette, and N. W. Fraser. 1994. The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology. 204(2):717-28.
Nilheden, E., S. Jeansson, and A. Vahlne. 1985. Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells. Arch Virol. 83(3-4):319-25.
Nishiyama, Y., R. Kurachi, T. Daikoku, and K. Umene. 1993. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice. Virology. 194(1):419-23.
Niwamoto, H., E. Okamoto, J. Fujimoto, M. Takeuchi, J. Furuyama, and Y. Yamamoto. 1995. Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci. 40(4):859-64.
Noisakran, S., W. P. Halford, L. Veress, and D. J. Carr. 1998. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress- induced reactivation of latent herpes simplex virus type 1. J Immunol. 160(11):5441-7.
Noisakran, S., I. L. Campbell, and D. J. Carr. 1999. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol. 162(7):4184-90.
Noisakran, S., and D. J. Carr. 2000. Plasmid DNA encoding IFN-alpha 1 antagonizes herpes simplex virus type 1 ocular infection through CD4+ and CD8+ T lymphocytes. J Immunol. 164(12):6435-43.
Novotny, M. J., M. L. Parish, and P. G. Spear. 1996. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity. Virology. 221(1):1-13.
Nugent, C. T., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection. J Virol. 68(11):7644-8.
O'Boyle, D. R., 2nd, K. A. Pokornowski, P. J. McCann, 3rd, and S. P. Weinheimer. 1997. Identification of a novel peptide substrate of HSV-1 protease using substrate phage display. Virology. 236(2):338-47.
O'Brien, W. J., A. P. Segundo, J. Guy, E. M. Dorn, and J. L. Taylor. 1996. Herpetic stromal disease: response to acyclovir/steroid therapy. Acta Ophthalmol Scand. 74(3):265-70.
O'Brien, W. J., L. S. Tsao, and J. L. Taylor. 1998. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits. Invest Ophthalmol Vis Sci. 39(10):1847-53.
O'Hare, P., and G. S. Hayward. 1984. Expression of recombinant genes containing herpes simplex virus delayed- early and immediate-early regulatory regions and trans activation by herpesvirus infection. J Virol. 52(2):522-31.
O'Rourke, D., and P. O'Hare. 1993. Mutually exclusive binding of two cellular factors within a critical promoter region of the gene for the IE110k protein of herpes simplex virus. J Virol. 67(12):7201-14.
Obara, Y. 1994. [Distribution of herpes simplex virus type 1 and 2 genomes in the human spinal ganglia]. Hokkaido Igaku Zasshi. 69(5):1132-9.
Obara, Y., Y. Furuta, T. Takasu, S. Suzuki, H. Suzuki, S. Matsukawa, Y. Fujioka, H. Takahashi, T. Kurata, and K. Nagashima. 1997. Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. J Med Virol. 52(2):136-42.
Oberman, F., and A. Panet. 1988. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J Gen Virol. 69(Pt 6):1167-77.
Ogle, W. O., and B. Roizman. 1999. Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein. J Virol. 73(5):4305-15.
Oh, J. S., D. I. Paik, and N. H. Park. 1989. Effect of smoked tobacco tar on the growth, cytolytic action, DNA synthesis, and gene expression of herpes simplex virus. Oral Surg Oral Med Oral Pathol. 68(2):189-94.
Ojala, P. M., B. Sodeik, M. W. Ebersold, U. Kutay, and A. Helenius. 2000. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol. 20(13):4922-31.
Olgiate, J., G. L. Ehmann, S. Vidyarthi, M. J. Hilton, and S. L. Bachenheimer. 1999. Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes. Virology. 258(2):257-70.
Oligino, T., P. L. Poliani, P. Marconi, M. A. Bender, M. C. Schmidt, D. J. Fink, and J. C. Glorioso. 1996. In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16. Gene Ther. 3(10):892-9.
Olofsson, S., M. Lundstrom, H. Marsden, S. Jeansson, and A. Vahlne. 1986. Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J Gen Virol. 67(Pt 4):737-44.
Ongkosuwito, J. V., E. J. Feron, C. E. van Doornik, A. Van der Lelij, C. B. Hoyng, E. C. La Heij, and A. Kijlstra. 1998. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis [see comments]. Invest Ophthalmol Vis Sci. 39(13):2659-65.
Ono, E., Y. Sakoda, S. Taharaguchi, S. Watanabe, N. Tonomura, H. Kida, and Y. Shimizu. 1995. Inhibition of pseudorabies virus replication by a chimeric trans-gene product repressing transcription of the immediate-early gene. Virology. 210(1):128-40.
Ono, N., S. Iwayama, K. Suzuki, T. Sekiyama, H. Nakazawa, T. Tsuji, M. Okunishi, T. Daikoku, and Y. Nishiyama. 1998. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'- yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus. Antimicrob Agents Chemother. 42(8):2095-102.
Openshaw, H., J. I. McNeill, X. H. Lin, J. Niland, and E. M. Cantin. 1995. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J Med Virol. 46(1):75-80.
Orle, K. A., C. A. Gates, D. H. Martin, B. A. Body, and J. B. Weiss. 1996. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol. 34(1):49-54.
Ostrove, J. M., J. Leonard, K. E. Weck, A. B. Rabson, and H. E. Gendelman. 1987. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol. 61(12):3726-32.
Otero, G. C., and T. J. Hope. 1998. Splicing-independent expression of the herpes simplex virus type 1 thymidine kinase gene is mediated by three cis-acting RNA subelements. J Virol. 72(12):9889-96.
Otsuka, H., and S. Kit. 1984. Nucleotide sequence of the marmoset herpesvirus thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide. Virology. 135(2):316-30.
Overton, H., D. McMillan, L. Hope, and P. Wong-Kai-In. 1994. Production of host shutoff-defective mutants of herpes simplex virus type 1 by inactivation of the UL13 gene. Virology. 202(1):97-106.
Owen, L. J., and H. J. Field. 1988. Genomic localization and sequence analysis of the putative bovine herpesvirus-1 DNA polymerase gene. Arch Virol. 98(1-2):27-38.
Oxford, J. S., A. A. al-Jabri, C. A. Stein, and P. Levantis. 1996. Analysis of resistance mutants of viral polymerases. Methods Enzymol. 275:555-600.
Ozaki, N., Y. Sugiura, M. Yamamoto, and Y. Nishiyama. 1996. Induction of Fos protein expression in spinal cord neurons by herpes simplex virus infections in the mouse. Neurosci Lett. 216(1):61-4.
Palamara, A. T., C. F. Perno, M. R. Ciriolo, L. Dini, E. Balestra, C. D'Agostini, P. Di Francesco, C. Favalli, G. Rotilio, and E. Garaci. 1995. Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res. 27(3):237-53.
Palfreyman, J. W., J. B. Maclean, E. Messeder, and R. C. Sheppard. 1984. Successful use of oligopeptides as immunogens in the preparation of antisera to immediate-early gene products of herpes simplex virus type 1. J Gen Virol. 65(Pt 5):865-74.
Panagiotidis, C. A., S. Artandi, K. Calame, and S. J. Silverstein. 1995. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res. 23(10):1800-9.
Panagiotidis, C. A., E. K. Lium, and S. J. Silverstein. 1997. Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J Virol. 71(2):1547-57.
Panagiotidis, C. A., and S. J. Silverstein. 1999. The host-cell architectural protein HMG I(Y) modulates binding of herpes simplex virus type 1 ICP4 to its cognate promoter. Virology. 256(1):64-74.
Pande, N. T., M. D. Petroski, and E. K. Wagner. 1998. Functional modules important for activated expression of early genes of herpes simplex virus type 1 are clustered upstream of the TATA box. Virology. 246(1):145-57.
Panet, A., and H. Falk. 1983. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells. J Gen Virol. 64(Pt 9):1999-2006.
Panning, B., and J. R. Smiley. 1995. Activation of expression of multiple subfamilies of human Alu elements by adenovirus type 5 and herpes simplex virus type 1. J Mol Biol. 248(3):513-24.
Para, M. F., L. Goldstein, and P. G. Spear. 1982. Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol. 41(1):137-44.
Paragas, J., and J. A. Blaho. 1998. Cosolvents facilitate DNA synthesis in the herpes simplex virus 1 unique short (Us) inverted repeat. J Virol Methods. 73(1):53-8.
Park, M., D. M. Lonsdale, M. C. Timbury, J. H. Subak-Sharpe, and J. C. Macnab. 1980. Genetic retrieval of viral genome sequences from herpes simplex virus transformed cells. Nature. 285(5764):412-5.
Parker, J. N., G. Y. Gillespie, C. E. Love, S. Randall, R. J. Whitley, and J. M. Markert. 2000. From the cover: engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A. 97(5):2208-13.
Parkes, D. L., C. M. Smith, J. M. Rose, J. Brandis, and S. R. Coates. 1991. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J Clin Microbiol. 29(4):778-81.
Parra, B., and J. Slots. 1996. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol Immunol. 11(5):289-93.
Patel, A. H., and J. B. MacLean. 1995. The product of the UL6 gene of herpes simplex virus type 1 is associated with virus capsids. Virology. 206(1):465-78.
Patel, A. H., F. J. Rixon, C. Cunningham, and A. J. Davison. 1996. Isolation and characterization of herpes simplex virus type 1 mutants defective in the UL6 gene. Virology. 217(1):111-23.
Patel, A. H., J. H. Subak-Sharpe, N. D. Stow, H. S. Marsden, J. B. Maclean, and D. J. Dargan. 1996. Suppression of amber nonsense mutations of herpes simplex virus type 1 in a tissue culture system. J Gen Virol. 77(Pt 2):199-209.
Patel, A., J. Hanson, T. I. McLean, J. Olgiate, M. Hilton, W. E. Miller, and S. L. Bachenheimer. 1998. Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication. Virology. 247(2):212-22.
Pavic, I., A. Hartmann, A. Zimmermann, D. Michel, W. Hampl, I. Schleyer, and T. Mertens. 1997. Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob Agents Chemother. 41(12):2686-92.
Pawlik, T. M., H. Nakamura, S. S. Yoon, J. T. Mullen, S. Chandrasekhar, E. A. Chiocca, and K. K. Tanabe. 2000. Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res. 60(11):2790-5.
Payvandi, F., S. Amrute, and P. Fitzgerald-Bocarsly. 1998. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol. 160(12):5861-8.
Pearson, R. E., and A. J. Conley. 1984. Herpes simplex virus cloned DNA fragments induce coumermycin A1 resistance in Escherichia coli. J Virol. 52(2):370-6.
Pearson, R. E., B. Bejcek, and A. J. Conley. 1985. A physical domain of herpes simplex virus ICP8 is expressed and active in Escherichia coli. J Virol. 53(2):360-5.
Pechan, P. A., U. Herrlinger, M. Aghi, A. Jacobs, and X. O. Breakefield. 1999. Combined HSV-1 recombinant and amplicon piggyback vectors: replication- competent and defective forms, and therapeutic efficacy for experimental gliomas. J Gene Med. 1(3):176-85.
Pedroli, G. L., J. G. Garweg, P. Imesch, and M. Bohnke. 1998. [Varicella zoster virus and atypical necrotizing retinopathies in HIV and AIDS patients]. Klin Monatsbl Augenheilkd. 212(5):353-5.
Pellegrini, A., U. Thomas, M. Franchini, M. Stockli, S. Klauser, P. Hunziker, and R. von Fellenberg. 1994. Identification of an aprotinin antiviral domain. FEBS Lett. 344(2-3):261-5.
Pelletier, A., F. Do, J. J. Brisebois, L. Lagace, and M. G. Cordingley. 1997. Self-association of herpes simplex virus type 1 ICP35 is via coiled- coil interactions and promotes stable interaction with the major capsid protein. J Virol. 71(7):5197-208.
Pelosi, E., F. Rozenberg, D. M. Coen, and K. L. Tyler. 1998. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. Virology. 252(2):364-72.
Pelosi, E., G. B. Mulamba, and D. M. Coen. 1998. Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants. Antiviral Res. 37(1):17-28.
Peng, T., J. R. Hunter, and J. W. Nelson. 1996. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2. Virology. 216(1):184-96.
Peng, T., M. Ponce-de-Leon, H. Jiang, G. Dubin, J. M. Lubinski, R. J. Eisenberg, and G. H. Cohen. 1998. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge. J Virol. 72(1):65-72.
Pepose, J. S., and D. A. Leib. 1994. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases. Invest Ophthalmol Vis Sci. 35(6):2662-6.
Perng, G. C., E. C. Dunkel, P. A. Geary, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol. 68(12):8045-55.
Perng, G. C., H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994. An improved method for cloning portions of the repeat regions of herpes simplex virus type 1. J Virol Methods. 46(2):111-6.
Perng, G. C., J. C. Zwaagstra, H. Ghiasi, R. Kaiwar, D. J. Brown, A. B. Nesburn, and S. L. Wechsler. 1994. Similarities in regulation of the HSV-1 LAT promoter in corneal and neuronal cells. Invest Ophthalmol Vis Sci. 35(7):2981-9.
Perng, G. C., R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1995. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J Virol. 69(5):3033-41.
Perng, G. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3- kilobase primary transcript. J Virol. 70(2):976-84.
Perng, G. C., K. Chokephaibulkit, R. L. Thompson, N. M. Sawtell, S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J Virol. 70(1):282-91.
Perng, G. C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J Virol. 70(3):2014-8.
Perng, G. C., S. M. Slanina, A. Yukht, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1999. Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative viruses. J Virol. 73(11):9669-72.
Perng, G. C., S. M. Slanina, A. Yukht, B. S. Drolet, W. Keleher, Jr., H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1999. A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J Virol. 73(2):920-9.
Perng, G. C., C. Jones, J. Ciacci-Zanella, M. Stone, G. Henderson, A. Yukht, S. M. Slanina, F. M. Hofman, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science. 287(5457):1500-3.
Perng, G. C., S. M. Slanina, A. Yukht, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 2000. The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol. 74(4):1885-91.
Perry, L. J., F. J. Rixon, R. D. Everett, M. C. Frame, and D. J. McGeoch. 1986. Characterization of the IE110 gene of herpes simplex virus type 1. J Gen Virol. 67(Pt 11):2365-80.
Perry, L. J., and D. J. McGeoch. 1988. The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 69(Pt 11):2831-46.
Person, S., S. C. Warner, D. J. Bzik, C. Debroy, and B. A. Fox. 1985. Expression in bacteria of gB-glycoprotein-coding sequences of Herpes simplex virus type 2. Gene. 35(3):279-87.
Person, S., S. Laquerre, P. Desai, and J. Hempel. 1993. Herpes simplex virus type 1 capsid protein, VP21, originates within the UL26 open reading frame. J Gen Virol. 74(Pt 10):2269-73.
Person, S., and P. Desai. 1998. Capsids are formed in a mutant virus blocked at the maturation site of the UL26 and UL26.5 open reading frames of herpes simplex virus type 1 but are not formed in a null mutant of UL38 (VP19C). Virology. 242(1):193-203.
Pertel, P. E., and P. G. Spear. 1996. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition. Virology. 226(1):22-33.
Pertel, P. E., and P. G. Spear. 1997. Partial resistance to gD-mediated interference conferred by mutations affecting herpes simplex virus type 1 gC and gK. J Virol. 71(10):8024-8.
Pertuiset, B., M. Boccara, J. Cebrian, N. Berthelot, S. Chousterman, F. Puvion-Dutilleul, J. Sisman, and P. Sheldrick. 1989. Physical mapping and nucleotide sequence of a herpes simplex virus type 1 gene required for capsid assembly. J Virol. 63(5):2169-79.
Peterson, E. M., S. L. Aarnaes, R. N. Bryan, J. L. Ruth, and L. M. de la Maza. 1986. Typing of herpes simplex virus with synthetic DNA probes. J Infect Dis. 153(4):757-62.
Petrovskis, E. A., J. G. Timmins, and L. E. Post. 1986. Use of lambda gt11 to isolate genes for two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicella- zoster virus glycoproteins. J Virol. 60(1):185-93.
Pevenstein, S. R., R. K. Williams, D. McChesney, E. K. Mont, J. E. Smialek, and S. E. Straus. 1999. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol. 73(12):10514-8.
Peyman, A., M. Helsberg, G. Kretzschmar, M. Mag, S. Grabley, and E. Uhlmann. 1995. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. Biol Chem Hoppe Seyler. 376(3):195-8.
Phelan, A., M. Carmo-Fonseca, J. McLaughlan, A. I. Lamond, and J. B. Clements. 1993. A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution. Proc Natl Acad Sci U S A. 90(19):9056-60.
Phelan, A., and J. B. Clements. 1997. Herpes simplex virus type 1 immediate early protein IE63 shuttles between nuclear compartments and the cytoplasm. J Gen Virol. 78(Pt 12):3327-31.
Piiparinen, H., M. Koskiniemi, and A. Vaheri. 1995. [Polymerase chain reaction assay of HSV in the rapid diagnosis of encephalitis]. Duodecim. 111(2):129-33.
Pilger, B. D., R. Perozzo, F. Alber, C. Wurth, G. Folkers, and L. Scapozza. 1999. Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme. J Biol Chem. 274(45):31967-73.
Pilling, A., A. J. Davison, E. A. Telford, and D. M. Meredith. 1994. The equine herpesvirus type 1 glycoprotein homologous to herpes simplex virus type 1 glycoprotein M is a major constituent of the virus particle. J Gen Virol. 75(Pt 2):439-42.
Pilling, A., M. F. Rosenberg, S. H. Willis, J. Jager, G. H. Cohen, R. J. Eisenberg, D. M. Meredith, and A. Holzenburg. 1999. Three-dimensional structure of herpes simplex virus type 1 glycoprotein D at 2.4-nanometer resolution. J Virol. 73(9):7830-4.
Piret, J., J. Lamontagne, J. Bestman-Smith, S. Roy, P. Gourde, A. Desormeaux, R. F. Omar, J. Juhasz, and M. G. Bergeron. 2000. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J Clin Microbiol. 38(1):110-9.
Pivetti-Pezzi, P., M. Accorinti, R. A. Colabelli-Gisoldi, M. P. Pirraglia, and M. C. Sirianni. 1999. Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea. 18(1):47-51.
Podlech, J., F. Hengerer, M. Fleck, J. Kunkel, and D. Falke. 1997. Localization of latency-associated transcripts in the uterovaginal plexus of herpes simplex virus type 1 and 2 latently infected mice. J Gen Virol. 78(Pt 5):1103-8.
Poffenberger, K. L., and B. Roizman. 1985. A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection. J Virol. 53(2):587-95.
Poffenberger, K. L., P. E. Raichlen, and R. C. Herman. 1993. In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant. Virus Genes. 7(2):171-86.
Poffenberger, K. L., A. D. Idowu, E. B. Fraser-Smith, P. E. Raichlen, and R. C. Herman. 1994. A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo. Arch Virol. 139(1-2):111-9.
Pomeranz, L. E., and J. A. Blaho. 1999. Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J Virol. 73(8):6769-81.
Poon, A. P., and B. Roizman. 1995. The phenotype in vitro and in infected cells of herpes simplex virus 1 alpha trans-inducing factor (VP16) carrying temperature-sensitive mutations introduced by substitution of cysteines. J Virol. 69(12):7658-67.
Poon, A. P., and B. Roizman. 1997. Differentiation of the shutoff of protein synthesis by virion host shutoff and mutant gamma (1)34.5 genes of herpes simplex virus 1. Virology. 229(1):98-105.
Popik, W., and P. M. Pitha. 1994. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Virology. 202(2):521-9.
Popik, W., and P. M. Pitha. 1994. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1. J Virol. 68(3):1324-33.
Porcari, A. R., R. V. Devivar, L. S. Kucera, J. C. Drach, and L. B. Townsend. 1998. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)- 2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole. J Med Chem. 41(8):1252-62.
Portolani, M., A. M. Sabbatini, M. Meacci, P. Pietrosemoli, C. Cermelli, P. Lunghi, F. Golinelli, and R. Stacca. 1998. Epstein-Barr virus DNA in cerebrospinal fluid from an immunocompetent man with herpes simplex virus encephalitis. J Neurovirol. 4(4):461-4.
Portolani, M., C. Cermelli, M. Meacci, P. Pietrosemoli, A. M. Sabbatini, M. C. Cerri, G. Guaraldi, and B. De Rienzo. 1999. Epstein-barr virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus infection and central nervous system disorders. New Microbiol. 22(4):369-74.
Post, L. E., S. Mackem, and B. Roizman. 1981. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell. 24(2):555-65.
Post, L. E., B. Norrild, T. Simpson, and B. Roizman. 1982. Chicken ovalbumin gene fused to a herpes simplex virus alpha promoter and linked to a thymidine kinase gene is regulated like a viral gene. Mol Cell Biol. 2(3):233-40.
Pramod, N. P., S. P. Thyagarajan, K. V. Mohan, and K. Anandakannan. 2000. Polymerase chain reaction in the diagnosis of herpetic keratitis: experience in a developing country. Can J Ophthalmol. 35(3):134-40.
Preiser, W., B. Weber, G. Klos, P. A. Fischer, and H. W. Doerr. 1996. Unusual course of herpes simplex virus encephalitis after acyclovir therapy. Infection. 24(5):384-9.
Preston, V. G. 1981. Fine-structure mapping of herpes simplex virus type 1 temperature- sensitive mutations within the short repeat region of the genome. J Virol. 39(1):150-61.
Preston, V. G., J. W. Palfreyman, and B. M. Dutia. 1984. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. J Gen Virol. 65(Pt 9):1457-66.
Preston, V. G., A. J. Darling, and I. M. McDougall. 1988. The herpes simplex virus type 1 temperature-sensitive mutant ts1222 has a single base pair deletion in the small subunit of ribonucleotide reductase. Virology. 167(2):458-67.
Preston, V. G., M. F. al-Kobaisi, I. M. McDougall, and F. J. Rixon. 1994. The herpes simplex virus gene UL26 proteinase in the presence of the UL26.5 gene product promotes the formation of scaffold-like structures. J Gen Virol. 75(Pt 9):2355-66.
Preston, C. M., J. Russell, R. A. Harris, and D. R. Jamieson. 1994. Herpes simplex virus latency in tissue culture cells. Gene Ther. 1(Suppl 1):S49-50.
Preston, C. M., R. Mabbs, and M. J. Nicholl. 1997. Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression. Virology. 229(1):228-39.
Preston, V. G., J. Kennard, F. J. Rixon, A. J. Logan, R. W. Mansfield, and I. M. McDougall. 1997. Efficient herpes simplex virus type 1 (HSV-1) capsid formation directed by the varicella-zoster virus scaffolding protein requires the carboxy- terminal sequences from the HSV-1 homologue. J Gen Virol. 78(Pt 7):1633-46.
Preston, C. M., and M. McFarlane. 1998. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology. 249(2):418-26.
Preston, C. M., A. Rinaldi, and M. J. Nicholl. 1998. Herpes simplex virus type 1 immediate early gene expression is stimulated by inhibition of protein synthesis. J Gen Virol. 79(Pt 1):117-24.
Prideaux, C. T., K. Kongsuwan, M. A. Johnson, M. Sheppard, and K. J. Fahey. 1992. Infectious laryngotracheitis virus growth, DNA replication, and protein synthesis. Arch Virol. 123(1-2):181-92.
Prod'hon, C., I. Machuca, H. Berthomme, A. Epstein, and B. Jacquemont. 1996. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22. Virology. 226(2):393-402.
Purves, F. C., M. Katan, W. S. Stevely, and D. P. Leader. 1986. Characteristics of the induction of a new protein kinase in cells infected with herpesviruses. J Gen Virol. 67(Pt 6):1049-57.
Purves, F. C., D. Spector, and B. Roizman. 1991. The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene. J Virol. 65(11):5757-64.
Puvion-Dutilleul, F., and S. Besse. 1994. Induction of complete segregation of cellular DNA and non-encapsidated viral genomes in herpes simplex virus type 1 infected HeLa cells as revealed by in situ hybridization. Chromosoma. 103(2):104-10.
Puvion-Dutilleul, F., S. Besse, J. J. Diaz, K. Kindbeiter, M. Vigneron, S. L. Warren, C. Kedinger, J. J. Madjar, and E. Puvion. 1997. Identification of transcription factories in nuclei of HeLa cells transiently expressing the Us11 gene of herpes simplex virus type 1. Gene Expr. 6(5):315-32.
Pyles, R. B., and R. L. Thompson. 1994. Mutations in accessory DNA replicating functions alter the relative mutation frequency of herpes simplex virus type 1 strains in cultured murine cells. J Virol. 68(7):4514-24.
Pyles, R. B., and R. L. Thompson. 1994. Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J Virol. 68(8):4963-72.
Qi, J. S., V. Desai-Yajnik, M. E. Greene, B. M. Raaka, and H. H. Samuels. 1995. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation. Mol Cell Biol. 15(3):1817-25.
Qi, J., C. J. Link, Jr., and S. Wang. 2000. Direct observation of GFP gene expression transduced with HSV-1/EBV amplicon vector in unfixed tumor tissue. Biotechniques. 28(2):206-8.
Qin, K. F., Q. G. Yu, Q. Gao, M. X. Wang, and S. Z. Jiang. 1992. Identification and characterization of a 30K glycoprotein of herpes simplex virus type 2. J Gen Virol. 73(Pt 7):1693-701.
Quinn, J. P., R. A. McGregor, C. E. Fiskerstrand, C. Davey, J. Allan, and R. G. Dalziel. 1998. Identification of a novel multifunctional structural domain in the herpes simplex virus type 1 genome: implications for virus latency. J Gen Virol. 79(Pt 10):2529-32.
Quinn, J. P., R. G. Dalziel, and A. A. Nash. 2000. Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression. Prog Neurobiol. 60(2):167-79.
Rainbow, A. J. 1989. Role of the viral and cellular encoded thymidine kinase in the repair of UV-irradiated herpes simplex virus. Mutat Res. 227(4):263-7.
Rajcani, J., M. Kostal, and H. C. Kaerner. 1994. Regions US6 and US7 of herpes simplex virus type 1 DNA encoding glycoproteins D and I may influence neuroinvasivity. Acta Virol. 38(2):89-95.
Rajcani, J., A. Vojvodova, J. Matis, M. Kudelova, J. Dragunova, M. Krivjanska, and V. Zelnik. 1996. The syn3 strain HSZP of herpes simplex virus type 1 (HSV-1) is not pathogenic for mice and shows limited neural spread. Virus Res. 43(1):33-44.
Ralph, W. M., Jr., M. S. Cabatingan, and P. A. Schaffer. 1994. Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release. J Virol. 68(11):6871-82.
Ramakrishnan, R., M. Levine, and D. J. Fink. 1994. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase- deficient mutant. J Virol. 68(11):7083-91.
Ramakrishnan, R., D. J. Fink, G. Jiang, P. Desai, J. C. Glorioso, and M. Levine. 1994. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol. 68(3):1864-73.
Rand, T. H., and T. Ben-Porat. 1980. Distribution of sequences homologous to the DNA of herpes simplex virus, types 1 and 2, in the genome of pseudorabies virus. Intervirology. 13(1):48-53.
Randall, R. E., C. Newman, and R. W. Honess. 1985. Asynchronous expression of the immediate-early protein of herpesvirus saimiri in populations of productively infected cells. J Gen Virol. 66(Pt 10):2199-213.
Randall, G., M. Lagunoff, and B. Roizman. 1997. The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds to and inhibits in vitro binding of infected cell protein 4 to its cognate DNA site. Proc Natl Acad Sci U S A. 94(19):10379-84.
Randall, G., and B. Roizman. 1997. Transcription of the derepressed open reading frame P of herpes simplex virus 1 precludes the expression of the antisense gamma(1)34.5 gene and may account for the attenuation of the mutant virus. J Virol. 71(10):7750-7.
Randazzo, B. P., M. G. Bhat, S. Kesari, N. W. Fraser, and S. M. Brown. 1997. Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant. J Invest Dermatol. 108(6):933-7.
Rando, R. F., P. E. Pellett, P. A. Luciw, C. A. Bohan, and A. Srinivasan. 1987. Transactivation of human immunodeficiency virus by herpesviruses. Oncogene. 1(1):13-8.
Rani, D. B., M. E. Bayer, and D. M. Schifferli. 1999. Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria. Clin Diagn Lab Immunol. 6(1):30-40.
Rasty, S., P. Thatikunta, J. Gordon, K. Khalili, S. Amini, and J. C. Glorioso. 1996. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc Natl Acad Sci U S A. 93(12):6073-8.
Rasty, S., P. L. Poliani, D. J. Fink, and J. C. Glorioso. 1997. Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J Neurovirol. 3(4):247-64.
Ravishankar, R., M. Bidya Sagar, S. Roy, K. Purnapatre, P. Handa, U. Varshney, and M. Vijayan. 1998. X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG. Nucleic Acids Res. 26(21):4880-7.
Read, G. S., J. A. Sharp, and W. C. Summers. 1984. In vitro and in vivo transcription initiation sites on the TK-encoding BamHI Q fragment of HSV-1 DNA. Virology. 138(2):368-72.
Read, G. S., B. M. Karr, and K. Knight. 1993. Isolation of a herpes simplex virus type 1 mutant with a deletion in the virion host shutoff gene and identification of multiple forms of the vhs (UL41) polypeptide. J Virol. 67(12):7149-60.
Read, S. J., and J. B. Kurtz. 1999. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol. 37(5):1352-5.
Rebordosa, X., J. Pinol, J. A. Perez-Pons, J. Lloberas, J. Naval, and E. Querol. 1994. Mapping, cloning and sequencing of a glycoprotein-encoding gene from bovine herpesvirus type 1 homologous to the gE gene from HSV-1. Gene. 149(2):203-9.
Rechtin, T. M., M. E. Black, and R. R. Drake. 1996. Proteolytic mapping of the thymidine/thymidylate binding site of herpes simplex virus type 1 thymidine kinase: a general photoaffinity labeling method for identifying active-site peptides. Anal Biochem. 237(1):135-40.
Reddig, P. J., L. A. Grinstead, S. J. Monahan, P. A. Johnson, and D. S. Parris. 1994. The essential in vivo function of the herpes simplex virus UL42 protein correlates with its ability to stimulate the viral DNA polymerase in vitro. Virology. 200(2):447-56.
Register, R. B., and J. A. Shafer. 1996. A facile system for construction of HSV-1 variants: site directed mutation of the UL26 protease gene in HSV-1. J Virol Methods. 57(2):181-93.
Register, R. B., and J. A. Shafer. 1997. Alterations in catalytic activity and virus maturation produced by mutation of the conserved histidine residues of herpes simplex virus type 1 protease. J Virol. 71(11):8572-81.
Rehermann, B., K. Michitaka, M. Durazzo, K. Mergener, P. Velev, and M. P. Manns. 1994. Viruses and auto-immune hepatitis. Eur J Clin Invest. 24(1):11-9.
Reifel-Miller, A. E., and C. H. Lee. 1990. Detection of an IE responsive element(s) in the BamHI J fragment of human cytomegalovirus AD169. Virology. 177(2):496-504.
Rekabdar, E., P. Tunback, J. A. Liljeqvist, and T. Bergstrom. 1999. Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1. Clin Diagn Lab Immunol. 6(6):826-31.
Ren, D., L. F. Lee, and P. M. Coussens. 1994. Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1. Virology. 204(1):242-50.
Reyes, G. R., K. T. Jeang, and G. S. Hayward. 1982. Transfection with the isolated herpes simplex virus thymidine kinase genes. I. Minimal size of the active fragments from HSV-1 and HSV-2. J Gen Virol. 62(Pt 2):191-206.
Reyes, G. R., M. W. McLane, and G. S. Hayward. 1982. Transfection with the isolated herpes simplex virus thymidine kinase genes. II. Evidence for amplification of viral and adjacent cellular DNA sequences. J Gen Virol. 60(Pt 2):209-24.
Reynolds, A. E., Y. Fan, and J. D. Baines. 2000. Characterization of the U(L)33 gene product of herpes simplex virus 1. Virology. 266(2):310-8.
Rice, S. A., and V. Lam. 1994. Amino acid substitution mutations in the herpes simplex virus ICP27 protein define an essential gene regulation function. J Virol. 68(2):823-33.
Rice, S. A., M. C. Long, V. Lam, and C. A. Spencer. 1994. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J Virol. 68(2):988-1001.
Rice, S. A., M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer. 1995. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J Virol. 69(9):5550-9.
Riggio, M. P., A. A. Cullinane, and D. E. Onions. 1989. Identification and nucleotide sequence of the glycoprotein gB gene of equine herpesvirus 4. J Virol. 63(3):1123-33.
Riggio, M. P., and D. E. Onions. 1993. DNA sequence of a gene cluster in the equine herpesvirus-4 genome which contains a newly identified herpesvirus gene encoding a membrane protein. Arch Virol. 133(1-2):171-8.
Riggio, M. P., and D. E. Onions. 1994. Sequences of the ribonucleotide reductase-encoding genes of equine herpesvirus 4. Gene. 143(2):217-22.
Ripalti, A., M. C. Boccuni, F. Campanini, and M. P. Landini. 1995. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol. 69(4):2047-57.
Rivera-Gonzalez, R., A. N. Imbalzano, B. Gu, and N. A. Deluca. 1994. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Virology. 202(2):550-64.
Rixon, F. J., M. E. Campbell, and J. B. Clements. 1982. The immediate-early mRNA that encodes the regulatory polypeptide Vmw 175 of herpes simplex virus type 1 is unspliced. Embo J. 1(10):1273-7.
Rixon, F. J., C. Addison, A. McGregor, S. J. Macnab, P. Nicholson, V. G. Preston, and J. D. Tatman. 1996. Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins. J Gen Virol. 77(Pt 9):2251-60.
Robbins, A. K., D. J. Dorney, M. W. Wathen, M. E. Whealy, C. Gold, R. J. Watson, L. E. Holland, S. D. Weed, M. Levine, J. C. Glorioso, and et al. 1987. The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol. 61(9):2691-701.
Roberts, S. R., M. Ponce de Leon, G. H. Cohen, and R. J. Eisenberg. 1991. Analysis of the intracellular maturation of the herpes simplex virus type 1 glycoprotein gH in infected and transfected cells. Virology. 184(2):609-24.
Robertson, B. J., P. J. McCann, 3rd, L. Matusick-Kumar, W. W. Newcomb, J. C. Brown, R. J. Colonno, and M. Gao. 1996. Separate functional domains of the herpes simplex virus type 1 protease: evidence for cleavage inside capsids. J Virol. 70(7):4317-28.
Robertson, B. J., P. J. McCann, 3rd, L. Matusick-Kumar, V. G. Preston, and M. Gao. 1997. Na, an autoproteolytic product of the herpes simplex virus type 1 protease, can functionally substitute for the assembly protein ICP35. J Virol. 71(2):1683-7.
Rock, D. L., and N. W. Fraser. 1983. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 302(5908):523-5.
Rock, D. L., A. B. Nesburn, H. Ghiasi, J. Ong, T. L. Lewis, J. R. Lokensgard, and S. L. Wechsler. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol. 61(12):3820-6.
Rodahl, E., and L. Haarr. 1997. Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structure. J Virol. 71(2):1703-7.
Rogers, J. V., B. E. Hull, P. S. Fink, H. C. Chiou, and N. J. Bigley. 2000. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver. Vaccine. 18(15):1522-30.
Roizman, B., J. Warren, C. A. Thuning, M. S. Fanshaw, B. Norrild, and B. Meignier. 1982. Application of molecular genetics to the design of live herpes simplex virus vaccines. Dev Biol Stand. 52:287-304.
Roizman, B., and N. Markovitz. 1997. Herpes simplex virus virulence: the functions of the gamma (1)34.5 gene. J Neurovirol. 3 Suppl 1:S1-2.
Roizman, B. 1999. HSV gene functions: what have we learned that could be generally applicable to its near and distant cousins? Acta Virol. 43(2-3):75-80.
Rojas, J. M., J. Dopazo, M. Santana, C. Lopez-Galindez, and E. Tabares. 1995. Comparative study of the genetic variability in thymidine kinase and glycoprotein B genes of herpes simplex viruses by the RNase A mismatch cleavage method. Virus Res. 35(2):205-14.
Rojas, J. M., S. Sanchez-Palomino, M. Santana, C. Lopez-Galindez, and E. Tabares. 1995. Genetic analysis of herpes simplex virus type 1 isolates from recurrent lesions and clinical reinfections. J Infect Dis. 172(6):1602-5.
Roller, R. J., and B. Roizman. 1990. The herpes simplex virus Us11 open reading frame encodes a sequence- specific RNA-binding protein. J Virol. 64(7):3463-70.
Roller, R. J., and B. Roizman. 1991. Herpes simplex virus 1 RNA-binding protein US11 negatively regulates the accumulation of a truncated viral mRNA. J Virol. 65(11):5873-9.
Roller, R. J., and B. Roizman. 1994. A herpes simplex virus 1 US11-expressing cell line is resistant to herpes simplex virus infection at a step in viral entry mediated by glycoprotein D. J Virol. 68(5):2830-9.
Roller, R. J., L. L. Monk, D. Stuart, and B. Roizman. 1996. Structure and function in the herpes simplex virus 1 RNA-binding protein U(s)11: mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro. J Virol. 70(5):2842-51.
Roller, R. J., Y. Zhou, R. Schnetzer, J. Ferguson, and D. DeSalvo. 2000. Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment. J Virol. 74(1):117-29.
Romanelli, M. G., E. M. Cattozzo, L. Faggioli, and M. Tognon. 1991. Fine mapping and characterization of the Syn 6 locus in the herpes simplex virus type 1 genome. J Gen Virol. 72(Pt 8):1991-5.
Roop, C., L. Hutchinson, and D. C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol. 67(4):2285-97.
Rosen, A., and G. Darai. 1985. Investigation of the virulence genes of herpes simplex virus 2 by experimental infection in vivo with defined intertypic recombinants of a virulent HSV-2 X an avirulent HSV-1. Med Microbiol Immunol. 174(5):237-48.
Rosen, A., H. Gelderblom, and G. Darai. 1985. Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment. Med Microbiol Immunol. 173(5):257-78.
Rosen, A., F. Ernst, H. G. Koch, H. Gelderblom, G. Darai, J. Hadar, E. Tabor, T. Ben-Hur, and Y. Becker. 1986. Replacement of the deletion in the genome (0.762-0.789 mu) of avirulent HSV-1 HFEM using cloned MluI DNA fragment (0.7615-0.796 mu) of virulent HSV-1 F leads to generation of virulent intratypic recombinant. Virus Res. 5(2-3):157-75.
Rosen, A., D. M. Taylor, and G. Darai. 1987. Influencing of ionizing radiation on herpes simplex virus and its genome. Int J Radiat Biol Relat Stud Phys Chem Med. 52(5):795-804.
Rosen-Wolff, A., J. Scholz, and G. Darai. 1989. Organotropism of latent herpes simplex virus type 1 is correlated to the presence of a 1.5 kb RNA transcript mapped within the BamHI DNA fragment B (0.738 to 0.809 map units). Virus Res. 12(1):43-51.
Rosen-Wolff, A., K. Raab, L. Zoller, G. Darai, J. Eberle, and F. Deinhardt. 1990. Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants. Virus Genes. 4(4):325-37.
Rosen-Wolff, A., W. Lamade, C. Berkowitz, Y. Becker, and G. Darai. 1991. Elimination of UL56 gene by insertion of LacZ cassette between nucleotide position 116030 to 121753 of the herpes simplex virus type 1 genome abrogates intraperitoneal pathogenicity in tree shrews and mice. Virus Res. 20(3):205-21.
Rosen-Wolff, A., and G. Darai. 1991. Identification and mapping of the UL56 gene transcript of herpes simplex virus type 1. Virus Res. 19(1):115-26.
Rosen-Wolff, A., S. Frank, K. Raab, M. Moyal, Y. Becker, and G. Darai. 1992. Determination of the coding capacity of the BamHI DNA fragment B of apathogenic Herpes simplex virus type 1 strain HFEM by DNA nucleotide sequence analysis. Virus Res. 25(3):189-99.
Rosenthal, K. S., H. Mao, W. I. Horne, C. Wright, and D. Zimmerman. 1999. Immunization with a LEAPS heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1. Vaccine. 17(6):535-42.
Ross, L. J., M. M. Binns, and J. Pastorek. 1991. DNA sequence and organization of genes in a 5.5 kbp EcoRI fragment mapping in the short unique segment of Marek's disease virus (strain RB1B). J Gen Virol. 72(Pt 4):949-54.
Rouse, R. J., S. K. Nair, S. L. Lydy, J. C. Bowen, and B. T. Rouse. 1994. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J Virol. 68(9):5685-9.
Rudolph, S. A., J. E. Kuhn, K. Korn, R. W. Braun, and G. Jahn. 1990. Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type 1. J Gen Virol. 71(Pt 9):2023-31.
Rummelt, V., C. Rummelt, G. Jahn, H. Wenkel, C. Sinzger, U. M. Mayer, and G. O. Naumann. 1994. Triple retinal infection with human immunodeficiency virus type 1, cytomegalovirus, and herpes simplex virus type 1. Light and electron microscopy, immunohistochemistry, and in situ hybridization. Ophthalmology. 101(2):270-9.
Ruther, U., C. Nunnensiek, H. A. Muller, H. Bader, U. May, and P. Jipp. 1998. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Hepatogastroenterology. 45(21):691-9.
Rux, A. H., S. H. Willis, A. V. Nicola, W. Hou, C. Peng, H. Lou, G. H. Cohen, and R. J. Eisenberg. 1998. Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator. J Virol. 72(9):7091-8.
Ryncarz, A. J., J. Goddard, A. Wald, M. L. Huang, B. Roizman, and L. Corey. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol. 37(6):1941-7.
Saad, A., Z. H. Zhou, J. Jakana, W. Chiu, and F. J. Rixon. 1999. Roles of triplex and scaffolding proteins in herpes simplex virus type 1 capsid formation suggested by structures of recombinant particles. J Virol. 73(8):6821-30.
Sachs, M. S., E. U. Selker, B. Lin, C. J. Roberts, Z. Luo, D. Vaught-Alexander, and B. S. Margolin. 1997. Expression of herpes virus thymidine kinase in Neurospora crassa. Nucleic Acids Res. 25(12):2389-95.
Sado, K., T. Kimura, Y. Hotta, H. Sakuma, M. Hayakawa, K. Kato, and A. Kanai. 1994. Acute retinal necrosis syndrome associated with herpes simplex keratitis [see comments]. Retina. 14(3):260-3.
Saeki, Y., T. Ichikawa, A. Saeki, E. A. Chiocca, K. Tobler, M. Ackermann, X. O. Breakefield, and C. Fraefel. 1998. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther. 9(18):2787-94.
Saeki, Y. 2000. [Advanced methods for the manipulation of herpesvirus genomes]. Nippon Rinsho. 58(4):815-21.
Saharkhiz-Langroodi, A., and T. C. Holland. 1997. Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B. Virology. 227(1):153-9.
Saijo, M., T. Suzutani, K. Itoh, Y. Hirano, K. Murono, M. Nagamine, K. Mizuta, M. Niikura, and S. Morikawa. 1999. Nucleotide sequence of thymidine kinase gene of sequential acyclovir- resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir- resistant herpes simplex virus. J Med Virol. 58(4):387-93.
Saito, H., H. Sakaoka, T. Yamashita, and K. Fujinaga. 1989. A tandem repeat sequence found in a heterogeneous fragment of UL of herpes simplex virus type 1. J Gen Virol. 70(Pt 2):443-8.
Saitoh-Inagawa, W., K. Aoki, E. Uchio, N. Itoh, and S. Ohno. 1999. Ten years' surveillance of viral conjunctivitis in Sapporo, Japan. Graefes Arch Clin Exp Ophthalmol. 237(1):35-8.
Sakaoka, H., T. Aomori, O. Honda, Y. Saheki, S. Ishida, S. Yamanishi, and K. Fujinaga. 1985. Subtypes of herpes simplex virus type 1 in Japan: classification by restriction endonucleases and analysis of distribution. J Infect Dis. 152(1):190-7.
Sakaoka, H., T. Kawana, L. Grillner, T. Aomori, T. Yamaguchi, H. Saito, and K. Fujinaga. 1987. Genome variations in herpes simplex virus type 2 strains isolated in Japan and Sweden. J Gen Virol. 68(Pt 8):2105-16.
Sakaoka, H., H. Saito, K. Sekine, T. Aomori, L. Grillner, G. Wadell, and K. Fujinaga. 1987. Genomic comparison of herpes simplex virus type 1 isolates from Japan, Sweden and Kenya. J Gen Virol. 68(Pt 3):749-64.
Salmon, B., C. Cunningham, A. J. Davison, W. J. Harris, and J. D. Baines. 1998. The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA. J Virol. 72(5):3779-88.
Salmon, B., and J. D. Baines. 1998. Herpes simplex virus DNA cleavage and packaging: association of multiple forms of U(L)15-encoded proteins with B capsids requires at least the U(L)6, U(L)17, and U(L)28 genes. J Virol. 72(4):3045-50.
Salmon, B., D. Nalwanga, Y. Fan, and J. D. Baines. 1999. Proteolytic cleavage of the amino terminus of the U(L)15 gene product of herpes simplex virus type 1 is coupled with maturation of viral DNA into unit-length genomes. J Virol. 73(10):8338-48.
Salomon, B., P. Lores, C. Pioche, P. Racz, J. Jami, and D. Klatzmann. 1994. Conditional ablation of dendritic cells in transgenic mice. J Immunol. 152(2):537-48.
Salomon, B., S. Maury, L. Loubiere, M. Caruso, R. Onclercq, and D. Klatzmann. 1995. A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol Cell Biol. 15(10):5322-8.
Salomon, B., P. J. Leenen, and D. Klatzmann. 1997. Immune response in dendritic cell depleted mice. Adv Exp Med Biol. 417:547-50.
Salvucci, L. A., R. H. Bonneau, and S. S. Tevethia. 1995. Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes. J Virol. 69(2):1122-31.
Samaniego, L. A., A. L. Webb, and N. A. DeLuca. 1995. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol. 69(9):5705-15.
Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol. 72(4):3307-20.
Sanders, P. G., N. M. Wilkie, and A. J. Davison. 1982. Thymidine kinase deletion mutants of herpes simplex virus type 1. J Gen Virol. 63(2):277-95.
Sandri-Goldin, R. M., M. Levine, and J. C. Glorioso. 1981. Method for induction of mutations in physically defined regions of the herpes simplex virus genome. J Virol. 38(1):41-9.
Sandri-Goldin, R. M., A. L. Goldin, L. E. Holland, J. C. Glorioso, and M. Levine. 1983. Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Mol Cell Biol. 3(11):2028-44.
Sandri-Goldin, R. M., R. E. Sekulovich, and K. Leary. 1987. The alpha protein ICP0 does not appear to play a major role in the regulation of herpes simplex virus gene expression during infection in tissue culture. Nucleic Acids Res. 15(3):905-19.
Sandri-Goldin, R. M. 1994. Properties of an HSV-1 regulatory protein that appears to impair host cell splicing. Infect Agents Dis. 3(2-3):59-67.
Sandri-Goldin, R. M., M. K. Hibbard, and M. A. Hardwicke. 1995. The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however, these alterations are not sufficient to inhibit host cell splicing. J Virol. 69(10):6063-76.
Sandri-Goldin, R. M., and M. K. Hibbard. 1996. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction. J Virol. 70(1):108-18.
Sandri-Goldin, R. M. 1998. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes Dev. 12(6):868-79.
Sanna, P. P., R. A. Williamson, A. De Logu, F. E. Bloom, and D. R. Burton. 1995. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci U S A. 92(14):6439-43.
Sarisky, R. T., and P. C. Weber. 1994. Role of anisomorphic DNA conformations in the negative regulation of a herpes simplex virus type 1 promoter. Virology. 204(2):569-79.
Sarisky, R. T., and P. C. Weber. 1994. Requirement for double-strand breaks but not for specific DNA sequences in herpes simplex virus type 1 genome isomerization events. J Virol. 68(1):34-47.
Sathananthan, B., E. Rodahl, T. Ekberg, N. Langeland, and L. Haarr. 1996. Two-dimensional gel analysis of [35S]methionine labelled and phosphorylated proteins present in virions and light particles of herpes simplex virus type 1, and detection of potentially new structural proteins. Virus Res. 46(1-2):1-18.
Sathananthan, B., E. Rodahl, T. Flatmark, N. Langeland, and L. Haarr. 1997. Purification of herpes simplex virus type 1 by density gradient centrifugation and estimation of the sedimentation coefficient of the virion. Apmis. 105(3):238-46.
Savard, N., F. L. Cosset, and A. L. Epstein. 1997. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors. J Virol. 71(5):4111-7.
Savva, R., and L. H. Pearl. 1993. Crystallization and preliminary X-ray analysis of the uracil-DNA glycosylase DNA repair enzyme from herpes simplex virus type 1. J Mol Biol. 234(3):910-2.
Savva, R., and L. H. Pearl. 1995. Cloning and expression of the uracil-DNA glycosylase inhibitor (UGI) from bacteriophage PBS-1 and crystallization of a uracil-DNA glycosylase-UGI complex. Proteins. 22(3):287-9.
Savva, R., K. McAuley-Hecht, T. Brown, and L. Pearl. 1995. The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature. 373(6514):487-93.
Sawtell, N. M. 1997. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol. 71(7):5423-31.
Sawtell, N. M., D. K. Poon, C. S. Tansky, and R. L. Thompson. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol. 72(7):5343-50.
Schacher, S., J. G. Garweg, C. Russ, and M. Bohnke. 1998. [Diagnosis of herpetic uveitis and keratouveitis]. Klin Monatsbl Augenheilkd. 212(5):359-62.
Schaerer-Uthurralt, N., M. Erard, K. Kindbeiter, J. J. Madjar, and J. J. Diaz. 1998. Distinct domains in herpes simplex virus type 1 US11 protein mediate post-transcriptional transactivation of human T-lymphotropic virus type I envelope glycoprotein gene expression and specific binding to the Rex responsive element. J Gen Virol. 79(Pt 7):1593-602.
Schafer, S. L., J. Vlach, and P. M. Pitha. 1996. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol. 70(10):6937-46.
Schafer, S. L., J. Hiscott, and P. M. Pitha. 1996. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells. Virology. 224(1):214-23.
Schaffer, P. A., S. K. Weller, B. A. Pancake, and D. M. Coen. 1984. Genetics of herpes simplex virus. J Invest Dermatol. 83(1 Suppl):42s-47s.
Schalasta, G., A. Arents, M. Schmid, R. W. Braun, and G. Enders. 2000. Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection. 28(2):85-91.
Scheck, A. C., B. Wigdahl, and F. Rapp. 1987. Activation of latent herpes simplex virus type 2 infection in vitro requires a (E)-5-(2-bromovinyl)-2'-deoxyuridine-sensitive gene function. Intervirology. 27(3):121-9.
Schellekens, G. A., E. Lasonder, M. Feijlbrief, D. G. Koedijk, J. W. Drijfhout, A. J. Scheffer, S. Welling-Wester, and G. W. Welling. 1994. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Eur J Immunol. 24(12):3188-93.
Schlesinger, Y., R. S. Buller, J. E. Brunstrom, C. J. Moran, and G. A. Storch. 1995. Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr. 126(2):234-41.
Schmitz, J. B., A. G. Albright, P. R. Kinchington, and F. J. Jenkins. 1995. The UL37 protein of herpes simplex virus type 1 is associated with the tegument of purified virions. Virology. 206(2):1055-65.
Schnipper, L. E., and C. S. Crumpacker. 1980. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc Natl Acad Sci U S A. 77(4):2270-3.
Schreiner, U., J. Hansen, F. J. Kuhn, and C. W. Knopf. 1999. A novel protein tag from herpes simplex virus type 1 DNA polymerase. Intervirology. 42(1):17-21.
Schroder, C. H., J. DeZazzo, K. W. Knopf, H. C. Kaerner, M. Levine, and J. Glorioso. 1985. A herpes simplex virus type 1 mutant with a deletion in the polypeptide- coding sequences of the ICP4 gene. J Gen Virol. 66(Pt 7):1589-93.
Schulz, P., V. Arbusow, M. Strupp, M. Dieterich, E. Rauch, and T. Brandt. 1998. Highly variable distribution of HSV-1-specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett. 252(2):139-42.
Schust, D. J., A. B. Hill, and H. L. Ploegh. 1996. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J Immunol. 157(8):3375-80.
Sciammas, R., and J. A. Bluestone. 1998. HSV-1 glycoprotein I-reactive TCR gamma delta cells directly recognize the peptide backbone in a conformationally dependent manner. J Immunol. 161(10):5187-92.
Sears, A. E., and B. Roizman. 1985. Cell-specific selection of mutants of a herpes simplex virus recombinant carrying deletions. Virology. 145(1):176-80.
Seck, T., O. Koch, M. Lingen, and D. Falke. 1996. Influence of glycoproteins B, C and D on the conversion of virus-to- cell attachment from heparin sensitivity to resistance. Acta Virol. 40(4):179-85.
Sedarati, F., T. P. Margolis, and J. G. Stevens. 1993. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology. 192(2):687-91.
Severini, A., A. R. Morgan, D. R. Tovell, and D. L. Tyrrell. 1994. Study of the structure of replicative intermediates of HSV-1 DNA by pulsed-field gel electrophoresis. Virology. 200(2):428-35.
Shapira, M., F. L. Homa, J. C. Glorioso, and M. Levine. 1987. Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Res. 15(7):3097-111.
Sharkin, Y. A., L. A. Alexandrova, L. S. Victorova, E. V. Kuznetsova, and A. A. Krayevsky. 1995. Purine arabinonucleoside 5'-triphosphates with substituents at 2' position as substrates for DNA polymerases. Biochem Mol Biol Int. 35(5):1041-8.
Sharkin Iu, A., E. V. Kuznetsova, L. S. Viktorova, and L. A. Aleksandrova. 1995. [Purine arabinonucleoside-5'-triphosphates with substituents in the 2'- position as DNA polymerase substrates]. Mol Biol (Mosk). 29(4):918-29.
Shelton, L. S., M. N. Pensiero, and F. J. Jenkins. 1990. Identification and characterization of the herpes simplex virus type 1 protein encoded by the UL37 open reading frame. J Virol. 64(12):6101-9.
Shering, A. F., D. Bain, K. Stewart, A. L. Epstein, M. G. Castro, G. W. Wilkinson, and P. R. Lowenstein. 1997. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J Gen Virol. 78(Pt 2):445-59.
Shev, S., A. Widell, T. Bergstrom, S. Hermodsson, A. Lindholm, and G. Norkrans. 1995. Herpes simplex virus-2 may increase susceptibility of the sexual transmission of hepatitis C. Sex Transm Dis. 22(4):210-6.
Shih, M. F., M. Arsenakis, P. Tiollais, and B. Roizman. 1984. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. Proc Natl Acad Sci U S A. 81(18):5867-70.
Shillitoe, E. J., S. Zhang, G. Wang, and C. B. Hwang. 1993. Functions and proteins of herpes simplex virus type-1 that are involved in raising the mutation frequency of infected cells. Virus Res. 27(3):239-51.
Shimizu, K., L. Ren, D. Ayusawa, T. Seno, J. Balzarini, and E. De Clercq. 1986. Establishment of mutant murine mammary carcinoma FM3A cell strains transformed with the herpes simplex virus type 2 thymidine kinase gene. Cell Struct Funct. 11(3):295-301.
Shimojima, Y., H. K. Jang, M. Ono, K. Maeda, Y. Tohya, and T. Mikami. 1997. Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the thymidine kinase and UL24 genes of herpes simplex virus type 1. Virus Genes. 14(1):81-7.
Shiraki, K., M. Moriwaki, S. Ataka, K. Henmi, T. Miki, and Y. Kanaoka. 1998. Acute retinal necrosis late in the second trimester. Am J Ophthalmol. 125(1):103-4.
Shiraki, K., J. Yamamura, M. Kurokawa, T. Andoh, H. Sato, Y. Yoshida, Z. H. Li, T. Kamiyama, and S. Kageyama. 1998. A live non-neurovirulent herpes simplex virus vector expresses beta- galactosidase in the nervous system of the Wistar and Sprague-Dawley strain rat for a prolonged period. Neurosci Lett. 245(2):69-72.
Shoji, H., M. Koga, T. Kusuhara, M. Kaji, M. Ayabe, H. Hino, and R. Hondo. 1994. Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringent hybridization of PCR-amplified DNAs. J Neurol. 241(9):526-30.
Shoji, Y., M. Norimatsu, J. Shimada, and Y. Mizushima. 1998. Limited use of cationic liposomes as tools to enhance the antiherpetic activities of oligonucleotides in vero cells infected with herpes simplex virus type 1. Antisense Nucleic Acid Drug Dev. 8(4):255-63.
Shoji, Y., H. Ishige, N. Tamura, W. Iwatani, M. Norimatsu, J. Shimada, and Y. Mizushima. 1998. Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol. J Drug Target. 5(4):261-73.
Shukla, D., J. Liu, P. Blaiklock, N. W. Shworak, X. Bai, J. D. Esko, G. H. Cohen, R. J. Eisenberg, R. D. Rosenberg, and P. G. Spear. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99(1):13-22.
Shukla, D., C. L. Rowe, Y. Dong, V. R. Racaniello, and P. G. Spear. 1999. The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol. 73(5):4493-7.
Shyu, W. C., J. C. Lin, B. C. Chang, H. J. Harn, C. C. Lee, and W. L. Tsao. 1993. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection. Ann Neurol. 34(4):625-7.
Sifakis, S., E. Koumantakis, M. Koffa, M. Ergazaki, and D. A. Spandidos. 1998. Detection of herpes simplex virus (HSV) in aborted material using the polymerase chain reaction technique. Gynecol Obstet Invest. 45(2):109-15.
Silver, S., and B. Roizman. 1985. gamma 2-Thymidine kinase chimeras are identically transcribed but regulated a gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes. Mol Cell Biol. 5(3):518-28.
Simoes, C. M., M. Amoros, and L. Girre. 1999. Mechanism of antiviral activity of triterpenoid saponins. Phytother Res. 13(4):323-8.
Simonin, D., J. J. Diaz, K. Kindbeiter, P. Pernas, and J. J. Madjar. 1995. Phosphorylation of herpes simplex virus type 1 Us11 protein is independent of viral genome expression. Electrophoresis. 16(7):1317-22.
Simonin, D., J. J. Diaz, K. Kindbeiter, L. Denoroy, and J. J. Madjar. 1995. Phosphorylation of ribosomal protein L30 after herpes simplex virus type 1 infection. Electrophoresis. 16(5):854-9.
Simonsson, S., T. Samuelsson, and P. Elias. 1998. The herpes simplex virus type 1 origin binding protein. Specific recognition of phosphates and methyl groups defines the interacting surface for a monomeric DNA binding domain in the major groove of DNA. J Biol Chem. 273(38):24633-9.
Sinclair, M. C., J. McLauchlan, H. Marsden, and S. M. Brown. 1994. Characterization of a herpes simplex virus type 1 deletion variant (1703) which under-produces Vmw63 during immediate early conditions of infection. J Gen Virol. 75(Pt 5):1083-9.
Singh, J., and E. K. Wagner. 1995. Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally "neutral" segments of the viral genome. Virus Genes. 10(2):127-36.
Singh, A. K., G. S. Sidhu, R. M. Friedman, and R. K. Maheshwari. 1996. Mechanism of enhancement of the antiviral action of interferon against herpes simplex virus-1 by chloroquine. J Interferon Cytokine Res. 16(9):725-31.
Singh, S. P., and R. D. Odze. 1998. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol. 22(1):93-9.
Sisk, W. P., J. D. Bradley, R. J. Leipold, A. M. Stoltzfus, M. Ponce de Leon, M. Hilf, C. Peng, G. H. Cohen, and R. J. Eisenberg. 1994. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus- infected insect cells. J Virol. 68(2):766-75.
Sivadon, V., P. Lebon, and F. Rozenberg. 1998. Variations of HSV-1 glycoprotein B in human herpes simplex encephalitis. J Neurovirol. 4(1):106-14.
Sivaraja, M., H. Giordano, and M. G. Peterson. 1998. High-throughput screening assay for helicase enzymes. Anal Biochem. 265(1):22-7.
Sivropoulou, A., and M. Arsenakis. 1993. Regulation of glycoprotein D synthesis of herpes simplex virus 1 by alpha 4 protein, the major regulatory protein of the virus, in stably transformed cell lines: effect of the relative gene copy numbers. Arch Virol. 131(1-2):153-68.
Sivropoulou, A., and M. Arsenakis. 1993. Mapping of the functional domains of the alpha 4 protein of herpes simplex virus 1. Arch Virol. 129(1-4):317-25.
Sivropoulou, A., and M. Arsenakis. 1994. Transformed cells producing the glycoprotein D of HSV-1 are resistant to infection with clinical strains of HSV. Arch Virol. 137(3-4):397-404.
Sivropoulou, A., A. Vasilaki, and M. Arsenakis. 1994. Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay. Arch Virol. 139(1-2):183-8.
Skaliter, R., and I. R. Lehman. 1994. Rolling circle DNA replication in vitro by a complex of herpes simplex virus type 1-encoded enzymes. Proc Natl Acad Sci U S A. 91(22):10665-9.
Skaliter, R., A. M. Makhov, J. D. Griffith, and I. R. Lehman. 1996. Rolling circle DNA replication by extracts of herpes simplex virus type 1-infected human cells. J Virol. 70(2):1132-6.
Slobedman, B., S. Efstathiou, and A. Simmons. 1994. Quantitative analysis of herpes simplex virus DNA and transcriptional activity in ganglia of mice latently infected with wild-type and thymidine kinase-deficient viral strains. J Gen Virol. 75(Pt 9):2469-74.
Smibert, C. A., B. Popova, P. Xiao, J. P. Capone, and J. R. Smiley. 1994. Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J Virol. 68(4):2339-46.
Smiley, J. R., C. Lavery, and M. Howes. 1992. The herpes simplex virus type 1 (HSV-1) a sequence serves as a cleavage/packaging signal but does not drive recombinational genome isomerization when it is inserted into the HSV-2 genome. J Virol. 66(12):7505-10.
Smith, I. L., M. A. Hardwicke, and R. M. Sandri-Goldin. 1992. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology. 186(1):74-86.
Smith, R. L., J. M. Escudero, and C. L. Wilcox. 1994. Regulation of the herpes simplex virus latency-associated transcripts during establishment of latency in sensory neurons in vitro. Virology. 202(1):49-60.
Smith, R. L., A. I. Geller, K. W. Escudero, and C. L. Wilcox. 1995. Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector. J Virol. 69(8):4593-9.
Smith, C., R. H. Lachmann, and S. Efstathiou. 2000. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system. J Gen Virol. 81 Pt 3:649-62.
Smith, T. J., C. E. Ackland-Berglund, and D. A. Leib. 2000. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol. 74(8):3598-604.
Smythe, W. R., H. C. Hwang, A. A. Elshami, K. M. Amin, S. M. Albelda, and L. R. Kaiser. 1995. Differential sensitivity of thoracic malignant tumors to adenovirus- mediated drug sensitization gene therapy. J Thorac Cardiovasc Surg. 109(4):626-30; discussion 630-1.
Snoeck, R., G. Andrei, M. Gerard, A. Silverman, A. Hedderman, J. Balzarini, C. Sadzot-Delvaux, G. Tricot, N. Clumeck, and E. De Clercq. 1994. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3- hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin Infect Dis. 18(4):570-8.
Sodeik, B., M. W. Ebersold, and A. Helenius. 1997. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol. 136(5):1007-21.
Soliman, T. M., R. M. Sandri-Goldin, and S. J. Silverstein. 1997. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J Virol. 71(12):9188-97.
Soliman, T. M., and S. J. Silverstein. 2000. Herpesvirus mRNAs are sorted for export via Crm1-dependent and - independent pathways. J Virol. 74(6):2814-25.
Song, S., Y. Wang, S. Y. Bak, P. Lang, D. Ullrey, R. L. Neve, K. L. O'Malley, and A. I. Geller. 1997. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem. 68(5):1792-803.
Song, S., Y. Wang, S. Y. Bak, M. J. During, J. Bryan, O. Ashe, D. B. Ullrey, L. E. Trask, F. D. Grant, K. L. O'Malley, H. Riedel, D. S. Goldstein, K. A. Neve, G. J. LaHoste, J. F. Marshall, J. W. Haycock, R. L. Neve, and A. I. Geller. 1998. Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci. 18(11):4119-32.
Song, G. Y., G. DeJong, and W. Jia. 1999. Cell surface expression of MHC molecules in glioma cells infected with herpes simplex virus type-1. J Neuroimmunol. 93(1-2):1-7.
Spadari, S., G. Maga, A. Verri, A. Bendiscioli, L. Tondelli, M. Capobianco, F. Colonna, A. Garbesi, and F. Focher. 1995. Lack of stereospecificity of some cellular and viral enzymes involved in the synthesis of deoxyribonucleotides and DNA: molecular basis for the antiviral activity of unnatural L-beta-nucleosides. Biochimie. 77(11):861-67.
Spaete, R. R., and E. S. Mocarski. 1985. Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol. 56(1):135-43.
Spaete, R. R., and E. S. Mocarski. 1985. The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol. 54(3):817-24.
Spandidos, D. A., E. Y. Kam, and R. Balfour. 1985. Transformation of mammalian cell by iontophoretic pricking or iontophoretic microinjection. Eur J Cell Biol. 37:234-9.
Spatz, S. J., and R. K. Maes. 1993. Immunological characterization of the feline herpesvirus-1 glycoprotein B and analysis of its deduced amino acid sequence. Virology. 197(1):125-36.
Spatz, S. J., E. C. Nordby, and P. C. Weber. 1996. Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1. J Virol. 70(11):7360-70.
Spatz, S. J., E. C. Nordby, and P. C. Weber. 1997. Construction and characterization of a recombinant herpes simplex virus type 1 which overexpresses the transrepressor protein ICPOR. Virology. 228(2):218-28.
Spatz, A. M., S. A. Ali, M. Auer, C. Graf, M. M. Eibl, and A. Steinkasserer. 1998. High level expression and structural characterisation of herpes simplex virus type I transcriptional activator VP16 (alpha-trans inducing factor). Biochem Biophys Res Commun. 251(1):235-8.
Speck, P. G., S. Efstathiou, and A. C. Minson. 1996. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector. J Gen Virol. 77(Pt 10):2563-8.
Spector, F. C., L. Liang, H. Giordano, M. Sivaraja, and M. G. Peterson. 1998. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex. J Virol. 72(9):6979-87.
Speevak, M. D., N. G. Berube, I. J. McGowan-Jordan, C. Bisson, S. D. Lupton, and M. Chevrette. 1995. Construction and analysis of microcell hybrids containing dual selectable tagged human chromosomes. Cytogenet Cell Genet. 69(1-2):63-5.
Spencer, C. A., M. E. Dahmus, and S. A. Rice. 1997. Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J Virol. 71(3):2031-40.
Spencer, J. V., B. L. Trus, F. P. Booy, A. C. Steven, W. W. Newcomb, and J. C. Brown. 1997. Structure of the herpes simplex virus capsid: peptide A862-H880 of the major capsid protein is displayed on the rim of the capsomer protrusions. Virology. 228(2):229-35.
Spencer, J. V., W. W. Newcomb, D. R. Thomsen, F. L. Homa, and J. C. Brown. 1998. Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid. J Virol. 72(5):3944-51.
Spencer, B., S. Agarwala, M. Miskulin, M. Smith, and C. R. Brandt. 2000. Herpes simplex virus-mediated gene delivery to the rodent visual system. Invest Ophthalmol Vis Sci. 41(6):1392-401.
Spivack, J. G., and N. W. Fraser. 1987. Detection of herpes simplex virus type 1 transcripts during latent infection in mice [published erratum appears in J Virol 1988 Feb;62(2):663]. J Virol. 61(12):3841-7.
Spivack, J. G., and N. W. Fraser. 1988. Expression of herpes simplex virus type 1 (HSV-1) latency-associated transcripts and transcripts affected by the deletion in avirulent mutant HFEM: evidence for a new class of HSV-1 genes. J Virol. 62(9):3281-7.
Spivack, J. G., M. U. Fareed, T. Valyi-Nagy, T. C. Nash, J. S. O'Keefe, R. M. Gesser, E. A. McKie, A. R. MacLean, N. W. Fraser, and S. M. Brown. 1995. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model. J Gen Virol. 76(Pt 2):321-32.
Standring-Cox, R., T. H. Bacon, and B. A. Howard. 1996. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir. J Virol Methods. 56(1):3-11.
Stannard, L. M., S. Himmelhoch, and S. Wynchank. 1996. Intra-nuclear localization of two envelope proteins, gB and gD, of herpes simplex virus. Arch Virol. 141(3-4):505-24.
Starr, P. A., F. Lim, F. D. Grant, L. Trask, P. Lang, L. Yu, and A. I. Geller. 1996. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther. 3(7):615-23.
Stavropoulos, T. A., and C. A. Strathdee. 1998. An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol. 72(9):7137-43.
Steiner, I., N. Mador, I. Reibstein, J. G. Spivack, and N. W. Fraser. 1994. Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol. 20(3):253-60.
Steiner, I., and P. G. Kennedy. 1995. Herpes simplex virus latent infection in the nervous system. J Neurovirol. 1(1):19-29.
Steinmann, N. A., R. Nunez, R. Koppel, and M. Ackermann. 1998. Construction and characterization of a stably transformed HeLa cell line in which the expression of bovine herpesvirus 1 ICP0 (BICP0) is induced by tetracycline. Arch Virol. 143(1):35-48.
Stevens, J. G. 1993. HSV-1 neuroinvasiveness. Intervirology. 35(1-4):152-63.
Stevenson, A. J., E. E. Morrison, R. Chaudhari, C. C. Yang, and D. M. Meredith. 1997. Processing and intracellular localization of the herpes simplex virus type 1 proteinase. J Gen Virol. 78(Pt 3):671-5.
Stewart, J. F., M. C. Croxson, K. F. Powell, and P. J. Polkinghorne. 1993. Identification of cytomegalovirus in vitreous using the polymerase chain reaction. Aust N Z J Ophthalmol. 21(3):165-9.
Stokes, A., D. G. Alber, J. Greensill, B. Amellal, R. Carvalho, L. A. Taylor, T. R. Doel, R. A. Killington, I. W. Halliburton, and D. M. Meredith. 1996. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res. 40(1):91-107.
Stow, N. D. 1982. Localization of an origin of DNA replication within the TRS/IRS repeated region of the herpes simplex virus type 1 genome. Embo J. 1(7):863-7.
Stow, N. D., E. C. McMonagle, and A. J. Davison. 1983. Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA. Nucleic Acids Res. 11(23):8205-20.
Stow, N. D., and E. C. McMonagle. 1983. Characterization of the TRS/IRS origin of DNA replication of herpes simplex virus type 1. Virology. 130(2):427-38.
Stow, N. D., and E. C. Stow. 1986. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol. 67(Pt 12):2571-85.
Stow, N. D., and A. J. Davison. 1986. Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products. J Gen Virol. 67(Pt 8):1613-23.
Stow, E. C., and N. D. Stow. 1989. Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. J Gen Virol. 70(Pt 3):695-704.
Stow, N. D., G. Brown, A. M. Cross, and A. P. Abbotts. 1998. Identification of residues within the herpes simplex virus type 1 origin-binding protein that contribute to sequence-specific DNA binding. Virology. 240(2):183-92.
Strelow, L. I., K. A. Laycock, P. Y. Jun, K. A. Rader, R. H. Brady, J. K. Miller, J. S. Pepose, and D. A. Leib. 1994. A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae. J Gen Virol. 75(Pt 9):2475-80.
Strelow, L. I., and D. A. Leib. 1995. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J Virol. 69(11):6779-86.
Strelow, L., T. Smith, and D. Leib. 1997. The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle. Virology. 231(1):28-34.
Strick, R., J. Hansen, R. Bracht, D. Komitowski, and C. W. Knopf. 1997. Epitope mapping and functional characterization of monoclonal antibodies specific for herpes simplex virus type I DNA polymerase. Intervirology. 40(1):41-9.
Su, L., and D. M. Knipe. 1987. Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells. J Virol. 61(2):615-20.
Su, Y. H., X. T. Yan, J. E. Oakes, and R. N. Lausch. 1996. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol. 70(2):1277-81.
Su, Y. H., R. L. Meegalla, R. Chowhan, C. Cubitt, J. E. Oakes, R. N. Lausch, N. W. Fraser, and T. M. Block. 1999. Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J Virol. 73(5):4171-80.
Subak-Sharpe, J. H., S. A. Al-Saadi, and G. B. Clements. 1984. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia. J Invest Dermatol. 83(1 Suppl):67s-71s.
Subak-Sharpe, J. H., and D. J. Dargan. 1998. HSV molecular biology: general aspects of herpes simplex virus molecular biology. Virus Genes. 16(3):239-51.
Subramanian, G., D. S. McClain, A. Perez, and A. O. Fuller. 1994. Swine testis cells contain functional heparan sulfate but are defective in entry of herpes simplex virus. J Virol. 68(9):5667-76.
Subramanian, G., R. A. LeBlanc, R. C. Wardley, and A. O. Fuller. 1995. Defective entry of herpes simplex virus types 1 and 2 into porcine cells and lack of infection in infant pigs indicate species tropism. J Gen Virol. 76(Pt 9):2375-9.
Sullivan, V., and G. L. Smith. 1988. The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization. J Gen Virol. 69(Pt 4):859-67.
Sun, M., G. R. Zhang, T. Yang, L. Yu, and A. I. Geller. 1999. Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure. Hum Gene Ther. 10(12):2005-11.
Sun, Y., and J. Conner. 2000. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase. Biochem J. 347 Pt 1:97-104.
Suzuki, M., F. C. Christians, B. Kim, A. Skandalis, M. E. Black, and L. A. Loeb. 1996. Tolerance of different proteins for amino acid diversity. Mol Divers. 2(1-2):111-8.
Suzutani, T., S. Koyano, M. Takada, I. Yoshida, and M. Azuma. 1995. Analysis of the relationship between cellular thymidine kinase activity and virulence of thymidine kinase-negative herpes simplex virus types 1 and 2. Microbiol Immunol. 39(10):787-94.
Suzutani, T., M. Saijo, M. Nagamine, M. Ogasawara, and M. Azuma. 2000. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir- resistant viral infection. J Clin Microbiol. 38(5):1839-44.
Syrjanen, S., H. Mikola, M. Nykanen, and V. Hukkanen. 1996. In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture. J Virol. 70(9):6524-8.
Sze, P., and R. C. Herman. 1992. The herpes simplex virus type 1 ICP6 gene is regulated by a 'leaky' early promoter. Virus Res. 26(2):141-52.
Takahashi, I., T. K. Kobayashi, H. Suzuki, S. Nakamura, and F. Tezuka. 1998. Coexistence of Pemphigus vulgaris and herpes simplex virus infection in oral mucosa diagnosed by cytology, immunohistochemistry, and polymerase chain reaction. Diagn Cytopathol. 19(6):446-50.
Takakuwa, K., K. Fujita, A. Kikuchi, S. Sugaya, T. Yahata, H. Aida, T. Kurabayashi, I. Hasegawa, and K. Tanaka. 1997. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues. Jpn J Cancer Res. 88(2):166-75.
Takamiya, H., C. Wada, and H. Ohtani. 1995. [Molecular differential diagnosis of herpes virus using common primer pairs: detection of HSV-1, HSV-2, VZV and CMV by the PCR]. Rinsho Byori. 43(4):365-9.
Takasaki, I., T. Andoh, K. Shiraki, and Y. Kuraishi. 2000. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain. 86(1-2):95-101.
Tal-Singer, R., T. M. Lasner, W. Podrzucki, A. Skokotas, J. J. Leary, S. L. Berger, and N. W. Fraser. 1997. Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol. 71(7):5268-76.
Tal-Singer, R., W. Podrzucki, T. M. Lasner, A. Skokotas, J. J. Leary, N. W. Fraser, and S. L. Berger. 1998. Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interferon regulatory factor-1. J Virol. 72(2):1252-61.
Tal-Singer, R., R. Pichyangkura, E. Chung, T. M. Lasner, B. P. Randazzo, J. Q. Trojanowski, N. W. Fraser, and S. J. Triezenberg. 1999. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology. 259(1):20-33.
Tan, S. V., R. J. Guiloff, F. Scaravilli, P. E. Klapper, G. M. Cleator, and B. G. Gazzard. 1993. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann Neurol. 34(4):619-22.
Tang, Q., and R. L. Hendricks. 1996. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus- infected mouse corneas. J Exp Med. 184(4):1435-47.
Tatarowicz, W. A., C. E. Martin, A. S. Pekosz, S. L. Madden, F. J. Rauscher, 3rd, S. Y. Chiang, T. A. Beerman, and N. W. Fraser. 1997. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J Neurovirol. 3(3):212-24.
Tateishi, K., Y. Toh, H. Minagawa, and H. Tashiro. 1994. Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation. J Oral Pathol Med. 23(2):80-4.
Tatman, J. D., V. G. Preston, P. Nicholson, R. M. Elliott, and F. J. Rixon. 1994. Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J Gen Virol. 75(Pt 5):1101-13.
Taus, N. S., and J. D. Baines. 1998. Herpes simplex virus 1 DNA cleavage/packaging: the UL28 gene encodes a minor component of B capsids. Virology. 252(2):443-9.
Taus, N. S., B. Salmon, and J. D. Baines. 1998. The herpes simplex virus 1 UL 17 gene is required for localization of capsids and major and minor capsid proteins to intranuclear sites where viral DNA is cleaved and packaged. Virology. 252(1):115-25.
Taylor, J. L., P. Tom, J. Guy, R. M. Selvarajan, and W. J. O'Brien. 1994. Regulation of herpes simplex virus thymidine kinase in cells treated with a synergistic antiviral combination of alpha interferon and acyclovir. Antimicrob Agents Chemother. 38(4):853-6.
Taylor, J. L., P. Tom, and W. J. O'Brien. 1998. Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase. Antiviral Res. 38(2):95-106.
Tei, M., K. Nishida, and S. Kinoshita. 1996. Polymerase chain reaction detection of herpes simplex virus in tear fluid from atypical herpetic epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol. 122(5):732-5.
Thomas, S., R. S. Coffin, P. Watts, G. Gough, and D. S. Latchman. 1998. The TAATGARAT motif in the herpes simplex virus immediate-early gene promoters can confer both positive and negative responses to cellular octamer-binding proteins when it is located within the viral genome. J Virol. 72(4):3495-500.
Thomas, S. K., C. E. Lilley, D. S. Latchman, and R. S. Coffin. 1999. Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate- early gene defects. J Virol. 73(9):7399-409.
Thomas, S. K., G. Gough, D. S. Latchman, and R. S. Coffin. 1999. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J Virol. 73(8):6618-25.
Thompson, R. L., E. K. Wagner, and J. G. Stevens. 1983. Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology. 131(1):180-92.
Thompson, R. L., G. V. Devi-Rao, J. G. Stevens, and E. K. Wagner. 1985. Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol. 55(2):504-8.
Thompson, R. L., and E. K. Wagner. 1988. Partial rescue of herpes simplex virus neurovirulence with a 3.2 kb cloned DNA fragment. Virus Genes. 1(3):261-73.
Thompson, R. L., and N. M. Sawtell. 1997. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol. 71(7):5432-40.
Thompson, R. L., and N. M. Sawtell. 2000. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency. J Virol. 74(2):965-74.
Thomsen, D. R., L. L. Roof, and F. L. Homa. 1994. Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol. 68(4):2442-57.
Thomsen, D. R., W. W. Newcomb, J. C. Brown, and F. L. Homa. 1995. Assembly of the herpes simplex virus capsid: requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes. J Virol. 69(6):3690-703.
Thouvenot, D., and F. Najioullah. 1999. [Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2)]. Rev Prat. 49(20):2203-7.
Thust, R., M. Tomicic, R. Klocking, N. Voutilainen, P. Wutzler, and B. Kaina. 2000. Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches. Cancer Gene Ther. 7(1):107-17.
Tirado, R., R. E. Sarmiento, and B. Gomez. 1998. Spontaneous shift of an HSV type 1 productive, persistently infected macrophage-like culture to a non-productive culture. Res Virol. 149(3):145-51.
Tognon, M., D. Furlong, A. J. Conley, and B. Roizman. 1981. Molecular genetics of herpes simplex virus. V. Characterization of a mutant defective in ability to form plaques at low temperatures and in a viral fraction which prevents accumulation of coreless capsids at nuclear pores late in infection. J Virol. 40(3):870-80.
Tognon, M., R. Manservigi, M. G. Romanelli, A. Rotola, R. Gatti, L. Foa-Tomasi, and G. Campadelli-Fiume. 1988. A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncytial mutation. Arch Virol. 98(3-4):199-212.
Tognon, M., M. G. Romanelli, E. M. Cattozzo, C. Bovolenta, and E. Liboi. 1993. c-fos proto-oncogene transient transcription is negatively affected in the ELa4-2 transformed rat cell line. Pathobiology. 61(5-6):288-92.
Tognon, M., E. M. Cattozzo, S. Bianchi, and M. G. Romanelli. 1996. Enhancement of HSV-DNA infectivity, in Vero and RS cells, by a modified calcium-phosphate transfection technique. Virus Genes. 12(2):193-7.
Toh, Y., Y. Liu, S. Tanaka, and R. Mori. 1993. Nucleotide sequence of the major DNA-binding protein gene of herpes simplex virus type 2 and a comparison with the type 1. Arch Virol. 129(1-4):183-96.
Tomasec, P., C. M. Preston, E. A. Linton, I. Ahmed, P. R. Lowenstein, and M. G. Castro. 1999. Generation of a recombinant herpes simplex virus type 1 expressing the rat corticotropin- releasing hormone precursor: endoproteolytic processing, intracellular targeting and biological activity. Neuroendocrinology. 70(6):439-50.
Tornerup, N. R., A. Fomsgaard, and N. V. Nielsen. 2000. HSV-1--induced acute retinal necrosis syndrome presenting with severe inflammatory orbitopathy, proptosis, and optic nerve involvement. Ophthalmology. 107(2):397-401.
Toyoizumi, T., R. Mick, A. E. Abbas, E. H. Kang, L. R. Kaiser, and K. L. Molnar-Kimber. 1999. Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer. Hum Gene Ther. 10(18):3013-29.
Tran, L. C., J. M. Kissner, L. E. Westerman, and A. E. Sears. 2000. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc Natl Acad Sci U S A. 97(4):1818-22.
Tremblay, M. L., S. P. Yee, R. H. Persson, S. Bacchetti, J. R. Smiley, and P. E. Branton. 1985. Activation and inhibition of expression of the 72,000-Da early protein of adenovirus type 5 in mouse cells constitutively expressing an immediate early protein of herpes simplex virus type 1. Virology. 144(1):35-45.
Triezenberg, S. J., K. L. LaMarco, and S. L. McKnight. 1988. Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16. Genes Dev. 2(6):730-42.
Tronik-Le Roux, D., V. Roullot, A. Schweitzer, R. Berthier, and G. Marguerie. 1995. Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter [published erratum appears in J Exp Med 1995 Oct 1;182(4):1177]. J Exp Med. 181(6):2141-51.
Trousdale, M. D., I. Steiner, J. G. Spivack, S. L. Deshmane, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1991. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol. 65(12):6989-93.
Trybala, E., T. Bergstrom, B. Svennerholm, S. Jeansson, J. C. Glorioso, and S. Olofsson. 1994. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol. 75(Pt 4):743-52.
Tsurumi, T., K. Maeno, and Y. Nishiyama. 1987. Nucleotide sequence of the DNA polymerase gene of herpes simplex virus type 2 and comparison with the type 1 counterpart. Gene. 52(2-3):129-37.
Tunback, P., J. A. Liljeqvist, G. B. Lowhagen, and T. Bergstrom. 2000. Glycoprotein G of herpes simplex virus type 1: identification of type- specific epitopes by human antibodies. J Gen Virol. 81 Pt 4:1033-40.
Turner, E. E., J. M. Rhee, and L. T. Feldman. 1997. The POU-domain factor Brn-3.0 recognizes characteristic sites in the herpes simplex virus genome. Nucleic Acids Res. 25(13):2589-94.
Turner, A., B. Bruun, T. Minson, and H. Browne. 1998. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol. 72(1):873-5.
Turner, S. J., and F. R. Carbone. 1998. A dominant V beta bias in the CTL response after HSV-1 infection is determined by peptide residues predicted to also interact with the TCR beta-chain CDR3. Mol Immunol. 35(5):307-16.
Tyler, J. K., and R. D. Everett. 1993. The DNA binding domain of the varicella-zoster virus gene 62 protein interacts with multiple sequences which are similar to the binding site of the related protein of herpes simplex virus type 1. Nucleic Acids Res. 21(3):513-22.
Tyler, J. K., and R. D. Everett. 1994. The DNA binding domains of the varicella-zoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. Nucleic Acids Res. 22(5):711-21.
Tyler, J. K., A. Orr, and R. D. Everett. 1997. Replacement of the herpes simplex virus type 1 Vmw175 DNA binding domain with its varicella-zoster virus counterpart results in a protein with novel regulatory properties that can support virus growth. J Gen Virol. 78(Pt 1):179-88.
Umene, K., and L. W. Enquist. 1981. A deletion analysis of lambda hybrid phage carrying the US region of Herpes virus type 1 (Patton). II. Construction of an SmaI map. Gene. 13(3):269-79.
Umene, K., and L. W. Enquist. 1981. A deletion analysis of hybrid phage carrying the US region of Herpes simplex virus type 1 (Patton). I. Isolation of deletion derivatives and identification of chi-likes sequences. Gene. 13(3):251-68.
Umene, K. 1986. Conversion of a fraction of the unique sequence to part of the inverted repeats in the S component of the herpes simplex virus type 1 genome. J Gen Virol. 67(Pt 6):1035-48.
Umene, K., and M. Yoshida. 1989. Reiterated sequences of herpes simplex virus type 1 (HSV-1) genome can serve as physical markers for the differentiation of HSV-1 strains. Arch Virol. 106(3-4):281-99.
Umene, K., and H. Sakaoka. 1991. Homogeneity and diversity of genome polymorphism in a set of herpes simplex virus type 1 strains classified as the same genotypic group. Arch Virol. 119(1-2):53-65.
Umene, K., and M. Yoshida. 1993. Genomic characterization of two predominant genotypes of herpes simplex virus type 1. Arch Virol. 131(1-2):29-46.
Umene, K. 1994. Excision of DNA fragments corresponding to the unit-length a sequence of herpes simplex virus type 1 and terminus variation predominate on one side of the excised fragment. J Virol. 68(7):4377-83.
Umene, K., and M. Yoshida. 1994. Preparation of herpes simplex virus type 1 genomic markers to differentiate strains of predominant genotypes. Arch Virol. 138(1-2):55-69.
Umene, K., and T. Nishimoto. 1996. Inhibition of generation of authentic genomic termini of herpes simplex virus type 1 DNA in temperature-sensitive mutant BHK-21 cells with a mutated CCG1/TAF(II)250 gene. J Virol. 70(12):9008-12.
Umene, K., and T. Nishimoto. 1996. Replication of herpes simplex virus type 1 DNA is inhibited in a temperature-sensitive mutant of BHK-21 cells lacking RCC1 (regulator of chromosome condensation) and virus DNA remains linear. J Gen Virol. 77(Pt 9):2261-70.
Umene, K., M. Yoshida, and H. Sakaoka. 1996. Comparison of the association with eczema herpeticum in the two predominant genotypes of herpes simplex virus type 1. J Med Virol. 49(4):329-32.
Umene, K., and H. Sakaoka. 1997. Populations of two eastern countries of Japan and Korea and with a related history share a predominant genotype of herpes simplex virus type 1. Arch Virol. 142(10):1953-61.
Umene, K., and M. Yoshida. 1998. [Herpes simplex virus type 1-gene: functions and gene therapy]. Tanpakushitsu Kakusan Koso. 43(7):847-56.
Umene, K., and H. Sakaoka. 1999. Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch Virol. 144(4):637-56.
Uprichard, S. L., and D. M. Knipe. 1996. Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol. 70(3):1969-80.
Uprichard, S. L., and D. M. Knipe. 1997. Assembly of herpes simplex virus replication proteins at two distinct intranuclear sites. Virology. 229(1):113-25.
Vafai, A., Z. Wroblewska, and L. Graf. 1990. Antigenic cross-reaction between a varicella-zoster virus nucleocapsid protein encoded by gene 40 and a herpes simplex virus nucleocapsid protein. Virus Res. 15(2):163-74.
Valyi-Nagy, T., M. U. Fareed, J. S. O'Keefe, R. M. Gesser, A. R. MacLean, S. M. Brown, J. G. Spivack, and N. W. Fraser. 1994. The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol. 75(Pt 8):2059-63.
Van der Lelij, A., F. M. Ooijman, A. Kijlstra, and A. Rothova. 2000. Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology. 107(6):1164-70.
Van Sant, C., Y. Kawaguchi, and B. Roizman. 1999. A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate. Proc Natl Acad Sci U S A. 96(14):8184-9.
van Zijl, M., H. van der Gulden, N. de Wind, A. Gielkens, and A. Berns. 1990. Identification of two genes in the unique short region of pseudorabies virus; comparison with herpes simplex virus and varicella-zoster virus. J Gen Virol. 71(Pt 8):1747-55.
Vel'tishcheva, E., O. D. Viduta, A. M. Ponomareva, N. M. Karakhan, L. G. Nisan, N. M. Dement'eva, and V. A. Aleshkin. 1993. [The primary immune response and virus-specific and -nonspecific immune complexes in neonatal cytomegalovirus and herpetic infection]. Zh Mikrobiol Epidemiol Immunobiol(6):104-5.
Verhaagen, J., W. T. Hermens, M. G. Kaplitt, D. W. Pfaff, and W. H. Gispen. 1994. B-50/GAP-43 expression via a defective herpes simplex virus vector results in persistent morphological changes in non-neuronal cells. Gene Ther. 1(Suppl 1):S81.
Vesanen, M., H. Piiparinen, A. Kallio, and A. Vaheri. 1996. Detection of herpes simplex virus DNA in cerebrospinal fluid samples using the polymerase chain reaction and microplate hybridization. J Virol Methods. 59(1-2):1-11.
Villani, G., M. J. Pillaire, and P. E. Boehmer. 1994. Effect of the major DNA adduct of the antitumor drug cis- diamminedichloroplatinum (II) on the activity of a helicase essential for DNA replication, the herpes simplex virus type-1 origin-binding protein. J Biol Chem. 269(34):21676-81.
Vinogradov, S. V., Y. G. Suzdaltseva, and A. V. Kabanov. 1996. Block polycationic oligonucleotide derivative: synthesis and inhibition of herpes virus reproduction. Bioconjug Chem. 7(1):3-6.
Visalli, R. J., and C. R. Brandt. 1991. The HSV-1 UL45 gene product is not required for growth in Vero cells. Virology. 185(1):419-23.
Visalli, R. J., and C. R. Brandt. 1993. The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion. Virus Res. 29(2):167-78.
Vivian, J. L., W. H. Klein, and P. Hasty. 1999. Temporal, spatial and tissue-specific expression of a myogenin-lacZ transgene targeted to the Hprt locus in mice. Biotechniques. 27(1):154-62.
Vlazny, D. A., and N. Frenkel. 1981. Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes. Proc Natl Acad Sci U S A. 78(2):742-6.
Vlcek, C., V. Paces, and M. Schwyzer. 1989. Nucleotide sequence of the pseudorabies virus immediate early gene, encoding a strong transactivator protein. Virus Genes. 2(4):335-46.
Vogel, J. U., B. Weber, and H. W. Doerr. 1994. Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol. 281(4):502-12.
Vogel, J. L., and T. M. Kristie. 2000. The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP. Embo J. 19(4):683-90.
Vojvodova, A., J. Matis, M. Kudelova, and J. Rajcani. 1997. Herpes simplex virus type 1 (HSV-1) strain HSZP host shutoff gene: nucleotide sequence and comparison with HSV-1 strains differing in early shutoff of host protein synthesis. Virus Genes. 15(2):155-9.
Voss, J. H., and B. Roizman. 1988. Properties of two 5'-coterminal RNAs transcribed part way and across the S component origin of DNA synthesis of the herpes simplex virus 1 genome. Proc Natl Acad Sci U S A. 85(22):8454-8.
Wagner, E. K., J. F. Guzowski, and J. Singh. 1995. Transcription of the herpes simplex virus genome during productive and latent infection. Prog Nucleic Acid Res Mol Biol. 51:123-65.
Wagner, E. K., M. D. Petroski, N. T. Pande, P. T. Lieu, and M. Rice. 1998. Analysis of factors influencing kinetics of herpes simplex virus transcription utilizing recombinant virus. Methods. 16(1):105-16.
Wagstaff, M. J., C. E. Lilley, J. Smith, M. J. Robinson, R. S. Coffin, and D. S. Latchman. 1998. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo. Gene Ther. 5(11):1566-70.
Wain-Hobson, S., C. Pourcel, C. Brechot, P. Charnay, M. F. Dubois, A. Fritsch, M. Gervais, A. Louise, and P. Tiollais. 1981. Structure and expression of the hepatitis B virus genome. Dev Biol Stand. 50:293-300.
Wald, A., J. Zeh, S. Selke, T. Warren, A. J. Ryncarz, R. Ashley, J. N. Krieger, and L. Corey. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 342(12):844-50.
Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol. 73(9):7619-26.
Walro, D. G., and K. S. Rosenthal. 1997. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation. Antiviral Res. 36(1):63-72.
Wanas, E., S. Efler, K. Ghosh, and H. P. Ghosh. 1999. Mutations in the conserved carboxy-terminal hydrophobic region of glycoprotein gB affect infectivity of herpes simplex virus. J Gen Virol. 80(Pt 12):3189-98.
Wang, J. Y., and K. T. Montone. 1994. A rapid simple in situ hybridization method for herpes simplex virus employing a synthetic biotin-labeled oligonucleotide probe: a comparison with immunohistochemical methods for HSV detection. J Clin Lab Anal. 8(2):105-15.
Wang, H. L., M. M. Sheu, W. L. Huang, C. W. Chen, L. C. Chou, and K. H. Lin. 1995. A molecular study of ocular herpes simplex infection in Kaohsiung, Taiwan. Part I: Cleavage pattern analysis. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih. 11(9):507-13.
Wang, M. J., T. Friedmann, and P. A. Johnson. 1995. Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor. Gene Ther. 2(5):323-35.
Wang, S., S. Di, W. B. Young, C. Jacobson, and C. J. Link, Jr. 1997. A novel herpesvirus amplicon system for in vivo gene delivery. Gene Ther. 4(11):1132-41.
Wang, Y., L. Yu, and A. I. Geller. 1999. Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system. Hum Gene Ther. 10(11):1763-71.
Wang, J., H. Jiang, and F. Liu. 2000. In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. Rna. 6(4):571-83.
Wang, X., G. R. Zhang, T. Yang, W. Zhang, and A. I. Geller. 2000. Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain. Biotechniques. 28(1):102-7.
Wang, J., M. Froeyen, C. Hendrix, G. Andrei, R. Snoeck, E. De Clercq, and P. Herdewijn. 2000. The cyclohexene ring system as a furanose mimic: synthesis and antiviral activity of both enantiomers of cyclohexenylguanine. J Med Chem. 43(4):736-45.
Ward, P. L., G. Campadelli-Fiume, E. Avitabile, and B. Roizman. 1994. Localization and putative function of the UL20 membrane protein in cells infected with herpes simplex virus 1. J Virol. 68(11):7406-17.
Ward, P. L., W. O. Ogle, and B. Roizman. 1996. Assemblons: nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1. J Virol. 70(7):4623-31.
Ward, P. L., E. Avitabile, G. Campadelli-Fiume, and B. Roizman. 1998. Conservation of the architecture of the Golgi apparatus related to a differential organization of microtubules in polykaryocytes induced by syn- mutants of herpes simplex virus 1. Virology. 241(2):189-99.
Ward, P. L., B. Taddeo, N. S. Markovitz, and B. Roizman. 2000. Identification of a novel expressed open reading frame situated between genes U(L)20 and U(L)21 of the herpes simplex virus 1 genome. Virology. 266(2):275-85.
Warden, M. P., and J. P. Weir. 1996. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector. Virology. 226(1):127-31.
Watson, K., J. G. Stevens, M. L. Cook, and J. H. Subak-Sharpe. 1980. Latency competence of thirteen HSV-1 temperature-sensitive mutants. J Gen Virol. 49(1):149-59.
Watson, R. J., and G. F. Vande Woude. 1982. DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res. 10(3):979-91.
Watson, R. J. 1983. DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene. Gene. 26(2-3):307-12.
Watson, R. J., A. M. Colberg-Poley, C. J. Marcus-Sekura, B. J. Carter, and L. W. Enquist. 1983. Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes. Nucleic Acids Res. 11(5):1507-22.
Weber, P. C., M. Levine, and J. C. Glorioso. 1987. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science. 236(4801):576-9.
Weber, P. C., M. D. Challberg, N. J. Nelson, M. Levine, and J. C. Glorioso. 1988. Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell. 54(3):369-81.
Weber, P. C., S. J. Spatz, and E. C. Nordby. 1999. Stable ubiquitination of the ICP0R protein of herpes simplex virus type 1 during productive infection. Virology. 253(2):288-98.
Wechsler, S. L., A. B. Nesburn, R. Watson, S. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol. 69(Pt 12):3101-6.
Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol. 62(11):4051-8.
Weindler, F. W., and R. Heilbronn. 1991. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J Virol. 65(5):2476-83.
Weinheimer, S. P., and S. L. McKnight. 1987. Transcriptional and post-transcriptional controls establish the cascade of herpes simplex virus protein synthesis. J Mol Biol. 195(4):819-33.
Weinheimer, S. P., P. J. d. McCann, D. R. d. O'Boyle, J. T. Stevens, B. A. Boyd, D. A. Drier, G. A. Yamanaka, C. L. DiIanni, I. C. Deckman, and M. G. Cordingley. 1993. Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles. J Virol. 67(10):5813-22.
Weir, J. P., and P. R. Narayanan. 1988. The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses [published erratum appears in Nucleic Acids Res 1989 Mar 11;17(5):2157]. Nucleic Acids Res. 16(21):10267-82.
Weir, J. P., M. Bennett, E. M. Allen, K. L. Elkins, S. Martin, and B. T. Rouse. 1989. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J Gen Virol. 70(Pt 10):2587-94.
Weir, H. M., J. M. Calder, and N. D. Stow. 1989. Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication. Nucleic Acids Res. 17(4):1409-25.
Weir, J. P., E. J. Dacquel, and J. Aronovitz. 1996. Herpesvirus vector-mediated gene delivery to human monocytes. Hum Gene Ther. 7(11):1331-8.
Weise, K., H. C. Kaerner, J. Glorioso, and C. H. Schroder. 1987. Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes of plaque morphology and neuropathogenicity. J Gen Virol. 68(Pt 7):1909-19.
Weisshart, K., A. A. Kuo, C. B. Hwang, K. Kumura, and D. M. Coen. 1994. Structural and functional organization of herpes simplex virus DNA polymerase investigated by limited proteolysis. J Biol Chem. 269(36):22788-96.
Welch, A. R., E. C. Villarreal, and W. Gibson. 1995. Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase. J Virol. 69(1):341-7.
Weller, S. K., D. P. Aschman, W. R. Sacks, D. M. Coen, and P. A. Schaffer. 1983. Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment. Virology. 130(2):290-305.
Weller, S. K., E. P. Carmichael, D. P. Aschman, D. J. Goldstein, and P. A. Schaffer. 1987. Genetic and phenotypic characterization of mutants in four essential genes that map to the left half of HSV-1 UL DNA. Virology. 161(1):198-210.
Weller, S. K., M. R. Seghatoleslami, L. Shao, D. Rowse, and E. P. Carmichael. 1990. The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis: isolation and characterization of a lacZ insertion mutant. J Gen Virol. 71(Pt 12):2941-52.
Wera, S., B. Degreve, J. Balzarini, E. De Clercq, J. M. Thevelein, and J. Neyts. 1999. Budding yeast as a screening tool for discovery of nucleoside analogs for use in HSV-1 TK suicide-gene therapy. Biotechniques. 27(4):772-4, 776-7.
Werstuck, G., and J. P. Capone. 1989. Mutational analysis of the herpes simplex virus trans-inducing factor Vmw65. Gene. 75(2):213-24.
Westra, D. F., K. L. Glazenburg, M. C. Harmsen, A. Tiran, A. Jan Scheffer, G. W. Welling, T. Hauw The, and S. Welling-Wester. 1997. Glycoprotein H of herpes simplex virus type 1 requires glycoprotein L for transport to the surfaces of insect cells. J Virol. 71(3):2285-91.
Westra, D. F., H. B. Kuiperij, G. W. Welling, A. J. Scheffer, T. H. The, and S. Welling-Wester. 1999. Domains of glycoprotein H of herpes simplex virus type 1 involved in complex formation with glycoprotein L. Virology. 261(1):96-105.
Whalley, M., G. Robertson, C. Bell, D. Love, M. Elphinstone, L. Wiley, and D. Craven. 1991. Identification and comparative sequence analysis of a gene in equine herpesvirus 1 with homology to the herpes simplex virus glycoprotein D gene. Virus Genes. 5(4):313-25.
Whealy, M. E., A. K. Robbins, and L. W. Enquist. 1989. Replacement of the pseudorabies virus glycoprotein gIII gene with its postulated homolog, the glycoprotein gC gene of herpes simplex virus type 1. J Virol. 63(9):4055-9.
Whitbeck, J. C., L. J. Bello, and W. C. Lawrence. 1988. Comparison of the bovine herpesvirus 1 gI gene and the herpes simplex virus type 1 gB gene [published erratum appears in J Virol 1988 Dec;62(12):4835]. J Virol. 62(9):3319-27.
Whitbeck, J. C., W. C. Lawrence, and L. J. Bello. 1994. Characterization of the bovine herpesvirus 1 homolog of the herpes simplex virus 1 UL24 open reading frame. Virology. 200(1):263-70.
Whitbeck, J. C., M. I. Muggeridge, A. H. Rux, W. Hou, C. Krummenacher, H. Lou, A. van Geelen, R. J. Eisenberg, and G. H. Cohen. 1999. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J Virol. 73(12):9879-90.
Whiteley, A., B. Bruun, T. Minson, and H. Browne. 1999. Effects of targeting herpes simplex virus type 1 gD to the endoplasmic reticulum and trans-Golgi network. J Virol. 73(11):9515-20.
Whittle, I. R. 1995. Gene therapy for brain tumours [editorial]. Br J Neurosurg. 9(6):717-20.
Whitton, J. L., F. J. Rixon, A. J. Easton, and J. B. Clements. 1983. Immediate-early mRNA-2 of herpes simplex viruses types 1 and 2 is unspliced: conserved sequences around the 5' and 3' termini correspond to transcription regulatory signals. Nucleic Acids Res. 11(18):6271-87.
Whitton, J. L., and J. B. Clements. 1984. The junctions between the repetitive and the short unique sequences of the herpes simplex virus genome are determined by the polypeptide- coding regions of two spliced immediate-early mRNAs. J Gen Virol. 65(Pt 3):451-66.
Whitton, J. L., and J. B. Clements. 1984. Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus. Nucleic Acids Res. 12(4):2061-79.
Wigdahl, B. L., H. C. Isom, and F. Rapp. 1981. Repression and activation of the genome of herpes simplex viruses in human cells. Proc Natl Acad Sci U S A. 78(10):6522-6.
Wilber, B. A., and J. J. Docherty. 1994. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'- deoxyuridine. J Gen Virol. 75(Pt 7):1743-7.
Wilcox, C. L., R. L. Smith, R. D. Everett, and D. Mysofski. 1997. The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection. J Virol. 71(9):6777-85.
Wild, K., T. Bohner, A. Aubry, G. Folkers, and G. E. Schulz. 1995. The three-dimensional structure of thymidine kinase from herpes simplex virus type 1. FEBS Lett. 368(2):289-92.
Wild, K., T. Bohner, G. Folkers, and G. E. Schulz. 1997. The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci. 6(10):2097-106.
Wildemann, B., K. Ehrhart, B. Storch-Hagenlocher, U. Meyding-Lamade, S. Steinvorth, W. Hacke, and J. Haas. 1997. Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology. 48(5):1341-6.
Willemse, M. J., W. S. Chalmers, A. M. Cronenberg, R. Pfundt, I. G. Strijdveen, and P. J. Sondermeijer. 1994. The gene downstream of the gC homologue in feline herpes virus type 1 is involved in the expression of virulence. J Gen Virol. 75(Pt 11):3107-16.
Williams, M. V., and D. S. Parris. 1987. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme. Virology. 156(2):282-92.
Wilson, D. W., N. Davis-Poynter, and A. C. Minson. 1994. Mutations in the cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell fusion by a syncytial strain. J Virol. 68(11):6985-93.
Winkler, M., S. A. Rice, and T. Stamminger. 1994. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol. 68(6):3943-54.
Wintergerst, U., J. D. Gangemi, E. R. Kern, R. J. Whitley, and S. Chatterjee. 1996. Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells. Antiviral Res. 32(1):27-34.
Woerner, A. M., and J. P. Weir. 1998. Characterization of the initiator and downstream promoter elements of herpes simplex virus 1 late genes. Virology. 249(2):219-30.
Wollert, K., T. el Ansari, A. Rosen-Wolff, and D. Falke. 1991. The region 0.7615-0.796 m.u. of the HSV-1 genome determines suppression of humoral antibody formation against herpes simplex virus. Arch Virol. 116(1-4):175-84.
Wood, M. J., A. P. Byrnes, D. W. Pfaff, S. D. Rabkin, and H. M. Charlton. 1994. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1(5):283-91.
Wood, M. J., A. P. Byrnes, S. D. Rabkin, D. W. Pfaff, and H. M. Charlton. 1994. Immunological consequences of HSV-1-mediated gene transfer into the CNS. Gene Ther. 1(Suppl 1):S82.
Wright, C. A., Z. Haffajee, B. van Iddekinge, and K. Cooper. 1995. Detection of herpes simplex virus DNA in spontaneous abortions from HIV- positive women using non-isotopic in situ hybridization [see comments]. J Pathol. 176(4):399-402.
Wroblewska, Z., J. G. Spivack, J. Otte, I. Steiner, M. Brown, A. MacLean, and N. W. Fraser. 1991. The HSV-1 latency associated transcript (LAT) variants 1704 and 1705 are glycoprotein C negative. Virus Res. 20(2):193-200.
Wu, C. A., N. J. Nelson, D. J. McGeoch, and M. D. Challberg. 1988. Identification of herpes simplex virus type 1 genes required for origin- dependent DNA synthesis. J Virol. 62(2):435-43.
Wu, L. X., F. Anaraki, P. S. Morahan, and K. Leary. 1990. Transient expression of virus-specific promoters in murine resident peritoneal macrophages. J Leukoc Biol. 48(3):229-36.
Wu, C. L., and K. W. Wilcox. 1991. The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters. J Virol. 65(3):1149-59.
Wu, K., Q. Zhang, L. Zhuo, H. Chen, X. Zhang, J. Yang, and Y. Chen. 1993. Virus DNA detection of herpes simplex keratitis by PCR. Yen Ko Hsueh Pao. 9(3):126-8.
Wu, L., P. S. Morahan, and K. Leary. 1993. Regulation of herpes simplex virus type 1 gene expression in nonpermissive murine resident peritoneal macrophages. J Leukoc Biol. 53(1):61-5.
Wu, T. J., G. Monokian, D. F. Mark, and C. R. Wobbe. 1994. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides. Mol Cell Biol. 14(5):3484-93.
Wu, L., P. S. Morahan, J. A. Hendrzak, and T. K. Eisenstein. 1994. Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum. Microb Pathog. 16(6):387-99.
Wu, X., Y. Leduc, M. Cynader, and F. Tufaro. 1995. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging. J Virol Methods. 52(1-2):219-29.
Wu, T. T., Y. H. Su, T. M. Block, and J. M. Taylor. 1996. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol. 70(9):5962-7.
Wu, T. T., Y. H. Su, T. M. Block, and J. M. Taylor. 1998. Atypical splicing of the latency-associated transcripts of herpes simplex type 1. Virology. 243(1):140-9.
Wyborski, R. J., C. A. Goble, and J. Scholten. 1994. Expression of human amyloid precursor proteins in cultured neuronal cells through the use of HSV-1 defective vectors. Gene Ther. 1(Suppl 1):S83.
Wylie, B. A., J. A. Thomson, and B. D. Schoub. 1985. Identification of five new variable restriction sites in HSV-1 DNA. S Afr Med J. 68(2):98-102.
Xia, L., and R. J. Courtney. 1995. Initial characterization of the membrane-associated form of ICP4 of herpes simplex virus type 1. J Virol. 69(10):6548-52.
Xia, K., D. M. Knipe, and N. A. DeLuca. 1996. Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication. J Virol. 70(2):1050-60.
Xiao, W., L. I. Pizer, and K. W. Wilcox. 1997. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4. J Virol. 71(3):1757-65.
Xiao, H., C. Neuveut, M. Benkirane, and K. T. Jeang. 1998. Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. Biochem Biophys Res Commun. 244(2):384-9.
Xu, H., H. Federoff, J. Maragos, L. F. Parada, and J. A. Kessler. 1994. Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev Biol. 163(1):152-61.
Xu, X., X. Zhang, and Z. Guo. 1997. [Preclinical studies on thymidine kinase gene (TK) and gancyclovir system for treatment of malignant astrocytoma]. Chung Hua I Hsueh Tsa Chih. 77(1):35-8.
Xu, X., S. Ng, Z. L. Wu, D. Nguyen, S. Homburger, C. Seidel-Dugan, A. Ebens, and Y. Luo. 1998. Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins. J Biol Chem. 273(35):22428-34.
Yamada, H., T. Daikoku, Y. Yamashita, Y. M. Jiang, T. Tsurumi, and Y. Nishiyama. 1997. The product of the US10 gene of herpes simplex virus type 1 is a capsid/tegument-associated phosphoprotein which copurifies with the nuclear matrix. J Gen Virol. 78(Pt 11):2923-31.
Yamamoto, S., N. Hamada, and M. Shingu. 1993. Two novel genes of herpes simplex virus type 1 involved in cell fusion. Kurume Med J. 40(4):169-75.
Yamamoto, S., D. Pavan-Langston, R. Tada, R. Yamamoto, S. Kinoshita, K. Nishida, Y. Shimomura, and Y. Tano. 1995. Possible role of herpes simplex virus in the origin of Posner- Schlossman syndrome. Am J Ophthalmol. 119(6):796-8.
Yamamoto, K., T. S. Tochikura, S. Xiao, A. Sakurai, and A. Kawai. 1999. Association of a cellular 21-kDa transmembrane protein (VAP21) with enveloped viruses. Microbiol Immunol. 43(5):449-59.
Yamanaka, G., C. L. DiIanni, D. R. O'Boyle, 2nd, J. Stevens, S. P. Weinheimer, I. C. Deckman, L. Matusick-Kumar, and R. J. Colonno. 1995. Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts. J Biol Chem. 270(50):30168-72.
Yamashita, Y., M. Yamada, T. Daikoku, H. Yamada, A. Tadauchi, T. Tsurumi, and Y. Nishiyama. 1996. Calnexin associates with the precursors of glycoproteins B, C, and D of herpes simplex virus type 1. Virology. 225(1):216-22.
Yanagi, K. 1989. [Structure and functional analysis of genomes of herpesviruses: herpes simplex virus type 1 and type 2 (HSV-1, HSV-2)]. Nippon Rinsho. 47(2):290-301.
Yanagida, N., S. Yoshida, K. Nazerian, and L. F. Lee. 1993. Nucleotide and predicted amino acid sequences of Marek's disease virus homologues of herpes simplex virus major tegument proteins. J Gen Virol. 74(Pt 9):1837-45.
Yang, T. Y., and R. J. Courtney. 1995. Influence of the host cell on the association of ICP4 and ICP0 with herpes simplex virus type 1. Virology. 211(1):209-17.
Yang, L., C. C. Voytek, and T. P. Margolis. 2000. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol. 74(1):209-17.
Yao, F., and P. A. Schaffer. 1994. Physical interaction between the herpes simplex virus type 1 immediate- early regulatory proteins ICP0 and ICP4. J Virol. 68(12):8158-68.
Yao, F., and P. A. Schaffer. 1995. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol. 69(10):6249-58.
Yao, X. D., M. Matecic, and P. Elias. 1997. Direct repeats of the herpes simplex virus a sequence promote nonconservative homologous recombination that is not dependent on XPF/ERCC4. J Virol. 71(9):6842-9.
Yao, F., and E. Eriksson. 1999. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum Gene Ther. 10(11):1811-8.
Yao, F., and E. Eriksson. 1999. A novel tetracycline-inducible viral replication switch. Hum Gene Ther. 10(3):419-27.
Yasin, B., M. Pang, J. S. Turner, Y. Cho, N. N. Dinh, A. J. Waring, R. I. Lehrer, and E. A. Wagar. 2000. Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis. 19(3):187-94.
Ye, G. J., K. T. Vaughan, R. B. Vallee, and B. Roizman. 2000. The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J Virol. 74(3):1355-63.
Yeh, L., and P. A. Schaffer. 1993. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol. 67(12):7373-82.
Yei, S. P., S. I. Chowdhury, B. M. Bhat, A. J. Conley, W. S. Wold, and W. Batterson. 1990. Identification and characterization of the herpes simplex virus type 2 gene encoding the essential capsid protein ICP32/VP19c. J Virol. 64(3):1124-34.
Yoon, S. S., N. M. Carroll, E. A. Chiocca, and K. K. Tanabe. 1999. Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy. J Gastrointest Surg. 3(1):34-48.
Yoshikawa, T., J. M. Hill, L. R. Stanberry, N. Bourne, J. F. Kurawadwala, and P. R. Krause. 1996. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med. 184(2):659-64.
Yu, D., A. K. Sheaffer, D. J. Tenney, and S. K. Weller. 1997. Characterization of ICP6::lacZ insertion mutants of the UL15 gene of herpes simplex virus type 1 reveals the translation of two proteins. J Virol. 71(4):2656-65.
Yu, D., and S. K. Weller. 1998. Genetic analysis of the UL 15 gene locus for the putative terminase of herpes simplex virus type 1. Virology. 243(1):32-44.
Yu, D., and S. K. Weller. 1998. Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging. J Virol. 72(9):7428-39.
Yura, Y., J. Kusaka, Y. Kondo, H. Tsujimoto, H. Yoshida, and M. Sato. 1995. Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1. Arch Virol. 140(7):1181-94.
Zachos, G., B. Clements, and J. Conner. 1999. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J Biol Chem. 274(8):5097-103.
Zarling, J. M., P. A. Moran, R. L. Burke, C. Pachl, P. W. Berman, and L. A. Lasky. 1986. Human cytotoxic T cell clones directed against herpes simplex virus- infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J Immunol. 136(12):4669-73.
Zelnik, V., R. Darteil, J. C. Audonnet, G. D. Smith, M. Riviere, J. Pastorek, and L. J. Ross. 1993. The complete sequence and gene organization of the short unique region of herpesvirus of turkeys. J Gen Virol. 74(Pt 10):2151-62.
Zelus, B. D., R. S. Stewart, and J. Ross. 1996. The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro. J Virol. 70(4):2411-9.
Zhang, F., and C. N. Cole. 1987. Identification of a complex associated with processing and polyadenylation in vitro of herpes simplex virus type 1 thymidine kinase precursor RNA. Mol Cell Biol. 7(9):3277-86.
Zhang, Y. F., G. B. Devi-Rao, M. Rice, R. M. Sandri-Goldin, and E. K. Wagner. 1987. The effect of elevated levels of herpes simplex virus alpha-gene products on the expression of model early and late genes in vivo. Virology. 157(1):99-106.
Zhang, G., and D. P. Leader. 1990. The structure of the pseudorabies virus genome at the end of the inverted repeat sequences proximal to the junction with the short unique region. J Gen Virol. 71(Pt 10):2433-41.
Zhang, G., R. Stevens, and D. P. Leader. 1990. The protein kinase encoded in the short unique region of pseudorabies virus: description of the gene and identification of its product in virions and in infected cells. J Gen Virol. 71(Pt 8):1757-65.
Zhang, X., S. Efstathiou, and A. Simmons. 1994. Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies. Virology. 202(2):530-9.
Zhang, X., H. O'Shea, C. Entwisle, M. Boursnell, S. Efstathiou, and S. Inglis. 1998. An efficient selection system for packaging herpes simplex virus amplicons. J Gen Virol. 79(Pt 1):125-31.
Zhao, Z. S., F. Granucci, L. Yeh, P. A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection [see comments]. Science. 279(5355):1344-7.
Zheng, X., M. E. Marquart, J. M. Loustch, P. Shah, B. Sainz, A. Ray, R. J. O'Callaghan, H. E. Kaufman, and J. M. Hill. 1999. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. Invest Ophthalmol Vis Sci. 40(11):2490-7.
Zheng, X., M. Yamaguchi, T. Goto, S. Okamoto, and Y. Ohashi. 2000. Experimental corneal endotheliitis in rabbit. Invest Ophthalmol Vis Sci. 41(2):377-85.
Zhi, Y., K. S. Sciabica, and R. M. Sandri-Goldin. 1999. Self-interaction of the herpes simplex virus type 1 regulatory protein ICP27. Virology. 257(2):341-51.
Zhi, Y., and R. M. Sandri-Goldin. 1999. Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J Virol. 73(4):3246-57.
Zhong, F., S. L. Swendeman, W. Popik, P. M. Pitha, and M. Sheffery. 1994. Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV-1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. J Biol Chem. 269(33):21269-76.
Zhong, L., and G. S. Hayward. 1997. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays. J Virol. 71(4):3146-60.
Zhou, Z. H., J. He, J. Jakana, J. D. Tatman, F. J. Rixon, and W. Chiu. 1995. Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids. Nat Struct Biol. 2(11):1026-30.
Zhou, Z. H., S. J. Macnab, J. Jakana, L. R. Scott, W. Chiu, and F. J. Rixon. 1998. Identification of the sites of interaction between the scaffold and outer shell in herpes simplex virus-1 capsids by difference electron imaging. Proc Natl Acad Sci U S A. 95(6):2778-83.
Zhou, Z. H., D. H. Chen, J. Jakana, F. J. Rixon, and W. Chiu. 1999. Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J Virol. 73(4):3210-8.
Zhu, X. X., A. G. Papavassiliou, H. G. Stunnenburg, and S. Silverstein. 1991. Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells. Virology. 184(1):67-78.
Zhu, X. X., J. X. Chen, and S. Silverstein. 1991. Isolation and characterization of a functional cDNA encoding ICP0 from herpes simplex virus type 1. J Virol. 65(2):957-60.
Zhu, Z., W. Cai, and P. A. Schaffer. 1994. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J Virol. 68(5):3027-40.
Zhu, Z., and P. A. Schaffer. 1995. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27. J Virol. 69(1):49-59.
Zhu, J., W. Kang, M. E. Marquart, J. M. Hill, X. Zheng, T. M. Block, and N. W. Fraser. 1999. Identification of a novel 0.7-kb polyadenylated transcript in the LAT promoter region of HSV-1 that is strain specific and may contribute to virulence. Virology. 265(2):296-307.
Ziaie, Z., J. M. Brinker, and N. A. Kefalides. 1994. Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells. Lab Invest. 70(1):29-38.
Ziemann, K., T. C. Mettenleiter, and W. Fuchs. 1998. Gene arrangement within the unique long genome region of infectious laryngotracheitis virus is distinct from that of other alphaherpesviruses. J Virol. 72(1):847-52.
Zimmermann, J., and W. Hammerschmidt. 1995. Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J Virol. 69(5):3147-55.
Zipser, D., L. Lipsich, and J. Kwoh. 1981. Mapping functional domains in the promoter region of the herpes thymidine kinase gene. Proc Natl Acad Sci U S A. 78(10):6276-80.
Zsak, L., Z. Lu, G. F. Kutish, J. G. Neilan, and D. L. Rock. 1996. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene. J Virol. 70(12):8865-71.
Zvonarev, A., K. Shatalin, V. I. Klichko, E. V. Karaseva, and M. N. Kuliakina. 1994. [The production of recombinant polypeptides from the herpes simplex viruses types 1 and 2]. Vopr Virusol. 39(3):110-3.
Zwaagstra, J. C., H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1991. Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology. 182(1):287-97.